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Abstract 
 
This dissertation includes two publications and one chapter of so far unpublished 
material investigating the neuroprotective potential and mechanisms of umbilical cord 
blood and stem cell fractions thereof. In direct and indirect co-cultures of cord blood 
cells under investigation with hypoxically damaged neuronal cells or oxygen and 
glucose deprived rat hippocampal slice cultures apoptosis, necrosis, soluble 
mediators, and adhesion molecules were analyzed.  
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2 Introduction 
 
2.1 The mononuclear fraction of human umbilical cord blood as a 
source of adult stem and progenitor cells for cell based 
regenerative therapies 
In laboratories all over the world scientists have been working on the characterization 
and utilization of stem and progenitor cells for regenerative cell-based therapies of 
oncologic, immunologic and degenerative diseases. The term “stem cells” defines a 
special type of cells that are distinguished from other kind of cells by mainly three 
important characteristics: i) they are immature, not specialized cells ii) they have the 
ability to renew themselves indefinitely through numerous cell divisions while 
maintaining the undifferentiated state and iii) they are capable of becoming tissue- or 
organ- specific cells, highly specialized in function and structure.  
In mammals there are three types of stem cells: germinal, embryonic, and somatic 
stem cells, whereas the latter are also known as adult, foetal or tissue- derived stem 
cells. Those three major types of stem cells are characterized by different degrees of 
linage potential varying from the totipotency of zygotes to the pluripotency of 
embryonic cells and to the multipotentiality of adult stem cells.  
For the purpose of regenerative cell therapies embryonic and adult stem cells are of 
special interest. Embryonic stem cells originating from the inner cell mass of the 
blastocyst, proliferate by symmetric cell division. Other than adult stem cells 
embryonic stem cells can be kept in in vitro cultures for more than a year without 
differentiation and are than referred as embryonic stem cell lines (Pal et al., 2009; 
Irion et al., 2009). In general stem cells only rarely divide. Division needs appropriate 
external stimuli given by chemical and physical signals in the microenvironment of 
the cells. 
In some adult tissues, such as bone marrow, muscle and brain discrete numbers of 
adult stem cells reside in so called stem cell niches. Their primary role is to ensure 
maintenance of tissue characteristics by generation of replacement for tissue that got 
lost in the normal tissue turn over, by injury or by disease (Serakinci et al., 2006). 
Research on adult stem cells began in the 1950s when it was discovered that bone 
marrow contains two types of stem cells; mesenchymal- and hematopoietic stem 
cells. Hematopoietic stem cell populations which are also found in human umbilical 
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cord blood (HUCB) can give rise to all types of blood cells and also non-
hematopoietic neural, cardiac, epithelial, hepatocytic, and dermal tissue (van de Ven 
et al., 2007; Rogers et al., 2007, Jay et al., 2004). 
Given the unique potentials the adult stem and progenitor cells of HUCB they are a 
remarkable alternative to the controversial use of embryonic stem cells since those 
are obtained from fertilized eggs of four to five days old embryos, although those 
eggs have been given to the research as a donation.  
HUCB stem cells can be obtained non-invasively from the umbilical cord, a waste 
product after birth. Therefore, there are no ethical concerns and no legal restrictions 
comparable to the concerns of isolation and utilization of embryonic stem cells. In 
addition, there is no known risk of developing malignancy. Also when compared to 
other sources of adult stem cells and progenitor cells HUCB and HUCB stem cells 
offer some remarkable advantages: they are proven to have a low virus 
contamination (Frey et al., 2009), strong homing capabilities (Rosenkranz et al., 
2010) and long term storability (Sullivan et al., 2008). The low risk of a graft versus 
host reaction due to immature T cells producing only low amounts of activating 
cytokines (Rioradan et al., 2007) and a low amount of natural killer cells in the 
lymphoid fraction of umbilical cord blood (Garderet et al., 1998) adds to the 
advantages of the use of umbilical cord blood cells. The successful and safe 
utilization of the potential HUCB stem cells has been impressively shown in about 
15.000 cord blood transplantations in hematopoietic, cardiovascular and neurologic 
diseases performed since 1988 (Frey et al., 2009).  
 
2.2 The neural plasticity of adult progenitor and stem cells of 
human umbilical cord blood 
Human umbilical cord blood is rich in adult stem and progenitor cells, capable to 
differentiate in hematopoietic cell lines. Hematopoietic progenitor cells contain colony 
forming units (CFU) for granulocytes and macrophages (CFU-GM), erythroide cells 
(BFU-E), granulocyte-erythroide-macrophage-megacaryocyte (CFU-GEMM) as well 
as myeloid-lymphoid initiating cells (LTC-ICs) and therefore are the origins of all 
blood cell lines (Broxmeyer et al., 2006). According to the standard protocol of the 
International Society of Hematotherapy and Graft Engineering (ISHAGE) 
hematopoietic human umbilical cord blood cells represent one percent of the 
mononuclear cell fraction (MNC) of HUCB. In 1995 the ISHAGE Stem Cell 
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Enumeration Committee characterised stem cells by the expression of the surface 
markers CD (cluster of differentiation) 133/CD45 and CD34/CD45 as well as by a 
specific size and granularity shown by a characteristic deflection of the laser beam in 
the flow cytometer (Sutherland et a., 1996). Depending on the frequency of those 
markers a distinction is made between CD133+/CD34-, CD133+/CD34+ and CD133-
/CD34+ phenotypes which are characterised by decreasing pluripotency (Yin et al.; 
1997 and Pranke et al., 2001). In addition to mesodermal hematopoiesis it has been 
shown that HUCB stem cells can give rise to non-hematopoietic ectodermal tissue by 
crossing linage borders (Seidel et al., 2003).  
For regenerative medical therapies the mononuclear fraction of human umbilical cord 
blood (HUCB-MNC) as well as HUCB stem cells are of major interest, since both 
fractions can be differentiated into cells showing neuronal characteristics. MNC were 
shown to express the neuronal markers Musashi-1 and TUJ-1 and the astrocytic 
marker glial fibrillary acidic protein (GFAP) and there is transcription of nestin under 
the influence of retinoic acid and neuronal growth factor (Sanchez-Ramos et al., 
2001). Cultivated with beta-mercaptoethanol HUCB-MNC develop a neuronal 
phenotype characterized by the expression of the markers NeuN, neurofilament and 
GFAP as well as by the transcription of the MAP2 and the nestin gene (Ha et el., 
2001). 
If retinoic acid, a vitamin D derivate being a significant factor in the neuronal 
ontogenesis of vertebrates, is added to CD 133+/CD45+ cells, cultures express the 
neuronal markers beta III tubulin, neuronal specific enolase, neurofilament M and H, 
microtubuli assoziated protein 2, neuronal nuclei (NeuN), astrozytic marker (GFAP), 
and oligodendrozytic markers (myelin-basic protein [MBP], cyclic nucleotid 
phosphodiesterase [CNPase]) (Jang et al., 2004; Baal et al., 2004). The 
CD34+/CD45+ stem cell fraction also showed markers of early neurogenesis like 
neuronal nestin, MAP 2, beta III tubulin and astrocytic GFAP, and, oligodentrcytic 
galactocerebroside (Gal-C) in presence of retinoic acid and the neurotropin brain-
derived neurotrophic factor (BDNF) (Buzanska et al., 2002). 
That linage crossing differentiation into cells showing ectodermal characteristics 
makes HUCB-MNC and HUCBC highly promising tools for the treatment of central 
nervous system diseases. This is particularly valuable for neuronal disorders 
accompanied with cell loss since there is currently only symptomatic treatment but no 
cure available.  
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2.3 The ischemic stroke 
The brain is one of the most central organs of the body. It controls and coordinates 
fundamental life keeping functions and regulates the complex behavior of human 
beings. Malfunction of the brain can cause very severe diseases and lasting 
disabilities.  
Stroke, a medical emergency, is caused by critical decrease in blood supply of the 
brain. Depending on whether there is an obstruction or a disruption of a blood vessel 
leading to an acute circulatory disturbance or to bleeding in the brain, a distinction is 
drawn between an ischemic stroke and a hemorrhagic stroke occurring in 85% or 10-
15%, respectively. Causes for an ischemic stroke include thromboembolic, 
microangiophatic and hemodynamic mechanisms.  
After cardiovascular diseases and cancer, stroke is the third leading cause of death 
and the most common reason for disabilities in adulthood (Kolominsky-Rabas et al., 
2006). Stroke is the most common acute disease of the brain and a reason for 
degradation of quality of life in adulthood in industrialized countries (Mäkinen et al., 
2006 and European Stroke Organisation). For e.g. in the US every 40 seconds a 
person sustains a brain stroke which accumulates to about 795,000 new or 
reoccurring strokes per year (Lloyd-Jones et al., 2008) (Heart Disease and Stroke 
Statistics 2009 Update Circulation. 2009 Jan 27;119(3):e21-181. Epub 2008 Dec 15). 
In Germany too brain stroke is one of the most commonly occurring severe diseases. 
As per the last available statistics since 2006, with 65,133 incidents, stroke ranks at 
third position.  
To maintain the functional- and structural metabolism of brain tissue an optimal 
supply of oxygen and glucose is crucial since regular brain function is dependent on 
degradation of glucose. Oxygen being essential for the strictly aerobic degradation of 
glucose is permanently delivered by blood flow. Under normal conditions the brain, 
not having the ability to store oxygen and glucose, withdraws 30-40% of oxygen and 
2-5% of glucose from the blood.  
The consequences of constrained blood supplies depend on the degree of the 
insufficiency in blood supply and the duration of ischemia. Data from experimental 
total ischemia show that as early as a few seconds after a blood supply reduction to 
50 percent of the normal average cerebral blood flow (CRF, 0.8ml/g/min, in humans) 
clinical symptoms occur. No free oxygen can be measured after two to eight seconds 
of anoxia. Loss of consciousness appears after 12 seconds and after 30 seconds no 
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electric activity is measurable in the electroencephalogram. If anoxia continues for 
three to four minutes it results in an irreversible damage of the brain tissue. Finally, 
nine minutes of anoxia cannot be survived except under hypothermic conditions 
(Hartmann, Der Schlaganfall, 2001). In 1993 Gomez epitomized the sensitivity of 
brain tissue against reduced oxygen partial pressure in the sentence “Time is brain” 
(Gomez, 1993). His assertion was impressively underlined by a meta analysis 
investigating the average time of the development and the size of an average stroke. 
According to this study an average stroke with a size of 54 millimeters (19-100 ml) 
leads within an average time of ten hours (6-18 hours) to the death of 1.9 millions 
neurons and 14 billions synapses and to a destruction of twelve kilometers of 
myelinated nerve fibers per minute (Eschenfelder et al., 2006; Saver JL, 2006).  
The severity of insufficient circulation is also a crucial factor for the development of 
the damage. Based on early findings made by Opitz et al. describing a sequential 
correlation between the severity of a hypoxia and energy consuming processes in the 
brain, Symon et al. postulated a concept of two viability thresholds of ischemia (Opitz 
et al.,1950; Symon et al.,1977). The essence of the work is the definition of two 
critical CBF thresholds at which the electrical and structural integrity of the cell 
membrane can not be maintained anymore (also see paragraph 2.4). This concept 
also describes that the more complex functions of the brain are the more sensitive in 
their tolerance against reduction of oxygen. In addition to this correlation to 
complexity a cell type relation is included. It has been shown that CA-1 neurons of 
the hippocampus exhibit a strong sensitivity against oxygen deficiency. Neurons 
forming the basal ganglions and neurons of the cortex are very sensitive as well while 
glial cells and the blood vessel endothelium tolerate reduced oxygen supply best 
(Banasiak et al., 2000).  
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2.4 The relationship between the severity of reduction in oxygen 
supply and neuronal cell death and the concept of a penumbra 
The above mentioned concept of two viability thresholds defines two critical blood 
flow rates impairing function of neuronal cells as electrical or membrane failure. 
Those blood flow thresholds define lower and upper CBF limits beyond which brain 
tissue is destroyed or not harmed. Beyond the lower threshold, at a blood circulation 
of <0.1ml/g/min content of tissue oxygen and glucose tend towards zero (Endres and 
Dirnagl, 2002; Kaufmann et al., 1999). 
The concomitant lack of substrates switches the cell metabolism to anaerobic 
glycolysis leading to an energy crises through high consumption of glucose by 
generating a very reduced amount of ATP. Lactic acid produced in this metabolic 
state increases the permeability of the cell membrane and leads to an intracellular 
accumulation of potassium and calcium concentrations. Resulting anoxic 
depolarization of the cell membranes leads to collapse of intra- and extra cellular ion 
gradients accompanied by release of excitatory and inhibitory amino acids e.g. 
glutamate. By activation of glutamate-dependent calcium channels those high 
concentrations of glutamate support the influx of calcium. Calcium toxicity activates 
enzymes of osmolysis, lypolysis and proteolyses irreversibly leading to the death of 
cells, called necrosis (Siesjo, 1992). Necrotic intracellular processes include 
collapsing of the respiratory chain of mitochondria and therefore loss of cellular 
energy and lysis of the cell. Those lytic processes inevitably lead to the loss of the 
cell membrane and therefore to the release of disintegrated intracellular proteins and 
nucleoid acids into the intracellular space (Endres et al., 1997; Eliasson et al., 1997; 
Ferrer, 2006). That inflammatory milieu activates microglia and macrophages to 
phagocyte the necrotic tissue leaving cystic degenerated brain tissue. The region 
where necrosis happens is called the necrotic core of the infarction. 
Intercalated between the necrotic core and the not impaired regularly supplied brain 
tissue lies a rim of tissue that, according to the bright areas of the moon during a total 
eclipse, was named penumbra and since then has been a standard term of the 
medical language (Astrup et al.,1981). The ischemic penumbra is characterized by 
significant CBF threshold of 0.2 to 0.4 ml/g/min (Endres and Dirnagl, 2002; Kaufmann 
et al., 1999). Characteristic for that level of hypoperfusion neurons are not being able 
to maintain electrical activity but are able to preserve function of their ion channels 
and structural integrity (Ferrer, 2006). However, without restoration of blood flow the 
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singular status of the penumbra can not be maintained for more then 6-12 hours. 
This is attributable to an expansion of the ischemic core consuming the penumbra 
tissue. This is due to repeated peri-infarct depolarisations caused by glutamate 
massively released from the ischemic core.  
The extensive surplus of glutamate leads to an over stimulation of ionotrophic 
glutamate receptors and therefore to massive influx of calcium ions inhibiting 
generation of ATP in the mitochondria. In the area of tension caused by 
hyperexcitation and 
simultaneous reduced supply 
of ATP apoptotic cascades 
are activated (Ferrer, 2006). 
Without restoration of oxygen 
supply apoptotic signal 
cascades will consequently 
lead to degradation of nucleic 
acids and therefore to 
unavoidable death of the cells 
within the penumbra. 
However, the reversible 
character of those cascades 
also allows interruption of the 
signal transduction making the penumbra tissue a unique target to medical 
interventions aiming to preserve as much brain tissue as possible. 
Figure 1. Chronological succession of multiple damaging 
events in focal ischemia leading to apoptosis  
Restriction of blood flow to the brain as it occurs in focal 
ischemic stroke leads to insufficient supply of oxygen and 
glucose on which brain tissue is dependent on to maintain 
cellular homeostasis. Resulting pathophysiological processes 
including excitotoxicity, acidotoxicity, ionic imbalance, peri-
infarct depolarization, oxidative stress, and inflammation 
happening in a time frame lead to the apoptotic cell death of 
neurons, glia and endothelial cells,Diagram by Endres and 
Dirnagl, 2002. 
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2.5 The acute treatment of the ischemic stroke 
Since autumn 2004, recombinant tissue plasminogen activator (r-tPA) has been the 
approved gold standard for the acute treatment of ischemic stroke. However, the 
application of r-tPA is strictly limited to highly specialized intensive care wards, so 
called stroke units. Thrombolyzation by r-tPA allows a rapid revascularisation and is 
therefore strictly limited only for patients suffering from embolic strokes confirmed by 
exclusion of intracranial bleeding using imaging techniques (Klijn et al., 2003). R-tPA 
treatment is also clearly limited through a narrow time window: It is only approved for 
for use within three hours of onset of the first stroke symptoms (Toni et al., 2005) and 
optimal results can be achived if given within 90 minutes after stroke onset (Hacke et 
al., 2004). In fact, due to this narrow time window and due to contradictions in the use 
of r-tPA, this treatment is only avaliable to circa 5% of stroke patients and a treatment 
beyond the time window involves high risk of severe brain hemorrhages since the 
damage of the basal membrane of the endothelia increases with the duration of the 
ischemic condition (Albers et al., 2004). 
Therefore, the challenge for experimental stroke research is to find supplementary 
and less time-dependent therapeutic strategies to the lyzation treatment.  
2.6 Neuroprotection as a concept to limit neurodegradation and 
cellular damage after ischemic stroke  
Beyond acute phase treatment approaches to improve the CBF neuroprotection is in 
the focus of stroke therapy. The term neuroprotection describes every strategy or a 
compilation of strategies aiming to antagonize, to interrupt or to slow down 
destructive processes within the nervous system that would cause irreversible 
damage (Ginsberg et al., 2008). Starting in the late 1990s neuroprotection in stroke 
therapy has gained more and more importance. This is impressively illustrated by 
many scientific publications shown in the NCBI database. Beginning in the year 
1990, 2,314 articles dealing with neuroprotection and stroke/ischemia are listed. 
Beyond tests in animals, progress in the field of neuroprotection can be seen from 
the number of performed clinical trials. In November 2009 there were 160 trials listed 
in the Stroke Trial Registry of Center of Washington University School of Medicine. 
During the rapidly advancing progress in science in the last decade many potential 
strategies have been suggested that could positively influence the pathophysiological 
pathways of acute ischemia. Neuroprotection in this sense stands for interruption of 
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the pathological signal cascades of calcium and glutamate toxicity. In this context the 
scientific research focuses on the single components within a class of substances 
including calcium and sodium blockers, calcium chelating agents, GABA-, AMPA- 
and NMDA antagonists, nitrogen dioxides and inflammation inhibitors. However, 
given the complexity of events occurring during cerebral ischemia it might be elusive 
that single agent trials will demonstrate path-breaking benefits. In the future 
combinational therapies might gain more scientific attention. 
 
2.7 General considerations of the utilization of adult stem cells in 
the treatment of ischemic stroke 
In general adult stem cell therapy for stoke can be divided in an endogenous and an 
exogenous path.  
The ultimate goal of both approaches is to improve functional recovery not only by 
replacement of the infarced tissue in an organotypic manner but also by 
reestablishment of a functional neuronal circuitry supported by a working glial 
network.  
The endogenous approach has become an option since the biological dogma that 
regeneration of brain tissue is not possible has been unequivocally proven wrong 
with the discovery of neurogenic regions in the adult brains of many different 
mammalian species. In fact, neurogenesis occurs in the subventricular zone of the 
lateral ventricle and in a layer between the hilus and the granule cell layer of the 
hippocampal dentate gyrus in human. Additionally, some studies also indicate the 
existence of neurogenesis in the striatum, spinal cord, and neocortex in the adult 
rodent brain (Palmer et al., 1999; Yamamoto et al., 2001; Palmer et al., 1995). 
The discovery that the adult brain is a place of neurogenesis raises the opportunity 
that new born neuronal cells may have the potential to restore neurons and glia in 
brain areas damaged by stroke. In response to ischemic injury there is even a special 
enhancement of neurogenesis. Following global ischemia a more than 10-fold 
amplification of neurogenesis in the hippocampal dentate gyrus and in the 
subventricular zone of the lateral ventricle has been observed up to two weeks, 
although this neurogenesis did not lead to regeneration of pyramidal cells that are 
damaged in global ischemia (Liu et al., 1998; Tonchev et al., 2005). Likewise there is 
a neurogenic response to focal ischemic injury with a peak in proliferation at around 
one to two weeks (Arvidson et al., 2002; Parent at al., 2002). However, to date there 
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has been no convincing evidence that new born cells from the hippocampal dentate 
gyrus ever migrate out to replace lost cells after ischemia. By contrast, neuroblasts 
originating from the subventricular zone of the lateral ventricle have been shown to 
divert from their normal migration route toward the olfactory bulb but instead migrate 
toward the ischemic penumbra (Arvidson et al., 2002; Parent et al., 2002; Jin et al., 
2003b). However, although some migrated cells developed makers of matured 
neuronal cells, in none of those studies a full maturation, long term survival or 
synaptic integration into the cortical neural circuitry could be observed.  
Apparently, endogenic stroke-induced baseline neurogenesis is, also after 
pharmacological stimulation, not sufficient to functional replace lost tissue and might 
need external augmentation to provide a meaningful regeneration. Therefore, focus 
of scientific attention has shifted to transplantation of cells of various cell types. For 
this approach neuronal stem cells, embryonic stem cells as well as bone marrow and 
cord blood-derived stem cells have been employed.  
With the external approach, that not only makes use of the differentiation capacity but 
also of migratory potential of stem cells, come some remarkable advantages: control 
over cell numbers, cells can be pre-differentiated into the desired cells types, cells 
can be administered locally, if applicable and fate of transplanted cells is easier to 
trace since cells can be pre-labeled before administration. But most of all, many 
findings promise an expansion of the narrow therapeutic time window using external 
cell therapies. Bone marrow cells have even been administered a full week after focal 
ischemia and even if the observed benefit might not result from graft-derived tissue it 
argues for other mechanisms then cellular replacement of damaged tissue.  
In the resent years several possible modes of action of transplanted adult stem cells 
have come under intensive discussion: 
i) Systemically administered stem cells might cross the blood brain barrier, migrate 
into the degenerated region and restore the impaired tissue by transdifferentiation 
(Chu et al., 2004, Taguchi et al., 2004) ii) Stem cells might provide trophic factors 
enhance endogenous neurogenesis and stimulate restoration of damaged neuronal 
networks (Chu et al., 2004, Taguchi et al., 2004) iii) Administered stem cells might 
affect micro environmental conditions e.g. by suppression of proinflammatory 
cytokines like TNFα, IL-1ß and IL-2 and therefore enhance conditions for newly 
generated endogenous neuronal cells (Vendrame et al., 2005).  
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2.8 Specific neuroprotection mediated by stem cells of the 
umbilical cord blood in animal models of the ischemic stroke 
In the broadest sense the term neuroprotection also describes recovering of 
neurological functionality based on the ability of stem cells to differentiate across 
tissue linage boundaries. Especially, due to limited endogenous self-repair capacity 
of the brain, cell-based therapies are a highly promising option for the therapeutic 
intervention of stroke and stem cells from HUCB promise a great potential. Based on 
experimental knowledge on biochemical and molecular processes of apoptosis 
gained during the last decades the tissue of the penumbra is considered as a 
valuable target for neuroprotective cellular therapies. 
First indications for a clear reduction of the neuronal loss of function throughout 
transplantation of the mononuclear cell fraction of HUBC have been found in animal 
models of ischemic stroke. The intention to establish animal models is to mimic 
diseases in complex organisms to study pathophysiological reactions and therapeutic 
modes of actions. To create an experimental ischemic stroke that mimics the 
situation in humans a transient or permanent occlusion of the arteria cerebri media 
(MCAO) is performed in various species, predominantly rodents. That way the 
infarced areas occur in the cerebral cortex and in the striatum. Using the MCAO 
model in their pioneering work, Chen et al. were non-recurrently able to show the 
expression of neuronal (NeuN and MAP-2) and astroglial markers (GFAP) on 
intravenously transplanted HUCB-MNC (Chen at al., 2001). In 2004 Vendrame et al. 
showed a dose- dependent relationship between the amount of intravenously 
administered HUCB-MNC and the reduction of infarct volume and improvement of 
behavioral deficits in a rat MCAO model (Vendrame et al., 2004 and Willing et al., 
2003a/b). According to their results a significant reduction of the infarct size was 
reached at doses of 10E+07 HUCB-MNC. Behavioral performance reached 
significant levels after the administration of 10E+06 HUCB-MNC. Based on those 
results Newman et al. showed a targeted migration of transplanted HUCB-MNC 
towards the damaged brain tissue (Newman et al., 2006). Additional to the dose 
dependency a temporal relation was reported by Newcomb et al., 2006. They were 
able to show significant improvements in behavior and a diminished poststroke 
inflammation due to reduced infiltration of granulocytes and monocytes and to 
reduced activation of microglia at 48 hours following MCAO (Newcomb et al., 2006). 
On the basis of proven plasticity of HUCB-MNC in vitro it was originally assumed that 
the observed improvement seen in animal models after cell transplantation was due 
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to a functional recovery of the damaged tissue through cellular replacement by 
differentiated donor cells. However, transdifferentiated donor cells were transient and 
too minor to cause significant improvements in motor functions. A path breaking 
study by Borlongan and co-workers gave a hint that observed impressive 
improvements after HUCB-MNC transplantation might not only be due to 
transdifferentiation of the grafts. They showed that entry of grafted cells into the brain 
is not a prerequisite for acute neuroprotection since therapeutic molecules secreted 
by HUCB-MNC have the ability to cross the blood brain barrier (Borlongan et al., 
2004). The molecular signalling of those therapeutic molecules is assumed to include 
cascades of chemokines, cytokines and integrines and the activation of adhesion 
molecules, though the mode of action in regard to recuing cells within the penumbra 
remains elusive. 
Since the MNC-HUCB fraction is very heterogeneous it seems to be reasonable to 
investigate the capacity of purified or selected stem and progenitor cells.  
Especially since there is a spontaneous increase in the CD45+/CD34+ cell count in 
the peripheral blood after acute cerebral ischemia in humans the investigation of this 
cell type is highly interesting. It could be considered as an insufficient self-repair 
attempt of the body and therefore it seems plausible investigate whether a 
transplantation of CD34+ cells is beneficial after stroke. 
So far there is only one published study that investigated the impact of pure HUCB 
stem or progenitor cells on MCAO animal models of stroke: Application of HUCB-
CD34+ stem cell fraction on immunocompromised MCAO mice showed infract size 
reduction associated with enhanced neurovascularization and stimulated 
endogenous neurogenesis (Taguchi et al., 2004).  
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2.9 Objectives  
 
What we know about stroke-related pathophysiological pathways today has been 
mostly gained from experimental research utilizing rat or mice animal models of focal 
ischemia. That data is of inconsiderable value to understand the impact of stroke not 
only on the brain but also on other organ systems. Complexity of metabolic, electric, 
and immunologic stroke-induced cascades and the speed of damage development 
contribute to the problem to understand and to treat stroke in a sufficient manner. 
The cell transplantation approach builds upon the complexity of stroke events since 
the transplant is very heterogeneous and complex in itself. The cell culture models 
used in this study therefore focus on the interplay of transplanted HUCB cells and 
hypoxically damaged neuronal cells in reduced but still sufficiently complex 
experimental set ups.  
Using those in vitro approaches this study addresses the following questions: 
 
i) Is administration of enriched stem cell fractions obtained from HUCB more 
beneficial in reduction of levels of apoptosis and necrosis as compared to 
application of unfractioned HUCB-MNC?  
 
To know whether there are stem cell specific anti-apoptotic and/or anti-necrotic 
mechanisms would be groundbreaking for considerations in future clinical 
applications since stem cells are rare and enrichment is an elaborate procedure. If it 
should turn out that pure stem cell fractions are not highly superior to unfractioned 
HUCB-MNC in the treatment of neuronal injury, provision of sufficient cell numbers 
would be less problematic. In this study the neuroprotectional potential of 
unfractioned HUCB-MNC was compared to anti-apoptotic and anti-necrotic potential 
of stem cell containing and stem cell depleted fractions of HUCB. Enrichments and 
depletions of stem cells were achieved by magnetic cell separation methods that 
resulted in highly purified cell fractions. Both stem cell enriched and depleted 
fractions of HUCB were co-cultured with hypoxically damaged neuronal cells 
representing a self-developed cell culture model of neuronal hypoxia based on fully 
differentiated SH-SY5Y cells.  
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ii) Is direct application of HUCB-MNC superior to indirect application of 
HUCB- MNC in regard to levels of neuronal apoptosis and necrosis? 
 
Comparison of direct and indirect application modes allows further insights into 
conceivable modes of action of transplanted cells. This approach is very useful to 
examine whether cell- derived survival signals for neuronal cells are mediated by cell-
cell contacts or as soluble factors. Therefore, intercellular interactions like the 
expression of adhesion molecules were scrutinized along with release of a broad 
range of chemokines and cytokines. Indirect application was performed using cell 
impassable cell culture inserts separating administered HUCB cell fractions from 
hypoxically injured neuronal cells.  
 
iii) To what extent are results gained from the utilized cell culture model of 
hypoxically induced neuronal damage applicable to damage profiles of 
complex nervous tissue? 
 
The self-developed cell culture model of hypoxically damaged neuronal cells has 
proved to be very useful to investigate interactions between transplanted cell 
fractions and injured neuronal cells. The present study investigates whether findings 
made in this model apply to hypoxically injured organotypic rat hippocampal slices, 
which comprise all neural cell types in a complex three- dimensional network. Focus 
on alterations in necrotic cell death and in migration behavior of cellular fractions 
within HUCB-MNC. 
 
The following chapters include publications that examine and discuss the above 
mentioned questions in detail.  
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3 Preface to Chapter 1 
 
Utilization of animal models of stroke are highly suitable to investigate effects of cell 
transplantation on complex parameter like sensorimotor and cognitive functions and 
histological outcome of the subjected animals. However, to learn more about the 
therapeutically capacity and underlying mechanisms reduction of complexity seems 
to be reasonable. The following chapter introduces a human in vitro model of 
neuronal hypoxia consisting of fully differentiated vulnerable SH-SY5Y cells 
undergoing apoptosis and necrosis in the post-hypoxic state.  
The progression of apoptosis and necrosis was investigated after HUCB had been 
added. Special respect was drawn to graft secreted (soluble) factors and expression 
of adhesion molecules on target cells. 
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4.1 Abstract 
 
Background: One of the most promising options for treatment of stroke using adult 
stem cells are human umbilical cord blood (HUCB) cells that were already approved 
for therapeutic efficacy in vivo. However, complexity of animal models has thus far 
limited the understanding of beneficial cellular mechanisms. To address the influence 
of HUCB cells on neuronal tissue after stroke we established and employed a human 
in vitro model of neuronal hypoxia using fully differentiated vulnerable SH-SY5Y cells. 
These cells were incubated under an oxygen-reduced atmosphere (O2 < 1%) for 48 
hours. Subsequently, HUCB mononuclear cells (MNC) were added to post-hypoxic 
neuronal cultures. These cultures were characterized regarding to the development 
of apoptosis and necrosis over three days. Based on this we investigated the 
therapeutic influence of HUCB MNC on the progression of apoptotic cell death. The 
impact of HUCB cells and hypoxia on secretion of neuroprotective and inflammatory 
cytokines, chemokines and expression of adhesion molecules was proved. 
Results: Hypoxic cultivation of neurons initially induced a rate of 26% ± 13% of 
apoptosis. Hypoxia also caused an enhanced expression of Caspase-3 and cleaved 
poly(ADP-ribose)polymerase (PARP). Necrosis was only detected in low amounts. 
Within the next three days rate of apoptosis in untreated hypoxic cultures cumulated 
to 85% ± 11% (p ≤ 0.001). Specific cytokine (VEGF) patterns also suggest anti-
apoptotic strategies of neuronal cells. Remarkably, the administration of MNC 
showed a noticeable reduction of apoptosis rates to levels of normoxic control 
cultures (7% ± 3%; p ≤ 0.001). In parallel, clustering of administered MNC next to 
axons and somata of neuronal cells was observed. Furthermore, MNC caused a 
pronounced increase of chemokines (CCL5; CCL3 and CXCL10).  
Conclusions: We established an in vitro model of neuronal hypoxia that affords the 
possibility to investigate both, apoptotic neuronal cell death and neuroprotective 
therapies. Here we employed the therapeutic model to study neuroprotective 
properties of HUCB cells. 
We hypothesize that the neuroprotective effect of MNC was due to anti-apoptotic 
mechanisms related to direct cell-cell contacts with injured neuronal cells and distinct 
changes in neuroprotective, inflammatory cytokines as well as to the upregulation of 
chemokines within the co-cultures. 
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4.2 Background 
 
Acute ischemic stroke is characterised by the immediate depletion of oxygen and 
glucose in brain tissue. A residual cerebral blood flow (CBF) of ≤ 6 cm³ x 100g-1 x 
min-1 representing severe ischemia is associated with a nearly total loss of energy on 
vulnerable neurons. Ischemia therefore rapidly culminates in the formation of a 
necrotic core [Kaufmann et al., 1999]. In the penumbra, mild ischemia (CBF 11-20 
cm³ x 100g-1 x min-1) leads to the activation of complex neurochemical cascades of 
cell death, mainly apoptosis. In principle these apoptotic cascades are reversible and 
form an important aspect of the penumbra concept, which is the major target of 
therapeutic interventions [Kato et al., 1999; Saito et al., 2005]. Recent findings 
indicate that transplantation of external cell fractions could accompany established 
therapeutic procedures limited by narrow time windows [Newcomb et al., 2006], but 
the underlying processes are still rather unclear. 
Our insights into pathophysiological processes and new therapeutic strategies have 
mostly been obtained from animal models of focal cerebral ischemia [Ahmed et al., 
2000; Mergenthaler et al., 2004] and rodent organotypic hippocampal slice cultures 
[Lewczuk et al., 2000; Laskowski et al., 2005; Choi et al., 2007]. However, the 
complexity of those systems has limited the detailed understanding of mechanisms 
related to ischemic brain injury [Traystman et el., 2003] and possible interfering 
effects of cellular therapies [Haas et al., 2005] so far. Furthermore, results obtained 
from rodent models are not completely and unobjectionably transferable to human 
therapy [Heiss, 2002; Heiss et al., 2003]. Consequently, experimental expenditure 
and ethical considerations demand in vitro models representing the main properties 
of stroke-related processes as neuronal apoptosis to accompany more complex 
model systems. This would allow answering explicit questions concerning the role of 
cell-cell interactions and production of metabolites to verify observations made in in 
vivo models. It furthermore offers the possibility to precisely manipulate extra cellular 
environments. 
Well described human neuronal cell lines exhibit a multitude of characteristics of 
typical central-nervous-system (CNS) neurons, overall cell material can be achieved 
in large quantities. Therefore, human neuronal cell lines, such as the teratocarcinoma 
NT-2 cell line, became useful tools to study the effects of hypoxic conditions on 
neurons [Rootwelt et al., 1998]. However, the utilisation of NT-2 neuronal cultures is 
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restricted by time-consuming and expensive differentiation periods of up to 44-54 
days [Paquet-Durand et al., 2003; Pleasure et al., 1992] that are also sensitive to 
environmental disturbances. In contrast, the SH-SY5Y neuroblastoma cell line was 
shown to be differentiated into neuronal cells within a comparatively short time of 16 
days [Encinas et al., 2000]. Furthermore, the cell line fits major relevant criteria (high 
vulnerability, irreversible differentiation into pure neuronal cells) to serve as a model 
of hypoxic injury of central neurons [Lopez et al., 2000]. Hence, our exclusive human 
model of neuronal hypoxia forms the basis to identify possible anti-apoptotic 
neuroprotective potentials of therapeutic supplements. Mononuclear cells (MNC) 
from human umbilical cord blood (HUCB) were shown to improve functional outcome 
of animals after focal cerebral ischemia. The cellular effects causing the observed 
benefits are not fully understood for these cells [Chen et al., 2006; Vendrame et al., 
2004]. In this context we investigated whether injured post-hypoxic neuronal cells or 
MNC initiated an anti-apoptotic response mediated by cytokines or chemokines. 
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4.3 Methods 
 
4.3.1 Cultivation and differentiation of neuronal cells 
All experiments were performed using SH-SY5Y human neuroblastoma cells (DSMZ, 
German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) 
between passages 4-7. The common medium was Dulbecco's Modified Eagle 
Medium (DMEM, high glucose 4.5 g/l, L-Glutamine 580 mg/l; PAA, Pasching, Austria) 
with penicillin G (10,000 U/ml; PAA Laboratories, Pasching, Austria) and 
streptomycin (10 mg/ml; PAA Laboratories, Pasching, Austria]. Cells were maintained 
in MM in a humidified atmosphere with 5.5% CO2 at 37 °C (Table 1). When cultures 
achieved subconfluence, cells were subcultured with trypsin/EDTA (PAA 
Laboratories, Pasching, Austria). Differentiation was carried out according to the 
protocol of Encinas and colleagues [17] but was adapted as follows: cells were plated 
at an initial density of 0.9x104/cm² in 16-mm-diameter cavity (Greiner Bio-One, 
Frickenhausen, Germany) and differentiated over a period of 16 days in relevant 
media and cultured thereafter according to Table 1. Cultivation procedure is 
illustrated by Fig. 1. 
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Table 1  - Composition of culture media 
supplements in DMEM  
day of 
culture 
 
culture 
condition
 
description of 
media FCS (15%)
RA 
(10 µM)
BDNF 
(5 ng/ml) 
HSA 
(0.1%) 
Ham`s 
F12 
seeding normoxia maintenance medium (MM) x - - - - 
1 - 4 normoxia basic medium (BM) x x - - - 
5 - 16 normoxia differentiation medium (DM) - x x x x 
16 - 18 normoxia / hypoxia 
differentiation 
medium (DM) - x x x x 
18 - 21 normoxia post-hypoxic medium (PHM) - - x x x 
 
The experimental design demanded varying culture media. Supplements in DMEM were purchased 
from: fetal calf serum (FCS, PAN-Biotech, Aidenbach, Germany), all-trans-retinoic acid (RA, Sigma-
Aldrich, Steinheim, Germany), recombinant brain-derived neurotrophic factor (rhBDNF; ImmunoTools, 
Friesoythe, Germany), human serum albumin (HSA, PAN Biotech, Aidenbach, Germany). 
 
4.3.2 Immunocytofluorescence of neuronal markers 
The primary antibodies used against neuronal epitopes were: ß-tubulin III (rabbit 10 
µg/ml; BD PharMingen, Heidelberg, Germany), taurin I and neurofilament (NF) H/M 
(rabbit 5 µg/ml and mouse 1:200; Chemicon, Hampshire, UK), neuron-specific 
enolase (NSE) and microtubule-associated proteins (Map) 2a/b (mouse 1:2 and 
mouse 5 µg/ml; Sigma-Aldrich, Munich, Germany). Fluorochrome-conjugated 
secondary antibodies were purchased from DAKO, Carpinteria, CA, USA (goat anti-
mouse-PE [1:200] and pork anti-rabbit-FITC [1:30]). Indirect immunostaining was 
processed according to manufacturer’s instructions. 
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4.3.3 Hypoxia and post-hypoxic cultivation 
Before enddifferentiated neuronal cells were exposed to hypoxia they were refreshed 
with DM. Hypoxic conditions were O2 < 1% (oxygen substituted with nitrogen) and 
lasted 48 hours in a 37 °C tempered and humidified incubator (Binder GmbH, 
Tuttlingen). After hypoxia, cultures were supplied with PHM (Table 1) and were 
transferred back to normoxic conditions for the following three days (Fig. 1). 
 
 
Figure 1 - Schematic illustration of experimental set up  
Sixteen days of differentiation were followed by 48 hours cultivation under hypoxic conditions. 
Following hypoxia cultures were maintained under normoxic conditions for three days and are referred 
as post-hypoxic. Subsequently, cultures were analysed daily. 
 
4.3.4 Quantification of cell numbers by nuclear staining 
The total number of cells was measured by nuclear staining with 4', 6-diamidino-2-
phenylindole (DAPI, Invitrogen, Karlsruhe, Germany). Cells were washed and stained 
with 1 μg/ml (DAPI/Methanol) for 15 minutes at 37 °C. 25 microphotographs of 
randomised fields were taken per cavity using a Zeiss fluorescence microscope (Carl 
Zeiss AG, Jena, Germany) equipped with Zeiss AxioVision-Software. The number of 
nuclei was automatically determined by means of Zeiss AutMess (Carl Zeiss AG, 
Jena, Germany).  
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4.3.5 Cell viability assay 
Apoptosis was determined via annexin-fluorescein isothiocyanate (FITC) or annexin-
phycoerythrin (PE; both 1:20 reaction buffer; BD PharMingen, Heidelberg, Germany) 
using fluorescence microscopy. Necrosis was identified by propidium iodide (PI) 
staining (1 µg/ml phosphate-buffered saline [PBS]; Bender medSystems, Vienna, 
Austria). Both methods detect cells in a late state of apoptosis. Apoptosis and 
necrosis were ascertained in different cavities. Calcein-AM (40 µM/PBS; Invitrogen, 
Karlsruhe, Germany) was utilised for detection of living cells. 
 
4.3.6 Quantification of apoptotic proteins 
BD Cytometric Bead Array for human apoptosis (Becton Dickinson, Erembodegem, 
Belgium) was used for the quantitative measurement of apoptotic proteins (cleaved 
PARP and Caspase-3). Manufacturer’s instructions were adapted to lyse cells 
directly within multi-well plates. For cell lyses differentiated cells were rinsed with 
PBS and incubated on ice in the provided buffer for 20 minutes. 
 
4.3.7 Determination of adhesion molecules by immunocytochemistry 
and cell-based fluorescence measurement 
The cultures were stained with antibodies against CD56-phycoerythrin (PE; NCAM), 
CD171 (L1, both Becton Dickinson, Erembodegem, Belgium), CD54-PE (ICAM-1; 
Immunotech, Hamburg, Germany) and CD106-PE (VCAM-1; Southern Biotech, 
Birmingham, Alabama, USA) in order to investigate the distribution and localisation of 
adhesion molecules on differentiated neuronal cells. The staining protocol proceeded 
as follows: Medium (DM, Table 1) was removed and dishes were washed twice with 
PBS. The cells were incubated with primary labelled or unlabelled antibodies (1:100) 
for 10 minutes at 37 °C and afterwards washed in PBS. Thereafter the cells were 
incubated with goat anti-mouse-PE (DAKO, Hamburg, Germany) antibody for 10 
minutes at 37 °C for CD171 detection. After labelling the cultures were immersed in 
PBS. 
The spatial distribution of adhesion molecules was observed using fluorescence 
microscopy (Carl Zeiss AG, Jena, Germany). The density of molecule expression 
was measured in cell lysates. Therefore, antibody-labelled cultures were treated with 
1% Triton X 100 (Ferak, Berlin, Germany)/PBS at 37 °C. Whole-cell lysates were 
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transferred to black 96-well-plates (Greiner Bio-One, Frickenhausen, Germany). PE-
fluorescence signals were determined with a spectrafluorometer (Tecan Spectrafluor 
Plus, Tecan Trading AG, Switzerland) at an excitation wavelength of 488 nm and an 
emission wavelength of 590 nm. Specific isotypes and 1% Triton X 100 served as 
negative controls. 
 
4.3.8 Preparation of Human Umbilical Cord Blood (HUCB) samples  
Cord blood samples were obtained anonymously in accordance to ethical prescripts 
immediately after delivery. HUCB samples of healthy full-term neonates were 
processed according experienced methods including density gradient separation 
using Lymphocyte Separation Medium (PAA Laboratories, Cölbe, Germany). Gained 
MNC fraction was stored by freezing in the gaseous phase of liquid nitrogen after the 
addition of FCS/8% dimethyl sulfoxide (Serumwerke Bernburg Inc., Bernburg, 
Germany). Prior to use cryopreserved MNC were thawed rapidly in 75U/ml 
DNaseI/0.5M MgCl2 (Roche Diagnostics GmbH, Mannheim, Germany/ Sigma, 
Germany) and washed in RPMI (PAA Laboratories, Austria). Cell suspension was 
stained with carboxy fluoresceindiacetate succinimidyl ester (CFSE 5µM; Molecular 
Probes, Inc., Eugene, OR, USA) for 10 minutes at 37 °C. 
 
4.3.9 Co-culture of neuronal cells and MNC 
Direct co-culturing of fully differentiated neuronal cells and MNC was carried out 
under normoxic conditions (37 °C) over a period of 3 days following 48 hours of 
hypoxia. A total amount of 4.5x105 CFSE stained MNC were dissolved in 500µl PHM 
and were added to the post-hypoxic neuronal cells (0.3x105/cavity). The ratio of 
neuronal cells to MNC was 1:15. 
 
4.3.10 Cytokine profiling 
The supernatants from normoxic cultures on Day 21 as well as from hypoxic cultures 
on Day 3 post-hypoxia were collected in order to characterise soluble factors 
produced by cultured cells. They were detected simultaneously by means of Becton 
Dickinson Cytometric Bead Array. Supernatants were tested for neuroprotective 
(Granulocyte Colony-Stimulating Factor [G-CSF], Vascular Endothelial Growth Factor 
[VEGF]) and inflammatory cytokines (Interleukin [IL]-1ß, IL-6, CXCL8) as well as 
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chemokines (CXCL10, CCL3, CCL4, CCL5, CCL2). The detection limit was 0.02 
ng/ml, except for VEGF and CCL2 (0.04 ng/ml). 
 
4.3.11 Statistical analyses of data 
Except for apoptosis and necrosis rates all results have been reported as mean 
values ± SD. Statistical differences were analysed by the Student’s t-test or the 
Mann-Whitney rank sum-test. P values of ≤ 0.05 were considered statistically 
significant (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). Apoptosis and necrosis rates were 
logit-transformed to obtain normally distributed quantities. The effects of time, 
experimental setting (hypoxia), experimental run and the investigated cavity were 
determined univariately, and, finally multivariately using a mixed-model approach with 
time and experimental setting as fixed effects and cavity and experimental run as 
random effects. Cytokine concentrations were compared between the normoxic and 
the hypoxic group by means of the Mann-Whitney rank sum test. Cytokine 
concentrations measured in co-cultures were compared with the sum of the 
concentrations obtained in the post-hypoxic neuronal cultures and in the MNC mono-
cultures via a bootstrapping algorithm. This was performed by resampling and by the 
addition of concentrations of cytokines measured in post-hypoxic neuronal cultures 
and MNC mono- cultures. Results were compared with the Mann-Whitney rank sum 
test. The mean and standard deviations of the sum of the concentrations were also 
determined by bootstrapping. Bootstrapping analysis was performed using the 
statistical software package “R” [The R Project for Statistical Computing; Ihanka et 
al., 1996]. Mixed-model analyses were performed using PROC MIXED from the 
statistical software package SAS 9.1 (SAS Institute Inc., Cary, NC, USA). Box plots 
(if applicable) and univariate analyses were determined using the software package 
SPSS (SPSS Inc., Chicago IL, USA). 
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4.4 Results 
 
4.4.1 After differentiation SH-SY5Y exhibited neuronal morphology and 
specific neuronal markers  
Sixteen days of differentiation yielded cultures of fully matured neuronal cells shown 
in Fig. 2A, B. Following the seventh day of differentiation, the majority of SH-SY5Y 
cells were stained positive for the specific neuronal markers (ß-tubulin III, taurin I, 
neuron-specific enolase [NSE], neurofilament [NF] H/M and microtubule-associated 
proteins [Map] 2a/b). At Day 16 all cells exhibited all of these markers. Time course 
of marker expression showing continuously increasing stages of differentiation is 
given in Fig. 2C. Markers showed typical localisation to cytoplasm and dendrites. The 
explicit majority of differentiated SH-SY5Y cells (73% ± 11%) resembled typical 
neuronal morphology with round phase-bright somata and long, terminal- branched 
dendrites forming a dense network (Fig. 2A, arrow 1). However, the neuronal culture 
is also characterised by a cell type (only 27% ± 11%) which shows abundant 
cytoplasm and a lack of axonal extensions (Fig. 2A, arrow 2). Remarkably, no 
differences were noted with regard to expression of neuronal markers. Furthermore, 
the number of this type of cells remained constant during the culture time. 
 
Figure 2  - Phase contrast and 
fluorescence imaging of fully 
differentiated SH-SY5Y cells 
and the development of 
neuronal markers 
Phase contrast image of fully 
matured SH-SY5Y cells at Day 16 
(A) after seeding. Phase-bright 
neuronal cells (arrow 1) with long 
dendrites forming a dense neuronal 
network and cells with large 
cytoplasm and no axonal 
extensions (arrow 2).  
Immunocytofluorescence micro-
graph of fully differentiated SH-
SY5Y cells (Day 16) shows cultures 
stained positive for the neuronal marker ß-tubulin III (FITC, green) and nuclei (DAPI, blue) 
represented in B. Time course of detection of neuronal markers (ß-tubulin III, taurin, NSE, NF-H/M 
and Map2a/b) on SH-SY5Y cells during the differentiation period at Day 0, 4, 7, 16 and 21 (C). 
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4.4.2 Absence of proliferation after termination of differentiation  
At Day 4 of differentiation the total number of SH-SY5Y cells, counted by nuclear 
staining with DAPI, increased by twofold (21.2 ± 6.7x103/cm2) since seeding. 
Beginning on the seventh day of culture numbers of nuclei remained nearly stable 
(18.2 ± 2.2x103/cm2). Subsequent to hypoxia, there was no significant alteration in 
numbers of counted nuclei. Hence, the influence of oxygen deprivation induced no 
further proliferation and also no significant loss of cells in comparison to normoxic 
control cultures (Fig. 3). Therefore all following results should be seen in the context 
of the nearly constant numbers of neuronal cells under normoxic and hypoxic 
cultivation conditions. It is of note that the amount of stained nuclei as the equivalent 
of adherent cells gives no information about the physiologic status of these cells. On 
the whole the cultures include cells in a viable, apoptotic or necrotic state. 
 
 
 
Figure 3  - Progression of the number of nuclei after differentiation period and effect of 
hypoxia on cell count 
Nuclei were stained with DAPI and counted in fluorescence micrographs. Data were calculated from 
three independent experiments including multiple wells, each based on 25 micrographs. The white 
circles represent cultures that were cultivated under continuously normoxic conditions. The black 
circles illustrate the progression of the number of nuclei in post-hypoxic cultures. Under both 
conditions number of nuclei remained stable. 
4.4.3 Hypoxia induced apoptosis in the majority of neuronal cells 
Post-hypoxic and normoxic control cultures exhibited pronounced differences in the 
quantity of apoptotic cells as well as in cell morphology. Hypoxic conditions for 48 
day of culture
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hours induced an initial apoptosis rate of 26% ± 13%. There was a continuous 
increase in the apoptotic cell fraction to 85% ± 11% within 3 days post-hypoxia as 
compared to control cultures (p ≤ 0.001; Fig. 4). The clearest effects of oxygen 
deficiency were seen three days following induction of hypoxia as shown by annexin-
V staining (green fluorescence, Fig. 6A and 6B). Additionally, post-hypoxic cultures 
were characterised by retracted dendrites, indicating a loss of multiple cell-cell 
contacts. Debris and apoptotic bodies were found in most culture dish areas, 
evidencing late stage of apoptosis (Fig. 6A). In contrast, normoxic cultures displayed 
a much more reduced amount of apoptotic cells (Fig. 6B). Over the whole time, 
apoptosis in these control cultures remained stable at about 7% ± 3% (Fig. 4).  
After hypoxia, on Day 0 and Day 1, number of late apoptotic/necrotic cells 
significantly increased up to 27% ± 13%. Further progression of propidium iodide (PI) 
positive cells in post-hypoxic cultures resulted in 23 ± 16% on Day 3 (Fig.5). By 
comparison, in normoxic control cultures, necrosis levels remained stable below 17% 
and therefore did not statistically differ from post-hypoxic cultures on this time point. 
This fact was corroborated by images that show no observable deviation in the 
amount of necrotic and late apoptotic cells, as indicated by PI staining (red 
fluorescence, Fig. 6C and 6D).  
In general, an increased release of calcein-AM also indicated a strong decrease of 
neuronal cell viability which verifies the results of the apoptosis and necrosis rates 
(data not shown). 
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Figure 4  - Temporal 
progression of annexin-V 
positive cells in post-hypoxic 
and normoxic cultures 
Results are derived from three 
independent experiments. For each 
experiment 75 pictures were taken. 
Consistently, annexin-V positive 
(apoptotic) values in post-hypoxic 
cultures are markedly higher 
compared to control cultures 
increasing to an average level of 85% 
± 11% within three days.  
The number of apoptotic cells did not 
vary significantly in normoxic cultures. 
 
 
Figure 5  - The 
progression of PI 
positive cells in 
post-hypoxic and 
normoxic SH-
SY5Y cultures  
Results are derived 
from three 
independent ex-
periments, in which 
75 pictures were 
taken for each 
analysis. Significant 
increases in the rate 
of PI positive cells 
were observed only 
at Day 0 (10% ± 6%) 
and Day 1 (27% ± 13%) compared to normoxic cultures (Day 0: 9% ± 10%); Day 1: 9% ± 6%). Note PI 
stains necrotic and late apoptotic cells. No significant difference of necrosis rate was detected of post-
hypoxic cultures as well as in control cultures during the observation period. 
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Figure 6  - Long term effect of 48 hours of hypoxia on apoptosis (A-B) and necrosis (C-
D) 
Cultures at Day 3 after hypoxia were compared with normoxic cultures of the same age. Combined 
phase contrast / fluorescence micrographs of neuronal post-hypoxic cultures (A) and normoxic control 
cultures (B) show a conspicuous increase of apoptotic cells (annexin-V-staining, green fluorescence) 
and morphologic changes due to hypoxia (cell debris, retraction of dendrites). Propidium iodide (PI, 
red fluorescence) staining shows the influence of hypoxia (C) on the number of necrotic cells and cells 
in a late state of apoptosis compared to control cultures (D). In contrast to the level of apoptosis, there 
was no clear difference in the number necrotic cells following both culture conditions. 
 
4.4.4 Hypoxia increased quantities of Caspase-3 and cleaved PARP 
immediately and secretion of VEGF in delay 
Bar charts in Figure 7 show the concentrations of Caspase-3 and cleaved poly(ADP-
ribose) polymerase (PARP). In post-hypoxic cultures apoptotic proteins drastically 
rose after oxygen deprivation. The highest concentration of Caspase-3 was 
measured directly after hypoxia on Days 0 and 1 (2-fold and 5.8-fold, respectively). 
From Day 2 on, the level of active Caspase-3 sharply decreased. The distribution of 
cleaved PARP levels showed patterns similar to Caspase-3. This decline was 
accompanied by a secretion of VEGF on Day 3 after hypoxia (Fig. 10). 
 
post-hypoxia normoxia control
A B
C D
an
ne
xi
n-
V
(g
re
en
)
PI
 (r
ed
)
Chapter 1 
39 
 
 
Figure 7  - Effect of 48 hours of hypoxia on the concentration of active Caspase-3 and 
cleaved PARP 
Data are taken in a time course of three days after hypoxia and are based on pooled lysates of the 
totality of SH-SY5Y cells taken out of 12 individual wells. Data are expressed in units of protein (active 
Caspase-3) and cleaved protein (PARP) per millilitres. Hypoxia induced apoptosis specific proteins 
(Caspase-3, cleaved PARP) in a time-related manner. 
 
4.4.5 Adhesion molecules (L1, NCAM and ICAM-1) were upregulated 
after hypoxia 
Independent of cultivation conditions immunofluorescence analysis revealed that 
nearly all (98%) of the cells were positive for neurite cell adhesion molecule (L1; 
98.3 ± 0.1%) and Neural Cell Adhesion Molecule (NCAM; 99 ± 0.8%) at Day 0. L1 
and NCAM were detected on somata and multiple dendrites. Furthermore, a few of 
the neuronal cells also expressed Vascular Cell Adhesion Molecule (VCAM-1; 5.7%) 
and Intercellular Adhesion Molecule (ICAM-1; 14.6%) on their somata and dendrites. 
There was no change in relative numbers of marked cells and expression patterns in 
post-hypoxic cultures. To quantify the density of adhesion molecule expression, 
highly sensitive fluorescence measurement of supernatants of lysed cultures was 
performed. Here, comparative studies between cultures directly after 48 hours of 
hypoxia and normoxic control cultures showed a significant upregulation of L1, 
NCAM and ICAM-1 (Fig. 8). Hypoxic conditions determined a considerable increase 
in L1 and NCAM protein expressions of up to 189% ± 74% and 155% ± 50%, 
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respectively. Hypoxia also strongly upregulated the ICAM-1 expression up to 424% ± 
251%. The level of expression of VCAM-1 was not altered by the hypoxic 
environment. The continued degradation of the dendritic networks did not allow 
assaying the specific expression of adhesion molecules at late stages of post-hypoxic 
cultures. 
 
Figure 8  - Expression 
of adhesion molecules 
after 48 hours of 
hypoxic cultivation 
Fluorescence intensities of 
cell lysates are shown 
after subtraction of 
specific isotype values 
with respect to normoxia. 
Data arise from six 
independent experiments. 
The dotted line indicates 
level of adhesion molecule 
expression (100%) in 
normoxic control cultures. 
Note statistically 
significant upregulation of 
L1, NCAM and ICAM-1 
post-hypoxia. 
 
4.4.6 Co-culturing with HUCB MNC strongly reduced apoptosis in post-
hypoxic neuronal cell cultures 
We found noticeable neuroprotective properties of HUCB MNC in the co-culture 
experiments. Untreated post-hypoxic mono-cultures of neuronal cells showed 85% ± 
11% of apoptosis after three days, whereas in co-cultures with MNC the rate of 
apoptosis was stable at a level of 6.3% ± 1% (p ≤ 0.001). This is comparable to 
normoxic control cultures (7% ± 3%; Fig. 8A). Photographs of co-cultures with MNC 
revealed clear effort of MNC to localise next to somata and branches of post-hypoxic 
neuronal cells. In the course of clustering MNC mostly avoided areas that were not 
settled by neuronal cells (Fig. 9B). Furthermore, the administration of MNC showed 
positive influence on the conservation of neuronal networks as compared to cultures 
that did not receive any cell therapy (Fig. 6A and 6C).  
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Figure 9  - Effect of co-culturing of MNC on ratio of neuronal apoptosis and 
preservation of neuronal networks 
Apoptosis was induced by 48 hours incubation of neuronal cells under hypoxic conditions. Afterwards 
4.5x105 CFSE stained MNC were directly applied to neuronal cells (0.3x105/well). For three days co-
cultures were observed under normoxia. In co-cultures with MNC rate of apoptosis was clearly 
reduced compared to post-hypoxic cultures (A). Combined phase contrast and fluorescence 
micrograph of post-hypoxic neuronal cells and MNC (green) in direct co-culture (B). 
 
 
4.4.7 MNC increased CCL5, CCL3, CCL4 and CXCL10 in post-hypoxic 
neuronal cultures  
The investigation of neuroprotective cytokines (G-CSF, VEGF) (Fig. 10A), 
inflammatory cytokines (IL-1ß, IL-6, CXCL8) (Fig. 10B) and chemokines (CCL2, 
CCL5, CCL3, CCL4, CXCL10) (Fig. 10C) in supernatants of normoxic neuronal 
cultures revealed considerable amounts of CXCL8, CCL2 and VEGF. Remarkably, 
after three days under hypoxic conditions only VEGF was strongly upregulated 
(about threefold increase). After administration of MNC, VEGF was downregulated 
regarding to the total concentration measured in mono-cultures of MNC and in post-
hypoxic neuronal cells. Inflammatory cytokines as IL-1ß, IL-6 and CXCL8 were 
produced by MNC. The secretion of cytokines such as IL-1ß and IL-6 was not altered 
in post-hypoxic co-cultures, whereas CXCL8 was suppressed. Interestingly, the 
majority of chemokines was clearly upregulated in co-cultures with MNC. We could 
show that CCL5, CCL3, CCL4 and CXCL10 were increased up to the tenfold (CCL3, 
CCL4), whereas the concentration CCL2 was not regulated. 
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Figure 10  - Cytokine profile in hypoxic injured SH-SY5Y cells and in direct co-cultures 
with MNC at Day 3 
Cytokine concentrations were measured in supernantes via cytometric bead array. Data originate from 
five independent experiments and are expressed as ng/mg. “+” indicates significant differences in 
cytokine concentration of post-hypoxic SH-SY5Y mono-cultures compared to normoxic controls. 
Double bars are the sum of cytokine concentration from mono-cultures. “*” shows significant 
differences in cytokine concentration in co-cultures with MNC compared to the total of mono-cultures. 
Note different scaling. 
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4.5 Discussion 
 
In this study, we introduce an experimental human in vitro model to investigate (i) the 
mechanisms of neuronal hypoxia and (ii) the interaction of neuronal cells with 
external stem cell-containing fractions as possible therapeutic tools. According to the 
differentiation protocol of Encinas et al. [Encinas et al., 2000] we obtained fully 
matured neuronal cells after 16 days. Previous, orientating experiments showed 
typical response of differentiated SH-SY5Y cells to N-methyl-D-aspartate (NMDA; 
300 µM) application and most pronounced vulnerability after 48 hours hypoxic 
incubation (data not shown). These post-hypoxic neuronal cultures can be employed 
already 18 days after the seeding of naive cells. Therefore the time period until the 
model of hypoxic neuronal cells is available is very short. In comparison to other 
approaches that provide assimilable hypoxic models using teratocarcinoma cell lines 
[Pleasure et al., 1992] the generation of our model is shortened by at least 10 days 
[Paquet-Durand et al., 2004]. The proved expression of specific neuronal markers 
and the absence of any proliferation gave clear evidence of matured neuronal cells in 
the G0-phase of the cell cycle. This steady state allows making direct conclusions 
about the influence of any external manipulation because any change will most 
probably be due to these procedures. Hence, the model of neuronal hypoxia affords 
the possibility to investigate manifold questions concerning mechanisms triggered in 
response to hypoxia and therapeutic interventions e.g. application of HUCB MNC.  
Following hypoxia, neuronal cultures displayed a correlation between morphological 
changes and increase of annexin-V positive cells as well as changes in adhesion 
molecule expression. The specific apoptosis marker annexin-V indicated that hypoxic 
cultivation preferentially induced apoptosis. Moreover, there was a continuous 
enlargement in number of apoptotic cells from initial 26% ± 13% until cultures almost 
completely consisted of apoptotic cells (85% ± 11%) within three days. Conforming to 
changes of morphology in post-hypoxic cultures, there was an enhanced release of 
calcein-AM also observable due to the loss of the integrity of membrane. This is 
typical for late stages of apoptosis as well as of necrosis. The model of neuronal 
hypoxia was approved by moderate rates of PI positive cells (23% ± 16% at Day 3 
post-hypoxia). Therefore the overrun of 100% by the summation of annexin-V 
positive and PI positive cells is due to a proportion of cells in a late state of apoptosis 
that are positive for annexin-V and PI [Stroh et al., 2004]. We focused on apoptosis 
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because it is a reversible process which could be modulated by external stimulation 
[Ferrer, 2006; Fisher, 2006]. Moreover after stroke cell death in the penumbra is 
predominantly considered to be apoptosis [Ferrer et al., 2003; Stefanis et al., 2005; 
Nishioka et al., 2006; Hossmann et al., 2006]. Therefore apoptosis is a therapeutic 
target of anti-apoptotic therapies like stem cells or cytokines [Schneider et al., 2006; 
Chang et al., 2007; Shyu et al., 2006; Chairns et al., 2003]. 
Apoptosis in the penumbra takes place in a time span of about 72 hours after vessel 
occlusion in the rat after middle cerebral artery occlusion (MCAO) [Xu et al., 2006]. 
This time course is represented by the model system introduced in this study. The 
fact that there was no major alteration in the number in DAPI-positive nuclei 
underlines that the influence of hypoxia did not lead to an immediate destruction of 
the cells but allows investigating apoptosis and subsequent therapeutic interventions 
within 72 hours. These facts were also confirmed by characteristic changes in the 
morphology of post-hypoxic cells. There was a total retraction of dendrites and a 
resulting destruction of neuronal networks, grained cell surfaces and extended cell 
degradation. This damage was accompanied by an upregulation of neuronal 
adhesion molecules. We hypothesize that this upregulation indicates a cellular 
answer to compensate for a loss of direct cell-cell interaction as a consequence of 
the preceding hypoxic stress as described by several authors [Aubert et al., 1995, 
Holm et al., 1995; Martini et al., 1988]. However, the final loss of intercellular 
networks could not be compensated by the increased expression of neuronal 
adhesion molecules alone. 
Neuronal cell death after hypoxia is caused by membrane depolarisation subsequent 
to energy failure [Hou et al., 2002; Smith et al., 2004]. The resulting calcium overload 
is the initial point of the activation of manifold biochemical pathways that affect 
caspases, free radicals and gene expression [Valencia et al., 2006; White et al., 
2000]. The specific apoptotic proteins Caspase-3 and cleaved PARP were quantified 
to prove whether our microscopic observations are corroborated by biochemical 
pathways [Prunell et al., 2005; Zheng et al., 2003; Ferrer et al., 2003]. After 24 hours 
post-hypoxia, both marker proteins extensively increased. This was followed by a 
sharp drop in their expression level. This reduced amount of cleaved PARP might be 
due to an aggravating energy failure in the cell. This in turn is attributed to the high 
levels of cleaved PARP, evidenced above, which caused adenosintriphosphate 
(ATP) depletion [Sugawara et al., 2004; Endres et al., 1997] and which in this context 
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prevents the enzymatic activity of caspases. Furthermore, an increase of the 
expression of VEGF, a key mediator of angiogenesis [Greenberg et al., 1998; Schoch 
et al., 2002], was observed in higher concentrations in late post-hypoxic cultures. 
This might be a reflection of compensatory in vivo processes of revascularisation in 
our model [Marti et al., 1999; Namiecinska et al., 2005]. VEGF is also known to be 
involved in neuronal protection through inhibition of Caspase-3 [Gora-Kupilas et al., 
2005; Jin et al., 2001]. The time-delayed increased release of VEGF as an effect of 
hypoxia does not seem to influence the number of apoptotic cells in our cultures. This 
may be a result of concentrations of VEGF that did not reach efficient thresholds. In 
this context the measured reduction of caspases on Days 2 and 3 after hypoxia is 
caused by the already described ongoing energy failure in the post-hypoxic cells. 
However, the regulation of those apoptotic proteins is probably not related to VEGF 
mediated-effects. 
The therapeutic benefit of cell administration after stroke has been demonstrated in 
numerous animal studies [Chen et al., 2001; Christensen et al., 2005]. However, 
important questions in basic cellular and molecular mechanisms of neuronal cell 
death and its prevention after inadequate oxygen supply still remain unanswered. To 
understand the mechanisms of cellular neuroprotection after stroke we employed the 
model of neuronal hypoxia and applied MNC from HUCB. 
In vivo MNC are supposed to differentiate into neuronal cells [Chu et al., 2004; 
Taguchi et al., 2004] to trophically support neuronal tissue through the production of 
growth factors [Chen et al., 2001], to support the new formation of synapses and 
migration as well as the differentiation of endogenous neuronal progenitors [Chu et 
al., 2004; Taguchi et al., 20045]. In our experiments, the administration of MNC from 
HUCB to post-hypoxic neuronal cultures showed remarkable beneficial effects. Over 
three days we could show a clear reduction of neuronal apoptosis, even to the level 
of normoxic control cultures (7% ± 3%). There are two observations that contribute to 
an explanation of neuroprotective mechanisms. First, MNC were preferentially 
located close to hypoxically injured neuronal cells. This phenomenon was facilitated 
through an intensive upregulation of ICAM-1 on neuronal cells which is the specific 
ligand for leukocyte cell adhesion molecule [LFA-1] expressed by all immune cell 
subsets [Giblin et al., 2006]. However, the formation of cell chimera was not 
observed, as there were no CFSE-stained cells with neuronal morphology. In future 
experiments we will investigate whether blocking of adhesion molecules on the 
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surface of neuronal cells can inhibit the co-localisation of MNC. Further it will be 
proved whether this influences the rate of apoptosis. An increase of apoptosis would 
be an evidence for the significance of direct cell-cell-contacts in context of therapeutic 
mechanisms of MNC. The second observation would be concomitance of an MNC 
indicated specific alteration in levels of soluble factors. That change might be held 
responsible for neuroprotection. Pronounced upregulation of chemokines (CCL5, 
CCL3, CCL4, CXCL10) might be causal for the enhanced effort of MNC to localise 
near neuronal structures. High concentrations of VEGF are known to be 
neuroprotective [Sun et al., 2003; Wang et al., 2006]. In contrast to post-hypoxic 
mono-cultures, we found no increase of VEGF after administration of MNC. It seems 
that presence of MNC inhibited the induction of elevated levels of VEGF and 
compensated its neuroprotective effects by other mechanisms. Cord blood contains 
distinct cell types capable to differentiate into neuronal cells [Rien-Zakay et al., 2007]. 
However, the differentiation of stem cells (about 1% within the MNC fraction) was not 
expected because of the short time of co-cultivation that clearly undershoots time 
frames responsible for neuronal differentiation.  
So far, it is unclear whether neuroprotection resulted from one of the observed effects 
or from a combination of spatial proximity and specific cytokine patterns. 
Consequently, further studies in indirect co-cultures will be necessary.  
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4.6 Conclusions 
 
Pathophysiological models developed from animal studies form the basis of our 
understanding of the development of stroke. In vivo data display a perfusion-related 
dependency of neuronal cell damage. Residual energy supply in the penumbra 
induces apoptosis, the early phases of which are reversible. Consequently, rescue of 
the penumbra is a major target of experimental stroke therapy. Data obtained from 
complex animal models of stroke strongly suggest that transplanted cells enhance 
neuronal survival. 
We established a standardized human in vitro model of neuronal apoptotic cell death 
after hypoxia that can facilitate to address specific pathophysiological processes 
underlying hypoxic damage and cell-mediated neuroprotection more precisely.  
Interestingly, transplanted MNC not only strongly decreased the ratio of apoptosis in 
neuronal cells but also triggered retaining neuronal characteristics such as forming 
networks. MNC clustered around post-hypoxic neuronal cells and induced an 
alteration in cytokine and chemokine concentrations. Our data suggest that the 
neuroprotective effects of MNC might result from direct cell-cell contacts and/or the 
adjustment of specific soluble mediators. 
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5 Preface to Chapter 2 
 
Based on the observations described in the foregoing paragraph the experiments 
presented in the following chapter focused on the question that which of the 
heterogeneous cell fractions composing HUCB has the highest neuroprotective 
capacity. Therefore, unsorted HUCB-MNC, a stem cell enriched fraction and a stem 
cell depleted fraction obtained from HUCB-MNC (CD133+ and CD133-, respectively) 
were either directly or indirectly co-cultivated with post-hypoxic neuronal cells 
(differentiated SH-SY5Y). Cultures were investigated regarding development of 
apoptosis and necrosis of neuronal cells, chemotaxis of MNC and production of 
chemokines and growth factors.  
After a co-cultivation time of three days MNC and surprisingly CD133- significantly 
reduced neuronal apoptosis in both co-cultivation types. In direct co-cultures CD133- 
produced high concentrations of CCL3 and neuroprotective G-CSF. CD133+ cells 
effectively reduced neuronal damage in direct co-cultures only.
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6 Neuronal Hypoxia in vitro: Investigation of Therapeutic 
Principles of HUCB-MNC and CD133+ Stem Cell
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6.1 Abstract 
 
Background: The therapeutic capacity of human umbilical cord blood mononuclear 
cells (HUCB-MNC) and stem cells derived thereof is documented in animal models of 
focal cerebral ischemia, while mechanisms behind the reduction of lesion size and 
the observed improvement of behavioral skills still remain poorly understood. 
Methods: A human in vitro model of neuronal hypoxia was used to address the 
impact of total HUCB-MNC (tMNC), a stem cell enriched fraction (CD133+, 97.38% 
CD133-positive cells) and a stem cell depleted fraction (CD133-, 0.06% CD133-
positive cells) of HUCB-MNC by either direct or indirect co-cultivation with post-
hypoxic neuronal cells (differentiated SH-SY5Y). Over three days, development of 
apoptosis and necrosis of neuronal cells, chemotaxis of MNC and production of 
chemokines (CCL2, CCL3, CCL5, CXCL8, CXCL9) and growth factors (G-CSF, GM-
CSF, VEGF, bFGF) were analyzed using fluorescence microscopy, FACS and 
cytometric bead array. 
Results: tMNC, CD133+ and surprisingly CD133- reduced neuronal apoptosis in direct 
co-cultivations significantly to levels in the range of normoxic controls (7% ± 3%). 
Untreated post-hypoxic control cultures showed apoptosis rates of 85% ± 11%. tMNC 
actively migrated towards injured neuronal cells. Both co-cultivation types using 
tMNC or CD133- reduced apoptosis comparably. CD133- produced high 
concentrations of CCL3 and neuroprotective G-CSF within indirect co-cultures. 
Soluble factors produced by CD133+ cells were not detectable in direct co-cultures. 
Conclusion: Our data show that heterogeneous tMNC and even CD133-depleted 
fractions have the capability not only to reduce apoptosis in neuronal cells but also to 
trigger the retaining of neuronal phenotypes.  
 
Chapter 2 
51 
6.2 Background 
 
Transplantation of adult stem cells has been shown to be an auspicious and effective 
treatment for degenerative and traumatic neurological diseases [Serakinci et al., 
2006]. Among degenerative neurological disorders acute ischemic stroke is the 
leading cause of disability and death in industrial nations [Egan et al., 2000; Hinkle et 
al., 2007; Meister et al., 2000].  
Acute stroke leads to an increased release of hematopoietic stem and progenitor 
cells from bone marrow into peripheral blood [Paczkowska et al., 2005]. It is assumed 
that these cells take part in self-healing processes occurring after neuronal injury. 
They are supposed to promote the survival of the injured brain tissue by producing 
neurotrophic factors [Newman et al., 2006], to enhance endogenous angiogenesis 
[Taguchi et al., 2004] and neurogenesis [Chu et al., 2004] or even to 
transdifferentiate into neuronal cells [Lu et al., 2002]. However, the stroke induced 
endogenous release of hematopoietic stem and progenitor cells seems not to be 
sufficient to compensate massive loss of brain tissue after extended ischemic stroke. 
Therefore, external application of hematopoietic stem and progenitor cells is 
expected to complement current treatment of acute stroke based on thrombolytic 
therapy. An appropriate source of hematopoietic stem cells is the mononuclear cell 
(MNC) fraction of human umbilical cord blood (HUCB) [Goldstein et al., 2007, 
Sanchez-Ramos et al., 2006; Weiss et al., 2006]. Transplantation of HUCB-MNC as 
well as enriched HUCB hematopoietic stem cells into animals which were subjected 
to focal stroke caused by middle cerebral artery occlusion (MCAO) ameliorated the 
animals’ functional outcome and reduced the lesion size [Chen et al., 2001]. 
However, there are still manifold unanswered questions addressing the beneficial 
influence of such grafts on injured neuronal cells.  
It has been documented that there is no neuronal transdifferentiation of 
hematopoietic stem cells in vitro [Bossolasco et al., 2005; McGuckin et al., 2004; 
Reali et al., 2006]. Though so far there is no convincing proof that locally 
administered hematopoietic stem cells transdifferentiate into functionally neuronal 
cells forming the basis of the animals’ behavioral progression [English et al., 2006].  
It has recently been shown that there is no need for MNC to enter the brain for 
neuroprotection. Soluble factors like GDNF, NGF, BDNF or G-CSF are known to 
promote neuroprotection over long-distances [Borlongan et al., 2004; Schabitz et al., 
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2003]. This raises many questions about the cellular mechanisms causing the 
functional improvement after grafting [Arvidsson et al., 2002]. Prevention of neurons 
from apoptotic cell death [Ferrer et al., 2006] is considered to be supported by the 
transplantation and could be directly connected to improved tissue conservation, 
lesion size reduction and superior functional outcome [Romero et al., 2002]. 
Cell culture models of neuronal hypoxia complement the exploration of particular 
interactions between grafts and neuronal tissue. Our study is based on a well 
established post-hypoxic neuronal cell culture model (SH-SY5Y). This model was 
used to address (i) the neuroprotective potential of stem cell enriched and -depleted 
HUCB derived cell fractions, (ii) the impact of these cells especially on apoptotic 
status of oxygen-deprived neurons, and (iii) the mediation of cell-derived survival 
signals (soluble or cell-attached). 
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6.3 Methods 
 
6.3.1 Preparation of HUCB samples and isolation of CD133+ cells 
HUCB samples of healthy full-term neonates were obtained in accordance with 
ethical prescripts immediately after delivery. Samples were processed and analyzed 
as described previously [Hau et al., 2008]. The total MNC (tMNC) fraction gained 
from Ficoll density gradient (Tab. 1) was stored in the gaseous phase of liquid 
nitrogen. Cellular sub-fractions of tMNC were characterized using CD3-Phycoerythrin 
(PE, Immunotech, Hamburg, Germany), CD14-Fluorescein isothiocyanate (FITC), 
CD16+56-PE (both, Becton-Dickinson, Franklin Lakes, NJ, USA), CD19-
Allophycocyanin (APC) and CD45-FITC, (both, Beckman Coulter, Krefeld, Germany). 
Prior to use tMNC were thawed and stained with carboxy fluoresceindiacetate 
succinimidyl ester (CFSE, Invitrogen, Karlsruhe, Germany).  
CD133 positive cells (CD133+) were isolated from HUCB-MNC using the MACS® 
immunomagnetic positive selection protocol (Miltenyi Biotech, Bergisch Gladbach, 
Germany). The flow-through fraction was collected as negative fraction (CD133-) 
depleted of CD133+. Final populations were analyzed using a FACSCalibur flow 
cytometer equipped with the CellQuest™ software (both Becton-Dickinson, Franklin 
Lakes, NJ, USA) and characterized by the use of the following antibodies: CD133/2-
PE, Miltenyi Biotech Bergisch Gladbach, Germany), CD45-FITC and CD34-APC 
(both Beckman Coulter, Krefeld, Germany). Isotype-identical monoclonal antibodies 
served as controls. CD133+ and CD133- fractions contained 97.38% and 0.06% 
CD133 positive cells, respectively. 
Status of activation of tMNC and CD133- was analyzed via FACS using the 
antibodies CD25-PE, HLA-DR (Major Histocompatibility Complex, class II, cell 
surface receptor)-APC (both Becton-Dickinson, Franklin Lakes, NJ, USA), CD38-PE 
and CD71-FITC (both Beckman Coulter, Krefeld, Germany). 
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Table 1: Cellular sub fractions of MNC 
 
Cellular fractions of Markers Content in 
tMNC (%) 
Content in 
CD133- (%) 
I) Myeloid cells CD14+/CD45+ 14.1 ± 4.4 19.5 ± 2.4 
II) Lymphocytes  
(including stem cells) 
 85.9 ± 4.4 80.5 ± 2.4 
Subpopulations of II    
B-lymphocytes CD19+/CD45+ 12.3 ± 5.5 14.6 ± 0.5 
T-lymphocytes CD3+/CD45+ 73.0 ± 10.2 76.8 ± 1.9 
NK-cells CD56+/CD45+ 12.7 ± 4.5 8.3 ± 1.4 
Hematopoietic stem/progenitor cells CD133+/CD34+ 1.2 ± 1.0 0.03 ± 0.01 
 CD133+/CD34- 0.4 ± 0.2 0.03 ± 0.02 
 CD133-/CD34+ 0.4 ± 0.2 0.34 ± 0.06 
 
Cellular fractions of HUCB-MNC after thawing of cryopreservated cells. 
Subpopulations of lymphocytes and stem/progenitor cells are expressed as percent of total 
lymphocytes. 
 
6.3.2 Differentiation and hypoxic induction of SH-SY5Y cells 
For differentiation 0.9 × 104/cm2 SH-SY5Y cells were seeded in 16-mm-diameter 
wells (Greiner Bio-One, Frickenhausen, Germany). After 5 days Dulbecco's Modified 
Eagle Medium (DMEM) /10 μM all-trans retinoic acid (Sigma-Aldrich, Steinheim, 
Germany) /15% fetal calf serum (PAN-Biotech, Aidenbach, Germany) media was 
changed into DMEM-Ham´s F12/10 µM RA/5 ng/ml Brain Derived Neuronal Factor 
[BDNF, Immunotools Biolance GmbH, Hanover, Germany] /0.1% Human Serum 
Albumine [HSA, PAN Biotech GmbH, Aidenbach, Germany] for another 11 days. 
Media were exchanged every third day. Afterwards fully matured neuronal cells were 
cultured under a hypoxic atmosphere (< 1% O2) for 48 hours [Hau et al., 2008]. 
Number of viable cells remained stable between Day 16 and Day 21.  
 
6.3.3 Direct and indirect co-cultivation of post-hypoxic neuronal cells 
with tMNC, CD133+ and CD133- cell fractions 
Subsequent to hypoxia, direct and indirect co-cultivation with tMNC, CD133+ or 
CD133- was carried out under normoxic conditions over a period of three days. 
Added tMNC, CD133- (4.5 x 105 cells, both) and CD133+ (4.5 x 103 cells) were 
dissolved in 500 µl co-culture medium (DMEM-Ham`s F12, 5 ng/ml BDNF and 0.1% 
HSA) and added to differentiated post-hypoxic neuronal SH-SY5Y cells cultivated in 
adequate volume of post-hypoxic medium. Cell ratio of post-hypoxic neuronal cells to 
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MNC was 1:15 and to CD133+ 1:0.15. For indirect co-cultivation tMNC or CD133- 
were added in cell impassable cell culture inserts with a pore size of 0.4 µm (Greiner 
Bio-One GmbH, Frickenhausen, Germany). 
Prior to co-cultivation with post-hypoxic neuronal cells, tMNC as well as CD133+ and 
CD133- were labeled with CFSE.  
 
6.3.4 Cell viability assay of neuronal cells 
Within direct and indirect co-cultures and control cultures the influence of tMNC, 
CD133+ and CD133- on neuronal viability was detected via i) Propidium Iodide (PI, 
Invitrogen, Karlsruhe, Germany) assay for necrosis and late apoptosis and ii) 
annexin-V assay (Becton-Dickinson, Heidelberg, Germany) for apoptosis. The PI– 
and annexin-V assays were performed in cell culture plates as described previously 
[25]. tMNC, CD133+ and CD133- were distinguished from annexin-V-PE or PI positive 
neuronal cells by the green CFSE staining. 
Cytometric Bead Array for human apoptosis (CBA, Becton Dickinson, Erembodegem, 
Belgium) was used to quantify the apoptosis specific parameter cleaved Poly-ADP-
Ribose-Polymerase I (PARP) in lysates of post-hypoxic neuronal cells after indirect 
co-cultivation with tMNC and CD133-. For cell lyses adherent neuronal cells were 
rinsed with PBS and incubated on ice in the supplied buffer for 20 minutes. For 
analyses pooled samples obtained from three independent experiments were used.  
 
6.3.5 Cytokine profiling  
For cytokine profiling supernatants of direct and indirect co-cultures were analyzed 
on Day 3. Supernatants of tMNC, CD133+ and CD133- mono-cultures and those of 
post-hypoxic neuronal cells were also investigated on Day 3. Cytokines were 
simultaneously measured using CBA for human soluble proteins (Becton Dickinson, 
Erembodegem, Belgium).  
Supernatants were screened for the following cytokines: CCL2, CCL3, CCL5, 
CXCL8, CXCL9 and for the growth factors basic Fibroblast Growth Factor (bFGF), 
Granulocyte Colony-Stimulating Factor (G-CSF), Granulocyte-Macrophage Colony-
Stimulating Factor (GM-CSF) and Vascular Endothelial Growth Factor (VEGF). The 
detection limit was 20 pg/ml, except for CCL2 and VEGF (40 pg/ml). 
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6.3.6 Statistical analyses of data 
Except for apoptosis and necrosis rates all results have been reported as mean ± 
SD. Statistical differences were analyzed by Student’s t-test or Mann-Whitney rank 
sum-test. P values of ≤ 0.05 were considered statistically significant (* p ≤ 0.05, ** p ≤ 
0.01, *** p ≤ 0.001). Apoptosis and necrosis rates were logit-transformed to obtain 
normally distributed quantities. The effects of time, experimental setting (post-
hypoxia), experimental run and the investigated well were determined univariately, 
and, finally multivariately using a mixed-model approach with time and experimental 
setting as fixed effects and well and experimental run as random effects. 
Cytokine concentrations of indirect and direct co-cultures with tMNC, CD133- and 
CD133+ were compared with the sum of the concentrations obtained after post-
hypoxia of neuronal cells and corresponding tMNC, CD133+ and CD133- mono-
cultures using a bootstrapping algorithm. Therefore, we added concentrations which 
were resampled from e.g. the experiment post-hypoxia and the tMNC mono-culture 
and compared the results with concentrations obtained from e.g. the experiment of 
indirect co-culture with tMNC. Results were compared with Student’s t-test or Mann-
Whitney rank sum test. P-values reported are based on 10,000 bootstrapping 
simulations. We accounted for multiple comparisons of cytokine concentrations by 
using Bonferroni’s correction of significance level. 
Box plots (if applicable) and univariate analyses were determined using the software 
package SPSS (SPSS Inc., Chicago IL, USA). Mixed Model analyses were 
performed using PROC MIXED of the statistical software package SAS 9.1 (SAS 
Institute Inc., Cary, NC, USA). Bootstrapping analysis was using the statistical 
software package “R” [Holopainen et al., 2005; Hossman, 2006].  
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6.4 Results 
 
6.4.1 Direct co-cultivation with each fraction of HUCB-MNC reduced 
apoptosis in post-hypoxic neuronal cells 
Hypoxic cultivation (48 hours) of fully matured neuronal SH-SY5Y cells resulted in an 
initial rate of apoptosis of 26% ± 13%. Within the following three days rate of 
apoptosis increased to 85% ± 11%. By contrast, normoxic control cultures showed a 
stable amount of apoptotic cells (7% ± 3%) over the whole observation time (data not 
shown). Direct co-cultivation with tMNC and CD133- showed pronounced reduction of 
neuronal apoptosis. Similar results were obtained after application of CD133+. By 
application of 4.5 x 103 CD133+ they were given in equal amounts as they exist in 
tMNC. Though the whole cell amount of CD133+ was 100 times less then tMNC 
administered (Fig. 1A). 
Levels of necrosis in post-hypoxic control cultures remained nearly stable 
(approximately 25%) over three days. tMNC and CD133- cell application also induced 
a significant reduction of necrosis. CD133+ cells did not influence the level of necrosis 
(Fig. 1B).  
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Fig. 1: Time course of apoptosis and necrosis of post-hypoxic neuronal cells in direct 
co-cultures with tMNC, CD133+ and CD133- 
Box plots showing time course of apoptosis (A) and necrosis/ late apoptosis (B) in direct co-cultures of 
post-hypoxic neuronal cells with tMNC, CD133- or CD133+ (colored plots). Grey boxes display the 
development of cell death in post-hypoxic neuronal cells directly after hypoxic pre-cultivation of SH-
SY5Y cells (Day 0) and 1-3 days post-hypoxia. The ordinate represents the percentage of apoptotic 
and necrotic cells, respectively. Rates of apoptosis and necrosis were calculated in relation to the total 
number of SH-SY5Y cells. 
 
6.4.2 In indirect co-cultures tMNC and CD133- were also sufficient to 
decrease apoptosis of post-hypoxic neuronal cells  
Over the entire observation period, direct as well as indirect co-cultivation with tMNC 
or CD133- exhibited a significant reduction of apoptosis. In all co-culture set-ups 
percentage of annexin-V positive cells was significantly lower (p ≤ 0.001) than in 
post-hypoxic control cultures (Fig. 2A, B). Direct and indirect co-cultivation of CD133- 
resulted in similar rates of apoptosis continuously below 5% of annexin-V positive 
cells (Fig. 2B). However, still generating strong neuroprotective effects, the number of 
apoptotic neuronal cells in indirect tMNC co-cultures was significantly higher than in 
direct co-cultures at Day 2 and Day 3 (p ≤ 0.001) as shown in figure 2A. Direct co-
cultivation with tMNC resulted in a stable level of 6% ± 1% neuronal apoptosis and 
was therefore significantly lower than in post-hypoxic control cultures (Day 2: 46% ± 
20%; Day 3: 85% ± 11%). 
When tMNC were indirectly co-cultured neuroprotection was as pronounced as in 
direct co-cultures on the first day after hypoxia. Two and three days after application 
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there was still a significant, but compared to control cultures reduced, protective 
effect in the indirect co-cultures while protection in direct co-cultures was as distinct 
as on Day 1 (7% ± 8%). 
The comparison of both application types using tMNC and CD133- showed that 
soluble factors seem to have strong therapeutic potential (Fig. 2A, B).  
The positive influence of indirect co-cultivation on the amount of apoptotic cells, 
revealed by annexin-V detection, was also confirmed by typical patterns in the 
cleavage of PARP, a late marker of apoptosis (Fig. 3). In indirect co-cultures with 
tMNC and CD133- quantities of cleaved PARP were nearly at the same level on Day 
1 post-hypoxia. On Day 2 and Day 3 neuroprotection by CD133- resulted in 
concentrations of cleaved PARP ranging in the level of the normoxic control (Fig. 3). 
Only direct co-cultures of tMNC and CD133- displayed improved protection from 
necrosis/ late apoptosis as revealed by Propidium Iodide labeling of post-hypoxic 
neuronal cells (Fig. 2C, D). Indirect co-cultivation did not reduce the percentage of 
necrotic/ late apoptotic neuronal cells. 
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Fig. 2: Effects of direct and indirect application of tMNC and CD133- on apoptosis and 
necrosis of post-hypoxic neuronal cells 
Box plots represent the percentage of annexin-V positive post-hypoxic neuronal cells (A, B) and of PI 
positive post-hypoxic neuronal cells (C, D) in direct and indirect co-cultures. Co-cultures were 
performed with tMNC (A, C) and CD133- (B, D). The extents of apoptosis (annexin-V-binding) and 
necrosis (PI) were analyzed for three days after hypoxia. 
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Fig. 3: Direct comparison of effects of tMNC and CD133- on late apoptosis (PARP 
cleavage) 
Bar chart showing concentrations of cleaved PARP in lysates of post-hypoxic neuronal cells which 
were indirectly co-cultivated with tMNC (grey shaded bars) or CD133- (black bars). Controls are post-
hypoxic mono-cultures (grey bars) and normoxic cultures (white bars). Each bar visualizes pooled 
samples obtained from three independent experiments. 
 
6.4.3 tMNC localized in close proximity to post-hypoxic neuronal cells 
In direct co-cultures many tMNC were found in close spatial relation with post-
hypoxic neuronal cells already at Day 1 (Fig. 4B). This became even more evident at 
later time points (Fig. 4D, F). At Day 3, the vast majority of tMNC was found adjacent 
to neuronal somata and processes (Fig. 4F). Interestingly, co-cultivation with tMNC 
seemed to have strong positive effects on the preservation of typical neuronal cell 
morphology as the formation of branched processes.  
In contrast, in normoxic control cultures tMNC were evenly spread throughout the 
culture dish (Fig. 4A, C, E). 
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Fig. 4: Distribution of tMNC in 
direct co-cultures  
Phase contrast fluorescence 
micrographs of co-cultures of neuronal 
cells (unstained) and tMNC (green). 
Representative images show post-
hypoxic neuronal cultures (B, D, F) in 
contrast to normoxic control cultures (A, 
C, E) over a time course of three days. 
Images illustrate the distribution of 
tMNC in relation to neuronal cells. 
White arrows point at spatial 
accumulation of tMNC which are 
clustered around neuronal somata and 
processes in post-hypoxic cultures (B, 
D, F). In normoxic cultures no clustering 
of tMNC was observed (A, C, E). The 
black arrow points at a conserved 
neuronal morphology including 
branched processes. Scale bars 
indicate 100 µm. 
 
 
6.4.4 Cytokine secretion patterns induced by direct co-cultivation with 
tMNC or CD133- were similar; cytokines produced by CD133+ were 
not detectable 
In supernatants of direct co-cultures and corresponding mono-cultures we assessed 
concentrations of CCL2, CCL5, CXCL8, VEGF and bFGF (Fig. 5).  
Post-hypoxic neuronal cells secreted the chemokines CXCL8 and CCL2 and the 
growth factor VEGF. Low amounts of CCL5 and bFGF were detectable, as well. 
Mono-cultures of tMNC and CD133- displayed similar growth factor and chemokine 
secretion patterns: CXCL8 and CCL2 were produced in considerable amounts while 
CCL5 and bFGF were secreted at low levels. VEGF was not present. None of the 
investigated soluble factors was detected in supernatants of purified CD133+ mono-
cultures. 
In direct co-cultures with tMNC or CD133- secretion of cytokines was regulated very 
similar: reduction of CXCL8 (p ≤ 0.001) and VEGF (p ≤ 0.001) and increase of CCL5 
(Fig. 5). CD133+ co-cultivation only influenced VEGF levels, which decreased 
significantly (Fig. 5). 
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Fig. 5: Cytokine profile in direct co-
cultures with tMNC, CD133+and CD133- 
on Day 3 
Control: sum of cytokine concentration from 
single cultured (grey) post-hypoxic SH-SY5Y 
cells and HUCB-MNC (light green = tMNC, light 
red = CD133-, not detectable = CD133+). Co-
culture: direct co-culture of post-hypoxic SH-
SY5Y cells and HUCB-MNC (dark green = tMNC, 
dark red = CD133-, dark yellow = CD133+). Data 
are derived from four independent experiments 
and are expressed as pg/ml. *  significant 
differences in cytokine concentrations of co-
cultures compared to control cultures. Note 
different axis scaling. 
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6.4.5 Up-regulation of soluble factors in indirect CD133- co-cultures was 
associated with long term neuroprotection 
In a second set of experiments we investigated different effects of direct and indirect 
co-culturing on cytokine secretion. Therefore, concentrations of CXCL9, CCL3, 
VEGF, G-CSF and GM-CSF were measured in normoxic and post-hypoxic mono-
cultures, and co-cultures with tMNC and CD133-. 
Except VEGF neuronal cells did not secret detectable amounts of either CXCL9, 
CCL3, G-CSF nor GM-CSF in mono-cultures. Both, tMNC and CD133- cells 
expressed CCL3 and G-CSF but only CD133- produced GM-CSF (Fig. 6). 
In co-cultures with tMNC direct co-cultivation generated more pronounced effects 
than indirect co-cultivation, as seen for the relative up-regulation of CXCL9, GM-CSF 
(both, p ≤ 0.05) and CCL3 and the relative down-regulation of VEGF. Only direct 
CD133- co-cultivation had an impact on regulation of CCL3, VEGF and GM-CSF. 
Secretion of all three cytokines was markedly decreased compared to controls 
whereas indirect co-cultivation with CD133- had no effect. In contrast, the secretion of 
CXCL9 and G-CSF (p ≤ 0.01) was markedly induced by indirect co-cultivation with 
CD133-. For these cytokines direct co-cultivation showed no effect (G-CSF) or 
resulted in a remarkably reduced production (CXCL9) as compared to indirect co-
cultivation with CD133- (Fig. 6). The experiment also revealed the influence of 
different HUCB-MNC-derived cell preparations on the cytokine secretion. Most 
prominent, direct co-cultivation with tMNC significantly increased expression of CCL3 
(p ≤ 0.05) whereas direct co-cultivation with CD133- resulted in a relative reduction of 
this chemokine (p ≤ 0.01). 
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Fig. 6: Effect of co-cultivation 
system (direct v. indirect) on 
cytokine secretion during co-
cultivation of post-hypoxic 
neuronal cells with tMNC and 
CD133- 
Control: sum of cytokine 
concentration from single cultured 
(grey) post-hypoxic SH-SY5Y cells 
and HUCB-MNC (light green = tMNC, 
light red = CD133-). Co-cultures: 
co-culture of post-hypoxic SH-SY5Y 
cells and tMNC (direct: dark green, 
filled; indirect: dark green, striped), 
co-culture of post-hypoxic SH-SY5Y 
cells and CD133- (direct: dark red, 
filled; indirect: dark red, striped). 
Effects are displayed in percent as 
relative changes to control.  
Mono-cultures: absolute cytokine 
concentrations in supernatants of SH-
SY5Y normoxic and post-hypoxic 
mono-cultures (white or grey bars, 
respectively) and tMNC (light green 
bars) or CD133- (light red bars). 
* significant changes to control. 
+ significant differences between co-
cultivation systems.  
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6.5 Discussion 
 
It has been previously shown that HUCB derived MNC as well as nearly pure stem 
cell populations obtained from MNC are able to improve the clinical outcome of 
animals after MCAO [Vendrame et al., 2004]. In an in vitro model of neuronal hypoxia 
we discern cell populations within MNC being able to improve neuronal survival and 
disclose potential neuroprotective mechanisms.  
First we studied the effects of tMNC application on the apoptotic status of post-
hypoxic neurons. We found that direct application of tMNC results in preservation of 
neuronal morphology based on a constant protection from apoptosis (Fig. 2A). 
For in vivo experiments it has been described that none or only a minority of 
systemically administrated cells were detected in the brain while large quantities were 
found in the spleen, in the lungs and in the blood of the animals. Nevertheless, some 
studies showed that cell-treatment improved behavioral deficits [Borlongan et al., 
2004; Vendrame et al., 2004; Makinen et al., 2006]. This indicates the importance of 
soluble factors for neuroprotection. Our data obtained from indirect co-cultures 
strongly support this hypothesis. tMNC application was highly protective, although the 
anti-apoptotic effect was slightly weakened after two days (Fig. 2A). Probably, soluble 
factors act as “first aid” messengers while longer protection seems to demand close 
proximity between tMNC and neuronal cells. The comparison of direct application of 
tMNC to normoxic and post-hypoxic neuronal cells revealed that only post-hypoxic 
neuronal cells attracted tMNC (Fig. 4). The clustering of tMNC around neuronal cells 
could explain the enhanced protection from apoptosis in direct co-cultures with tMNC 
at Day 2 and Day 3 (Fig. 4, Fig. 2A). Spatial contiguity is possibly associated with 
higher concentrations of neuroprotective mediators in the micro-environment of 
injured neuronal cells. Post-hypoxic neuronal cells were shown to significantly up-
regulate the adhesion molecule ICAM-1 following hypoxia [Hau et al., 2008]. Hence, 
ICAM-1 (CD54) expression could underlay the observed co-localization via binding of 
LFA-1 (CD11) [Huang et al., 2007]. Besides adhesion molecules, chemotaxis could 
mediate this cellular co-localization. VEGF, known to exert chemotactic effects on 
monocytes [Moon et al., 2005], was produced by post-hypoxic SH-SY5Y cells (Fig. 
6).  
To focus the neuroprotective effects of stem cells we enriched or depleted CD133+ 
cells from HUCB-MNC. Purities of 97.38% for the stem cell preparation and a 
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reduction of CD133+ up to 0.06% for the stem cell depleted fraction were achieved. In 
direct co-cultures CD133+ were applied to neuronal cells in quantities of 4.5 x 103 
resembling 1% of the applied tMNC, since CD133+ account for about 1% of total cell 
number in tMNC preparations. Neuroprotective capacity of nearly pure CD133+ cells 
was comparable to tMNC (Fig. 1A). According to our analyses of cytokine production 
CD133+ cells did not secrete measureable cytokines neither in mono-cultures nor in 
co-cultures with injured neuronal cells (Fig. 5). Additional experiments using even 
tenfold elevated numbers of stem cells (4.5 x 104) also revealed no detectable 
cytokine concentrations and did not result in an increased neuroprotective capacity 
(data not shown). Neuroprotection by the absence of measurable soluble mediators 
argues for a stem cell specific therapeutic mechanism through contiguity. Due to this 
assumption we did not include CD133+ in the investigation of indirect co-cultures in 
this study.  
Surprisingly, CD133- cell fractions were also highly sufficient in protection from 
apoptosis. Therefore, the observed anti-apoptotic neuroprotective effects of tMNC in 
our experiments do not only relay on hematopoietic stem cell-specific mechanisms. 
This assumption is supported by the missing significance in the effect of CD133+ on 
necrotic/ late apoptotic loss of post-hypoxic neuronal cells (Fig. 1B). tMNC and 
CD133- significantly reduced the percentage of PI-positive neuronal cells, whereas 
CD133+ did not. Since CD133- in indirect co-cultures were superior to tMNC in 
protection from apoptosis and because of very low amounts of CD133+ in this 
preparation, CD133- seem to mediate additional neuroprotective effects. Possibly, the 
separation process influenced the functionality of CD133- cells. FACS analyses of the 
activation markers CD25, CD38, CD71 and HLA-DR on tMNC and on the separated 
CD133- fraction did not reveal an increased population of activated cells in our 
preparations (data not shown). However, the expression of other activation molecules 
cannot be excluded, since this cell population displayed an enhanced secretion of 
cytokines like G-CSF, GM-CSF and CCL-3 (Fig. 6). We also cannot rule out that 
remaining CD34+ cells could account for the neuroprotective activity of the CD133- 
fraction, since depletion did only reduce the number of CD34+ cells to 77% (Tab. 1). 
The investigation of soluble mediators exhibited that hypoxia induced a significant 
increase of VEGF in neuronal cells (Fig. 6, [Bergeron et al., 2000]). VEGF is 
documented to inhibit pro-apoptotic signaling by Bad (BCL2 antagonist of cell death), 
and cleavage of caspase-3, and caspase-9 [Gora-Kupilas et al., 2005] and therefore 
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can be claimed as an autocrine self-protection mechanism of damaged neuronal 
cells. The neuroprotective impact of tMNC and CD133- cells in direct applications was 
accompanied by prevention of VEGF production which is typically induced in post-
hypoxic neuronal cells (Fig. 5).  
Neuroprotective effects of cell application could be mediated by G-CSF that was 
found only in mono-cultures of CD133- but not in mono-cultures of post-hypoxic SH-
SY5Y cells. Schneider et al., 2005 [Schneider et al., 2005] pointed out that human 
SH-SY5Y neuroblastoma cells express the G-CSF receptor and that activation by the 
neurotrophic G-CSF reduced NO-induced poly-ADP ribose polymerase (PARP) and 
caspase-3 cleavage. Our data support these observations. At Day 3 in indirect co-
cultures supply of G-CSF by CD133- was associated with cleaved PARP levels in the 
range of normoxic cultures (Fig. 3, Fig. 6). G-CSF levels in mono-cultures of tMNC 
were only slightly above detection limit and could not provide this anti-apoptotic effect 
(Fig. 6). The decrease of cleaved PARP observed in post-hypoxic neuronal mono-
cultures at Day 3 (Fig. 3) was probably induced by rising lack of energy due to 
increased rate of apoptosis (Fig. 1). Noticeably, there are application-specific 
differences in the regulation of cytokine secretion in co-cultures with CD133- 
fractions. Concentrations of CCL3 and G-CSF were significantly higher in indirect co-
cultures than in direct co-cultures. Possibly these enhanced concentrations are 
responsible for a protection from apoptosis in indirect co-cultures similar to that in 
direct co-cultures at Day 3. Indirect co-cultivation with tMNC did not induce enhanced 
cytokine levels (Fig. 6) and at the same time did not exert the same neuroprotective 
effect on post-hypoxic SH-SY5Y neurons. This could be explained by spatial effects: 
paracrine released cytokines could be more effective than action of cytokines over a 
longer distance.  
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6.6 Conclusions 
 
In this study we investigated human umbilical cord blood derived cell populations 
(tMNC, CD133+, and CD133-) according to their ability to protect post-hypoxic 
neuronal cells. 
For different reasons, as the missing systemic effects and the disregard of brain cell 
interactions this in vitro system does only simplified reflect the action of MNC after 
hypoxic brain lesions in vivo. But taken this into account, our study delivers useful 
indications for the in vivo application of such cells:  
So, since purified CD133+ fractions are not superior to total HUCB-MNC in mediating 
neuroprotective anti-apoptotic effects, expensive and time consuming stem cell 
separations are not necessarily needed to yield neuroprotective cell populations. 
Furthermore, our study underlines the importance of MNC derived soluble factors for 
the mediation of neuroprotective effects visible as prevention of neuronal cells from 
apoptosis. Therefore, future therapeutic approaches should focus on the sufficient 
supply of soluble anti-apoptotic mediators, to reduce post-hypoxic brain damage. 
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7 Preface to Chapter 3 
 
The not yet published material in the following chapter takes the question on 
neuroprotective mechanisms of HUCB-MNC to a next level by administrating MNC, 
CD34- and CD34+ to ex vivo organotypic slice cultures subjected to oxygen and 
glucose deprivation. Compared to cultures of neuronal cells the utilization of 
organotypic hippocampal slice cultures allows investigation of MNC mediated effects 
in a multi cell type tree dimensional network of functional neuronal tissue forming a 
set up that is sufficiently complex and simple at the same time.  
Experiments on efficient cell doses revealed a direct relation in number of deployed 
MNC and reduction in neuronal damage. Migration assays showed that directly 
administered MNC actively migrate towards OGD damaged hippocampal slices 
whereas CD34+ cells showed highest homing activity. One aspect for the observed 
MNC related reduction in neuronal damage might be a reduced secretion of nerve 
growth factor in the hippocampal tissue.
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8 Human Umbilical Cord Blood Cells Reduce Neural 
Damage in Oxygen and Glucose Deprivated Rat 
Hippocampal Slices
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8.1 Abstract 
 
Transplantation of human umbilical cord blood mononuclear cells (HUCB-MNC) in 
animal models of stroke elucidated the therapeutic potential of these cells. However, 
effective cell populations within HUCB-MNC and their modes of action are not yet 
indentified. 
To assess the neuroprotective properties of different HUCB-MNC fractions rat 
organotypic hippocampal slice cultures were subjected to oxygen and glucose 
deprivation. HUCB-MNC or fractions thereof enriched (CD45+/CD34+) or depleted 
(CD45+/CD34-) for CD34-expressing stem and progenitor cells were (i) directly added 
onto hippocampal slices or (ii) co-cultivated indirectly. 
After direct application, HUCB-MNC were able to reduce neural damage in 
hippocampal slices throughout the full observation period (three days). CD34+ cells 
provided transient protection for two days, whereas the CD34- fraction failed to 
reduce neural degeneration. Direct addition of HUCB-MNC was superior to indirect 
co-cultivation of equal cell numbers (2.5x104 cells per slice). Rising concentrations of 
HUCB-MNC (up to 25x104) stepwise enhanced the protective effect to levels 
comparable to direct application. After direct application HUCB-MNC actively 
migrated into the slices. Flow cytometric analysis of migrated cells revealed that the 
CD34+ cells within HUCB-MNC were particularly attracted to supernatants of 
damaged hippocampal tissue. Analysis of trophic factor secretion indicates that 
HUCB-MNC-provided reduction of damage is accompanied by reduced nerve growth 
factor secretion from hippocampal tissue.  
The results of this study suggest that CD34+ cells are particularly involved in the 
protective action of HUCB-MNC after oxygen and glucose deprivation, at least partly 
by mediation of soluble factors derived by HUCB-MNC. Furthermore, CD34+ cells 
preferentially home to ischemic neuronal tissue.  
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8.2 Introduction 
 
Transplantation of human umbilical cord blood (HUCB) mononuclear cells (MNC) for 
experimental therapy of stroke has been thoroughly investigated since the first 
description of a therapeutic effect of these cells (Chen et al., 2001). Intravenous 
administration of HUCB-MNC reduced infarct volume and ameliorated behavioural 
deficits following middle cerebral artery occlusion in rodents (Vendrame et al., 2004). 
HUCB populations are proven not to induce severe graft versus host disease in 
allogenic use. These cells are also among the few stem cell containing populations 
allowing autologous application and might therefore become of clinical relevance 
(Brown et al., 2008; Yu et al., 2009).  
However, therapeutic mechanisms of HUCB transplanted after cerebral ischemia still 
remain speculative. Systemically delivered HUCB-MNC were identified near the 
lesion by immunohistochemistry and polymerase chain reaction (Vendrame et al., 
2004). Whereas, Chen et al. (2001) only localized 0.3% of administered cells near 
the ischemic lesion and proof for differentiation into functional neurons e.g. by using 
electrophysiological methods is still lacking. HUCB-MNC more likely influence the 
imbalanced neuronal microenvironment following stroke rather than to differentiate 
into functional brain tissue.  
There is growing evidence that HUCB therapy may exert neuroprotection by delivery 
of anti-inflammatory and immunomodulating molecules. HUCB contains a wide range 
of cell types that could mediate such effects. Beside potential therapeutic candidates 
like endothelial progenitors (Hildbrand et al., 2004) and mesenchymal stem cells 
(Tondreau et al., 2005), HUCB-MNC contain about 1% CD34+/CD45+ hematopoietic 
stem/progenitor cells as well as lymphoid and monocytic populations (Reich et al., 
2008). HUCB-MNC are known to secrete numerous soluble factors as interleukin 
(IL)-8, macrophage chemoattractive protein-1 (Newman et al., 2006), IL-10 
(Rainsford et al., 2002) and nerve growth factor (NGF, Bracci-Laudiero et al., 2003). 
By providing these factors, therapeutic cells may protect post stroke tissue by 
limitation of free radicals, inflammatory cytokines, lipases, and peroxidases and by 
neurotrophic signaling (Sanberg et al., 2005; Newman et al., 2006).  
Since the complexity of in vivo models for cell transplantation complicates focussed 
investigation of cellular interactions we used rat hippocampal slice cultures to 
determine effects of HUCB-MNC on survival of neurons after oxygen and glucose 
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deprivation (OGD). OGD of organotypic cultures has been widely proven to mimic 
many aspects of stroke and therefore is a well established tool to test potential 
neuroprotective therapies (Sarnowska et al., 2009). Comprising all types of neural 
cells in a three-dimensional network, hippocampal slice cultures offer the possibility 
to discriminate certain cellular effects in a sufficiently complex, but at the same time 
well defined experimental setup. Moreover, host immunologic responses after 
peripheral allogenic application possibly influencing stroke outcome are also 
excluded by using organotypic slices.  
Here, we investigated HUCB-MNC, CD34+, CD34- fractions, and Jurkat T cells, 
regarding to their ability to reduce neural cell damage in hippocampal slice cultures 
after OGD. In this context we addressed the protective potential in relation to 
application manner, cell number and secretion of soluble factors. We furthermore 
determined cell-type directed chemoattractive characteristics of damaged 
hippocampal tissue. 
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8.3 Materials and methods 
8.3.1 Preparation of umbilical cord blood samples 
Cord blood samples of healthy full-term neonates were taken in accordance to ethical 
regulations immediately after delivery. Samples were processed by density gradient 
separation using Lymphocyte Separation Medium (PAA Laboratories, Cölbe, 
Germany). The HUCB-MNC fraction suspended in fetal calf serum containing 8% 
dimethyl sulfoxide (Serumwerke Bernburg Inc., Bernburg, Germany) was 
cryopreserved in the gaseous phase of liquid nitrogen (Air Liquide GmbH, 
Düsseldorf, Germany). Prior to use, HUCB-MNC were rapidly thawed in phosphate 
buffered saline (PBS) supplemented with 75 U/ml DNase I (Roche Diagnostics, 
Mannheim, Germany; Sigma, Germany) and rinsed in RPMI 1640 (PAA).  
CD34+ cells were isolated from fraction by using the MACS® immunomagnetic 
positive selection protocol (Miltenyi Biotech, Bergisch Gladbach, Germany). Obtained 
cells were analyzed using a FACSCalibur flow cytometer equipped with the 
CellQuestTM software (both Becton-Dickinson, Franklin Lakes, USA) and 
characterized by the use of the following antibodies: CD45-fluorescein isothiocyanate 
(FITC) and CD34-allophycocyanin (APC, both Beckman Coulter, Krefeld, Germany). 
Isotype-identical monoclonal antibodies served as controls. CD34 enriched (CD34+) 
and CD34 depleted (CD34-) fractions contained 94.11% ± 3.42% and 0.06% ± 0.03% 
CD34 expressing cells, respectively. 
MNC, CD34+ and CD34- cell suspensions were stained (10 minutes at 37 °C) with 
carboxy fluoresceindiacetate succinimidyl ester (CFSE 5 µM; Molecular Probes, 
Leiden, The Netherlands) to visually control successful application of cells onto the 
slices. For migration studies HUCB-MNC were stained with CellTracker Orange (5- 
and-6- 4-chloromethyl benzoyl amino tetramethylrhodamine 5-
chloromethylfluorescein diacetate, CTO, 5 µM; Molecular Probes, Leiden, The 
Netherlands) according to manufacturer’s protocol. 
 
8.3.2 Experimental animals 
All experiments involving experimental animals were conducted according to the 
Magdeburg Regional Board, governmental commission for animal welfare and in 
compliance with the European Communities Council Directive of November 24, 1986 
(86/609/EEC). Organotypic hippocampal slice cultures were prepared from 60 
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postnatal Wister rat pubs (P7-9, Harlan Winkelmann, Borchen, Germany) as 
described previously (Stoppini et al., 1991).  
For migration experiments including confocal analysis, hippocampal slice cultures 
were prepared from 15 neonatal transgenic B6.Cg-TgN (Thy1-YFP) 16 Jrs mice (P5-
9, Jackson Laboratories, distributed by Charles River, Wilmington, USA). These 
animals express enhanced Yellow Fluorescent Protein (eYFP) at high levels in 
subsets of central neurons, including pyramidal cells of the hippocampus (Feng et al., 
2000). Briefly, rat and mouse pubs were sacrificed by rapid decapitation, a method 
recommended by the Magdeburg Regional Board. Afterwards, the brain was 
removed from the skull for ex vivo hippocampus preparation. 
8.3.3 Organotypic hippocampal slice cultures 
Hippocampi were dissected and transversely sliced (350 µm) on a McIlwain tissue 
chopper (The Mickle Laboratory Engineering, Guildford, UK). Slices were then 
carefully transferred onto humidified 0.4 µm porous Millicell membrane inserts 
(Millipore, Mosheim, France). Cultures were maintained in 1 mL of serum-based 
medium (50% MEM-Hanks, 25% HBSS, 17 mM HEPES, 5 mM glucose, 1 mM L-
glutamine, 25% horse serum and 0.5% gentamycin) at 37°C for three days. 
Thereafter, cultures were transferred to serum-free medium (50% MEM-Hanks, 25% 
HBSS, 17 mM HEPES, 5 mM glucose, 1 mM L-glutamine, 25% Neurobasal-A, 0.5% 
B27 and 0.5% gentamycin; referred as standard condition) and kept for 7 days at 
37°C in 5% CO2 with medium change twice a week. Twenty four hours before 
experimental use, 2 µL propidium iodide (PI; 1 mg/mL, Sigma, Deissenhofen, 
Germany) was added to the culture medium. Organotypic hippocampal slices were 
then screened by fluorescence microscopy to exclude cultures that were pre-
damaged during the preparation process. 
 
8.3.4 Oxygen and glucose deprivation injury 
For OGD, hippocampal slices were transferred to six-well-plates containing 1 mL of 
10 mM mannitol-containing glucose-free Ringer solution. Cultures were placed in a 
gas-tight chamber at 37°C. Oxygen was replaced by 95% N2 and 5% CO2 within 10 
minutes and slices were incubated for another 40 minutes. Untreated control cultures 
were maintained for the same time under a normoxic atmosphere in glucose-
containing Ringer solution.  
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8.3.5 Co-culturing of hippocampal slices and HUCB cell fractions  
After OGD slices were returned to normoxic standard culture conditions. Afterwards, 
1 µL Neurobasal A medium containing 2.5x104 HUCB-MNC (CTO-labelled for 
migration studies), CD34+, CD34- cells or Jurkat T cells was administered directly 
onto the slices. For indirect co-culturing, 2.5x104, 12.5x104 or 25x104 HUCB-MNC per 
slice were seeded under the interface cultures. Direct and indirect co-cultures were 
analyzed on three consecutive days. The experimental set ups for OGD and co-
culturing are shown in supplementary figures 1 and 2, respectively. 
 
8.3.6 Analysis of cellular damage 
After one, two or three days slices were incubated with 10 µl PI (1 mg/mL) for two 
hours. Damage was analyzed in the cornu ammonis (CA1-CA2-CA3). Propidium 
iodide fluorescence was elicited at 546 nm and recorded at >610 nm on an inverted 
Nikon Eclipse TE-2000 fluorescence microscope (4-fold magnification; Nikon, 
Duesseldorf, Germany) and subsequently analyzed using an image analysis software 
(LUCIA M, Nikon). To ensure comparability of data, in each individual experiment 
fluorimetric mean values obtained at Day 1 from slices that underwent OGD were 
defined as 100%. All other data obtained are given as relative values.  
 
8.3.7 Descriptive migration assay  
For descriptive migration assay, HUCB-MNC were stained with CTO as stated 
above. Migration studies were performed using OGD slices and normoxic control 
slices after 3 days of maintenance using a Zeiss LSM Pascal 5, Laserlinie 488 
confocal laser scanning microscope (Zeiss Plan Neofluar 20x or 40x, Jena, 
Gernany). 
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8.3.8 Quantitative flow cytometric analysis of migrating HUCB-MNC 
For quantitative migration assessment, slices were collected and stored at -80°C until 
further use. After thawing, slices were homogenized using 70 µm cell strainers (BD 
Falcon, Franklin Lakes, USA). Extracts were dissolved in serum-free medium and 
protein concentration was adjusted to 1 µg/ml. 500 µl homogenate solution were filled 
in the lower compartment of the migration chambers. Equal volumes of medium 
supplemented with 200 ng/ml recombinant Stromal Cell-Derived Factor (SDF; 
Immunotools, Friesoythe, Germany) served as controls. 1x106 HUCB-MNC were 
suspended in 100 µl medium and administrated into the upper part of the migration 
chamber build by 8 µm pore size cell culture inserts (Greiner, Frickenhausen, 
Germany). Cells were allowed to migrate for four hours in a humidified incubator at 
37°C and 5% CO2. Afterwards, inserts were removed and migrated HUCB-MNC were 
collected. Viability and numbers of migrated cells were determined using the Trypan 
Blue exclusion method and BD Truecount Tubes (BD Biosciences, San Jose, CA, 
USA), respectively. HUCB-MNC were characterized according to cellular subtypes by 
use of a FACSCalibur flow cytometer (Becton Dickinson) using the following sets of 
antibodies: (i) CD45-APC, CD19-phycoerythrin-cyanin 7 (PE-Cy7, both Beckman 
Coulter), CD14-FITC (Becton Dickinson), CD3-PE (Immunotech, Hohenlockstedt, 
Germany), (ii) CD45-PE-Cy7, CD133/2-PE, CD34-APC (Beckman Coulter), (iii) CD3-
FITC, CD56-PE (Becton Dickinson). Isotype-identical monoclonal antibodies served 
as controls. 
 
8.3.9 Analysis of human and rat soluble mediators 
To profile human and rat trophic factors supernatants of co-cultures were 
investigated using antibody array kits (RayBiotech, Norcross, USA). Membranes for 
analysis of soluble factors were plotted with antibodies against human brain derived 
neurotrophic factor (BDNF), NGF, epidermal growth factor (EGF), vascular 
endothelial growth factor (VEGF) and insulin-like growth factor 1 (IGF-1); or against 
rat ciliary neurotrophic factor (CTNF), NGF and VEGF. Supernatants were pooled 
from six wells, each containing three slices. Samples were centrifuged (400 x g, 10 
minutes) and stored at -80°C. Double concentrated (3400 x g, 20 minutes, Amicon 
Ultra-4, Millipore, Eschborn, Germany) supernatants from OGD cultures as well as 
supernatants after direct (2.5x104) and indirect (2.5x104, 12.5x104, 25x104) 
Chapter 3 
79 
application of HUCB-MNC were investigated. Array was performed according to 
manufacturer’s instructions. Chemiluminescence of membranes was visualized in the 
Intelligent Dark Box II (Fuji Photo Film, Düsseldorf, Germany) for 40 seconds.  
 
8.3.10 Statistical analysis of data 
All results are reported as mean ± standard deviation except for data on HUCB-MNC 
migration and rat soluble factors which, for methodological reasons, represent pooled 
samples. Statistical differences were analyzed using Mann-Whitney rank sum-test 
expect experiments on migration where Student´s t-test was used. P values of <0.05 
were considered statistically significant and are indicated by single asterisks or 
alternative symbols (*, or # and §).  
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8.4 Results 
 
8.4.1 Reduction of OGD induced damage in hippocampal slices after 
HUCB-MNC application 
In a first set of experiments we evaluated the protective properties of different cell 
preparations derived from human cord blood (HUCB-MNC, CD34+, CD34-) and of a T 
cell line by semiquantitative analysis of PI staining after OGD. OGD procedure 
induced broad cellular damage, predominantly in the pyramidal layer of hippocampal 
slices, which was indicated by a strong increase in PI staining. The degree of 
damage remained stable throughout the whole exploration period (Fig. 1A and Fig. 
1B upper vs. middle row). Direct application of HUCB-MNC had a significant 
protective impact (p<0.05) and reduced cellular degeneration by above 50% at every 
investigated time point (Fig. 1A, B lower row). 
Comparable to HUCB-MNC, the CD34+ fraction reduced cell degeneration at Day 1 
and Day 2 but failed to provide protection effect on Day 3. On the other hand, 
depletion of CD34 expressing cells (CD34-) from HUCB-MNC abolished reduction of 
neural damage, as indicated by higher PI staining. When applied on damaged 
hippocampal slices Jurkat T cells also did not reduce neural degeneration. 
Application of those cells was even associated with exacerbation of OGD induced 
cellular on Day 3 (p<0.05; Fig. 1A). 
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Figure 1. Evaluation of 
neuroprotective properties of 
HUCB-MNC, CD34+, CD34- and 
Jurkat T cells following OGD 
on rat hippocampal slices 
After OGD, 2.5x104 cells of each 
fraction were directly applied onto rat 
hippocampal slices. Cellular 
degeneration in the cornu ammonis 
was assessed by PI staining for 
three subsequent days. Application 
of HUCB-MNC and CD34+ cells 
diminished damage at Days 1 and 2 
(p<0.05, Mann-Whitney-Test) as 
indicated by reduced PI fluorescence 
intensity, but only HUCB-MNC were 
able to provide protection until the 
end of the observation period (A). 
CD34- cells failed to prevent cell 
damage in the cornu ammonis while 
the application of T cells even raised 
the amount of cellular damage at 
Day 3 (p<0.05, Mann-Whitney-Test). 
White bars represent PI 
fluorescence in normoxic control 
hippocampal slices. All bars 
represent relative mean values ± SD 
of PI fluorescence assessed in three 
separate experiments comprising six 
slices each (n=18). Fluorimetry 
values obtained from OGD slices at 
Day 1 were set 100%. 
Representative fluorescence micrographs of rat hippocampi cultivated under normoxic conditions, 
after OGD, and after OGD followed by HUCB-MNC application are given in (B).  
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8.4.2 Influence of OGD damaged hippocampal tissue on migration of 
HUCB-MNC fractions  
MNC were labelled with CTO and applied onto mouse slices with transgenic neuronal 
expression of eYFP (Fig. 2). Fluorescence microscopic evaluation revealed that after 
application of 2.5x104 HUCB-MNC onto damaged tissue more cells adhered to the 
slice as compared to application of the same HUCB-MNC number on normoxic 
hippocampal tissue (Fig. 2A vs. 2B). In addition, three-dimensional confocal analyses 
showed that HUCB-MNC preferentially invaded into the damaged nervous tissue 
(Fig. 2D and 2E). In contrast, HUCB-MNC predominantly remained at the slice 
surface when applied onto normoxic control slices (2E vs. 2F). Cocultivated with 
normoxic control slices slices, HUCB-MNC remained morphologically unchanged, 
whereas applied onto OGD slices, HUCB-MNC often converted from round to 
enlongated phenotype (Fig. 2C). 
A migration assay using supernatants of homogenized organotypic cultures 
(Newman et al., 2005) was used to obtain information about the cell population 
migrating into lesioned hippocampal tissue. In this assay undamaged normoxic 
control tissue and tissue that underwent OGD prior to homogenization induced 
migration of comparable cell numbers cells (Fig. 2G), each of them significantly 
differing from medium control (p<0.05). Addition of SDF-1 (CXCL-12), a potent 
chemoattractant for hematopoetic stem and progenitor cells (Aiuti et al., 1997), 
monocytes and lymphocytes (Bleul et al., 1996), markedly induced migration of 
HUCB-MNC towards the lower chamber of the culture system (p<0,01; Fig. 2G), thus 
serving as positive control in this assay.  
Migrated cells where analyzed by flow cytometry to investigate the chemotactic 
influence of damaged nervous tissue on different HUCB-MNC fractions (T cells, B 
cells, NK cells, CD34+, and CD133+ cells). Comparison of the total numbers of 
different migrated cells revealed no obvious differences between OGD slices and 
normoxic control tissue. In all setups, T cells were the most prominent fraction within 
migrated HUCB-MNC (Fig. 2H, note logarithmic scale). Relative comparison between 
originally applied cell numbers and migrated cells for every of the investigated cell 
population (see above) revealed that, in difference to normoxic tissue (control), OGD 
damaged hippocampal tissue preferentially attracted CD34+ stem/progenitor cells 
(Fig. 2I). Attraction of other cell fractions did not markedly differ between control and 
damaged hippocampal tissue extracts. 
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Figure 2. Induction of active migration of CD34+ cord blood cells by post ischemic 
hippocampal tissue  
A-F (results obtained from transgenic mice): When 2.5x104 CTO-labelled, HUCB-MNC (red) were 
added directly onto hippocampal slices of B6.Cg-TgN, Thy1-eYFP 16 Jrs transgenic mice (green 
fluorescence in pyramidal neurons) after three days of cultivation, only scattered, round HUCB-MNC 
were seen on control slices (A). In contrast, numerous HUCB-MNC were observed on OGD slices (B). 
These cells preferentially developed an elongated soma (C, insert in B). More cells migrated into the 
tissue (D, E) as compared to normoxic control slices (F). CTO signals from HUCB-MNC in the slices 
are indicated by white arrow heads. Scale bars represent 100 µm in (A) and (B) and 25 µm in (C) and 
(D). D shows total z view of an OGD slice. Inserts in E and F represent vertical sections at positions 
indicated by green or red lines. G-I (results obtained from rat hippocampal slices): Cell free 
supernatants were obtained from homogenates of 23 rat hippocampal slices after three days of 
cultivation and added to the lower compartment of a migration chamber. Migration of HUCB-MNC 
towards supernatants was investigated and compared to medium and medium supplemented with 
SDF-1 as negative and positive controls, respectively (n=6) (G). Hippocampal slices with and without 
previous OGD induced migration of similar numbers of HUCB-MNC (G; p<0.05 as compared to 
medium control, Student´s t-test), while strongest migration was observed towards SDF-supplemented 
medium (G, p<0.001, triple asterisks, Student´s t-test). However, absolute and relative number of 
migrated CD34+ cells was higher after OGD (H and I) as compared to slices maintained under 
normoxic conditions. Note logarithmic scaling of ordinate in H. 
 
8.4.3 Effects of application mode and cell dose on neurodegeneration in 
hippocampal slice cultures 
After HUCB-MNC application appeared to be highly effective we aimed to evaluate 
the role of direct cell contacts for mediation of the protective potential after OGD. For 
that reason effectiveness of directly applied HUCB-MNC was compared with indirect 
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application, the latter only allowing transposition of soluble factors, but not direct cell-
cell contact between damaged hippocampal tissue and HUCB-MNC.  
Indirect cocultivation of the same number of HUCB-MNC (2.5x104) had a markedly 
lower protective effect as revealed by PI-staining. In contrast to direct application, this 
effect could only be discriminated from spontaneous neurodegeneration in untreated 
OGD slices at Day 2 (p<0.05; Fig. 3A). To test whether this less pronounced effect 
could potentially be caused by lowered concentrations of soluble neuroprotective 
factors after indirect HUCB-MNC application, rising numbers of cell were applied to 
OGD damaged slices (Fig. 3B). Five-fold elevation of HUCB-MNC number (12.5x104) 
diminished degeneration at all time points investigated following OGD (p<0.05; 
Fig. 3B). At Day 2 after OGD, a further increase of applied HUCB-MNC number 
(25x104) caused an additional significant reduction of PI-staining (Fig. 3B) indicating 
a dose-depending protection by indirectly applied HUCB-MNC. 
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Figure 3. Dose-dependent reduction of cellular damage after indirect application of 
HUCB-MNC onto rat hippocmapal slices 
For indirect application, HUCB-MNC were placed under the slice culture inserts. Slices were observed 
for three days. In contrast to direct application, 2.5x104 HUCB-MNC were only transiently able to 
diminish cellular damage in hippocampal slices following OGD (A, p<0.05, Mann-Whitney-Test) and 
failed to provide cellular protection at Days 1 and 3 (A, p=0.189, Mann-Whitney-Test). Indirect co-
cultivation using 5- and 10-fold increased cell numbers was able to reduce OGD induced neural 
degeneration on all days (p<0.05, Mann-Whitney-Test). The protective effect of indirect HUCB-MNC 
application gradually increased with rising cell concentrations, in particular at Days 1 and 2 (B). Bars 
show the mean ± SD of three independent experiments each comprising six slices (n=18). Values 
were set in relation to OGD at Day 1 which was set 100%. (*) Significantly different from OGD; (#) 
from 2.5x104 HUCB-MNC indirect, and (§) from 12.5x104 HUCB-MNC indirect. 
 
8.4.4 Expression of neurotrophic factors  
Since evaluation of indirect application of HUCB-MNC indicated a potential role for 
soluble protection providing agents, HUCB-MNC induced changes in the expression 
of human and rat derived trophic factors were analyzed. Changes in the expression 
of human trophic factors secreted by applied HUCB-MNC were not detectable 
because concentrations of measured human factors (NGF, EGF, IGF-1, BDNF) were 
below the detection limit of the assay (40 pg/ml). VEGF secretion from rat 
hippocampal tissue did not change after direct or indirect application of human 
HUCB-MNC (Fig. 4, left). Evaluation of rat NGF levels revealed a reduction of NGF 
secretion from OGD slices after application of HUCB-MNC in all co-cultivation 
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paradigms (Fig. 4, right). Rat CNTF was not secreted in measurable amounts. Since 
analysis had to be carried out with pooled samples to reach detection limits, 
descriptive statistics were not applicable.  
 
 
Figure 4. Expression of neurotrophic factors 
Rat neurotrophic factors were measured in supernatants obtained from six pooled rat hippocampal 
slices that were co-cultivated with human HUCB-MNC. Bars illustrate relative intensity units. 
Evaluation of VEGF secretion from rat hippocampal tissue did not reveal changes, but NGF secretion 
was reduced in all performed co-cultivation setups. Values obtained from normoxic control slices 
without HUCB-MNC were set 100% and are indicated as dashed line.  
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8.5 Discussion 
 
MNC preparations from HUCB have been emerged as a highly promising tool for 
protection of neural tissue and for enhancement of regeneration following stroke. 
However, the mode of action underlying the therapeutic potential of HUCB-MNC is 
still a matter of debate. Some investigators found evidence for limited replacement of 
lost neuronal cells after ischemia (Chen et al., 2001). Stem cells contained in HUCB-
MNC are in principle able to transdifferentiate into neural cells (Greschat et al., 2008) 
but their functionality in vivo still remains unproven. Other results indicate that HUCB-
MNC could limit the progress of neuronal degeneration by delivering trophic factors 
(Arien-Zakay et al., 2009), by modulation of the neuroinflammatory response 
(Vendrame et al., 2005) and by activation of anti-apoptotic pathways (Dasari et al., 
2008).  
8.5.1 Ischemic damage reduction by HUCB cell populations 
To address the question how HUCB-MNC may diminish ischemic damage of nervous 
tissue we first analyzed the neuroprotective properties of different cell types within 
HUCB-MNC preparations. Neuronal loss in OGD damaged hippocampal tissue 
indicated by PI staining was reduced over 3 days only by the whole HUCB-MNC 
fraction. Purified CD34+ stem and progenitor cells provided protection on the Day 1 
and 2, but not thereafter. CD34 depleted HUCB-MNC (CD34-) abolished the 
observed reduction of PI-staining (Fig. 1). 
These results indicate that CD34+ cells might preferentially trigger the retaining of 
OGD damaged neuronal tissue. Comparison of the different results obtained with 
HUCB-MNC and CD34+ on Day 3 suggests that another cell type within both cell 
preparations could protective the effect maintenance (Fig. 1). Therefore, the main 
fraction within HUCB-MNC, CD4+ T cells, was taken into account (Brown et al., 2008) 
by using the Jurkat T cell line that is characterized by expression of CD4 and 
secretion of interferon gamma (Hayashi et al., 2008) as a surrogate.  
Though, the T cell line was not able to provide neuroprotection and even 
exacerbated tissue damage (Day 3). This argues against activated Th1 biased CD4 T 
cells as mediators of tissue protection and is in accordance with animal models of 
focal stroke. In those proinflammatory activated T cells exacerbated tissue damage 
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that probably lead to proinflammatory activation of microglial cells (Chabot et al., 
2001).  
The results obtained in the present study differ from data that we previously gained, 
using a post hypoxic neuronal cell culture model based on a fully differentiated a 
neuroblastoma cell line. In that experimental setup, both, stem cell enriched and stem 
cell depleted HUCB-MNC had strong protective capacity (Reich et al., 2008). Such 
divergent results obtained in two neuronal cell culture models indicate a strong 
system dependency, which always should be taken into consideration, while 
interpreting in vitro results. A major difference that could explain these variations in 
results is the preserved tissue architecture in organotypic hippocampal slices 
including functional neuronal contacts and the presence of glial cells. Results 
obtained by our group with the same organotypic system demonstrated that for 
instance microglia can enhance neuronal survival when applied without previous 
proinflammatory commitment by LPS (Neumann et al., 2006).  
 
8.5.2 Protective effects of HUCB-MNC after direct and indirect 
application to OGD OHC 
Two different experimental paradigms were used in this study: (i) direct application of 
HUCB-MNC and (ii) co-cultivation of hippocampal slices and HUCB-MNC separated 
by a porsous but cell dense membrane that allows detection neurotrophic effects 
provided by soluble HUCB-MNC derived factors. HUCB-MNC co-cultivated 
separately from neuronal tissue provided diminished protection of neural tissue 
compared to direct application of equal cell numbers. This observation could be 
explained by concomitant action of soluble factors and cell contact effects. Possibly, 
the diminished effects were caused by reduced concentrations of soluble mediators 
when cells where placed remote from post ischemic tissue. To test the latter we used 
rising numbers of HUCB-MNC in the indirect co-cultivation setup. With this approach 
we could reach protective effects comparable to direct application, only occurred by 
using 5- and 10-fold increased cell numbers (Fig. 3B). This dose-dependency further 
points to of soluble factors as main mediators of the reduced neural damage after 
OGD. 
This observation bears two practical consequences. First, the data imply peripheral 
intravenous application of cells as potential therapeutic strategy after stroke. Second, 
therapeutic effects would depend on sufficient concentrations of protection providing 
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substances at the site of action. Therefore, directed accumulation of systemically 
applied cells should enhance its therapeutic effect. 
 
8.5.3 Migration of HUCB-MNC towards OGD damaged OHC 
Migration studies showed that HUCB-MNC invaded the hippocampal tissue primarily 
after OGD (Fig. 2). The elongated morphology of invaded cells implies an active 
migration process (Ridley et al., 2003). To dissect subtypes of HUCB-MNC 
preferentially migrating towards the OGD damaged hippocampal tissue solution we 
employed a migration chamber and characterized migrated cells according to surface 
markers for T cells, B cells, NK cells, CD45/CD34+, and CD45/CD133- cells. We 
used SDF-1 (CXCL12) known to be strong regulator of cell recruitment as a positive 
control to demonstrate the migratory potential of HUCB-MNC fractions. SDF-1 affects 
lymphocytes, monocytes (Bleul et al., 1996) and, CD34+ progenitor cells (Aiuti et al., 
1997) expressing the SDF-1 receptor CXCR4. T cells, the most prominent cell type in 
our HUCB-MNC preparations, were also the most abundant cells migrating in all 
settings (Fig. 2H). But in relation to the total numbers of migrated cells the proportion 
of T cells was not noticeably enhanced after OGD (Fig. 2I). Applying control or OGD 
supernatants did not influence the proportion of most cell types. Remarkably, only the 
proportion of CD34+ cells was enhanced in the OGD system indicating a specific 
attraction of stem and progenitor cells to ischemic damaged neuronal tissue. This 
homing like process underlines observations describing graft enrichment at lesioned 
sites made in animal models of stroke (Taguchi et al., 2004; Piao et al., 2009). In 
contrast to the microscopic investigation, where we detected cells preferentially 
invading OGD slices, in this experimental set up OGD and control slice homogenates 
attracted the same amounts of HUCB-MNC (Fig. 2G). Most probably, additional 
migration enhancing molecules released during homogenisation does account for 
this result.  
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8.5.4 Modulation of NGF secretion by HUCB-MNC  
Previous results obtained in the neuroblastoma cell culture model showed a markedly 
increase in neuronal VEGF secretion. This hypoxia induced VEGF production was 
reduced after direct co-cultivation of neuronal cells with HUCB-MNC (Reich et al., 
2008). Based on those previous observations we monitored VEGF in the slices to 
learn more about the neuronal response to OGD and HUCB-MNC application. In 
contrast, HUCB-MNC application after OGD did not reduce VEGF secretion by 
hippocampal cells (Fig. 4). Explanations for this observation could be glial influences 
on neuronal VEGF secretion in the organotypic system or a different regulation in the 
release of VEGF from hippocampal glial cells (Schmid-Brunclik et al., 2008). This 
result again emphasizes the specific scope of different culture systems. 
NGF has been shown to reduce neuronal death in the gerbil hippocampus after 
ischemia (Shigeno et al., 1991). Different from VEGF, secretion of rat NGF was 
decreased after direct or indirect HUCB-MNC administration (Fig. 4). Reduction of 
neuronal damage after HUCB-MNC application could be associated with increased 
preservation of NGF receptive structures causing the observed decrease of unbound 
NGF in supernatants. More probably NGF reduction was due to decreased secretion 
by glial cells shown to upregulate NGF expression after ischemia induced neuronal 
damage (Himeda et al., 2007). In this case observed NGF reduction would account 
for reduced neuronal damage and subsequently diminished glial activation after 
HUCB-MNC application. 
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8.6 Conclusions 
 
In summary, the experiments described in this study indicate that HUCB-MNC (i) can 
enhance survival rates of pyramidal cells in hippocampal slices damaged by OGD 
and (ii) do promote neuroprotection at least in part not by direct cellular contact to 
injured neurons. Furthermore, CD34+ cells, a fraction of HUCB-MNC, were shown to 
preferentially provide neuroprotection in early stages following ischemia and are able 
to specifically accumulate at damaged tissue sites.  
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8.7 Abbreviations 
 
APC, allophycocyanin; BDNF, brain derived neurotrophic factor; CTNF, ciliary 
neurotrophic factor; CTO, Celltracker OrangeTM; EGF, epidermal growth factor; 
eYFP, enhanced Yellow Fluorescent Protein; FITC, fluorescein isothiocyanate; 
HUCB, human umbilical cord blood; IGF-1, insulin-like growth factor 1; IL, interleukin; 
MNC, mononuclear cells; NGF, nerve growth factor; OGD, oxygen glucose 
deprivation; PBS, phosphate buffered saline; PE, phycoerythrin; PE-Cy7 
phycoerythrin-cyanin7; PI, propidium iodide; VEGF vascular endothelial growth 
factor. 
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8.8 Supplementary Material 
 
Figure S1 
 
Figure S2 
 
Supp. Fig.:1+2: Chronological sequence of experimental setup 
OGD was performed on 12 days old hippocampal slices. One day before the OGD procedure 
predamaged slices were excluded from the experiment by using PI (Supp. Fig.1). Subsequent to 40 
minutes OGD cells (MNC, CD34+, CD34- or Jurkat T cells) were directly administrated onto the slices 
(Supp. Fig.1, Supp. Fig.2). Alternatively MNC were applied into the culture medium (Supp. Fig.1, 
Supp. Fig.2). All co-cultures were analyzed on three consecutive days. 
Abbreviations in Supp. Fig.2: a cell culture dish, b OHC, c cell culture insert, d culture media, e pipette 
applying cells directly onto OHC, f pipette applying cells into the culture media
 
direct application indirect application 
b 
c 
d 
a 
e 
f 
cultivation (12d) OGD (40´) post OGD – co-cultivation  
 Day 0 - 1 day  Day 1 Day 3 Day 2 
preselection daily analysis 
 
direct application of  
MNC, CD34+, CD34-, Jurkat T cells
indirect application of MNC 
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9 Summary 
 
As a compilation of two publications and unpublished material this work addresses 
the question which fraction (HUCB-MNC, CD45+/CD34+, and CD45+/CD133+) of the 
heterogeneous HUCB is most sufficient in providing neuronal protection after 
experimental stroke and what are mechanisms of action. A post hypoxic cell culture 
model and hippocampal slice cultures subjected to OGD were utilized to investigate 
molecular mechanisms involved in the interplay between HUCB fractions and 
damaged neuronal cells or tissue. HUCB fractions under investigation were directly 
or indirectly administered and their effect was investigated through three consecutive 
days. The molecular mirco environment created by hypoxically injured neuronal cells 
stimulated all fractions of HUCB to secrete neurotrophic factors and/or imunologically 
active substances influencing neuronal apoptosis.  
HUCB-MNC showed a compelling neuroprotective capacity in direct as well as in 
indirect co-cultures. Directly administered HUCB-MNC drastically reduced rates of 
neuronal apoptosis to range of controls. That might be caused through a marked 
increase of chemokines CCL5; CCL3 and CXCL10 released by HUCB-MNC which 
after active migration formed clusters in direct cell-cell contacts with axons and 
somata of neuronal cells. Surprisingly CD45+/CD133- had comparable potential to 
HUCB-MNC. Within indirect co-cultures this stem cell reduced fraction produced high 
concentrations of CCL3 and neuroprotective G-CSF triggering the retaining of 
neuronal phenotypes. 
CD45+/CD133+ stem cells separated from HUCB-MNC significantly reduced 
neuronal apoptosis in direct co-cultivations; however, soluble factors produced by 
CD45+/CD133+ cells were not detectable in a measurable concentration. 
Results obtained from hippocampal slices subjected to ODG showed that HUCB-
MNC can mediate direct neuroprotection especially when they were directly 
administered in sufficient cell numbers (12.5x104 MNC per slice). In addition, 
CD45+/CD34+, but not CD45+/CD34- cell fractions separated from HUCB-MNC 
transiently reduced the number of degenerating pyramidal neurons by a reduced 
secretion of nerve growth factor.  
Results obtained from the two different in vitro models that were employed here 
indicate that neuroprotection by HUCB-MNC is a stable approach to provide 
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neuroprotection while the divergent results for stem cell fractions differ and indicate a 
strong system dependency. Particularly in regard to the clinical use there seems to 
be no benefit in the use of pure stem cell fractions gained from HUCB-MNC that 
justifies the effort on selection of that small amount of cells from the HUCB-MNC 
fraction.
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Abstract
Background: One of the most promising options for treatment of stroke using adult stem cells are human umbilical cord blood
(HUCB) cells that were already approved for therapeutic efficacy in vivo. However, complexity of animal models has thus far
limited the understanding of beneficial cellular mechanisms. To address the influence of HUCB cells on neuronal tissue after
stroke we established and employed a human in vitro model of neuronal hypoxia using fully differentiated vulnerable SH-SY5Y
cells. These cells were incubated under an oxygen-reduced atmosphere (O2< 1%) for 48 hours. Subsequently, HUCB
mononuclear cells (MNC) were added to post-hypoxic neuronal cultures. These cultures were characterized regarding to the
development of apoptosis and necrosis over three days. Based on this we investigated the therapeutic influence of HUCB MNC
on the progression of apoptotic cell death. The impact of HUCB cells and hypoxia on secretion of neuroprotective and
inflammatory cytokines, chemokines and expression of adhesion molecules was proved.
Results: Hypoxic cultivation of neurons initially induced a rate of 26% ± 13% of apoptosis. Hypoxia also caused an enhanced
expression of Caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP). Necrosis was only detected in low amounts. Within
the next three days rate of apoptosis in untreated hypoxic cultures cumulated to 85% ± 11% (p ≤ 0.001). Specific cytokine
(VEGF) patterns also suggest anti-apoptotic strategies of neuronal cells. Remarkably, the administration of MNC showed a
noticeable reduction of apoptosis rates to levels of normoxic control cultures (7% ± 3%; p ≤ 0.001). In parallel, clustering of
administered MNC next to axons and somata of neuronal cells was observed. Furthermore, MNC caused a pronounced increase
of chemokines (CCL5; CCL3 and CXCL10).
Conclusion: We established an in vitro model of neuronal hypoxia that affords the possibility to investigate both, apoptotic
neuronal cell death and neuroprotective therapies. Here we employed the therapeutic model to study neuroprotective
properties of HUCB cells.
We hypothesize that the neuroprotective effect of MNC was due to anti-apoptotic mechanisms related to direct cell-cell 
contacts with injured neuronal cells and distinct changes in neuroprotective, inflammatory cytokines as well as to the 
upregulation of chemokines within the co-cultures.
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Acute ischemic stroke is characterised by the immediate
depletion of oxygen and glucose in brain tissue. A residual
cerebral blood flow (CBF) of ≤ 6 cm3 × 100 g-1 × min-1 rep-
resenting severe ischemia is associated with a nearly total
loss of energy on vulnerable neurons. Ischemia therefore
rapidly culminates in the formation of a necrotic core [1].
In the penumbra, mild ischemia (CBF 11–20 cm3 × 100 g-
1 × min-1) leads to the activation of complex neurochemi-
cal cascades of cell death, mainly apoptosis. In principle
these apoptotic cascades are reversible and form an
important aspect of the penumbra concept, which is the
major target of therapeutic interventions [2,3]. Recent
findings indicate that transplantation of external cell frac-
tions could accompany established therapeutic proce-
dures limited by narrow time windows [4], but the
underlying processes are still rather unclear.
Our insights into pathophysiological processes and new
therapeutic strategies have mostly been obtained from
animal models of focal cerebral ischemia [5,6] and rodent
organotypic hippocampal slice cultures [7-9]. However,
the complexity of those systems has limited the detailed
understanding of mechanisms related to ischemic brain
injury [10] and possible interfering effects of cellular ther-
apies [11] so far. Furthermore, results obtained from
rodent models are not completely and unobjectionably
transferable to human therapy [12,13]. Consequently,
experimental expenditure and ethical considerations
demand in vitro models representing the main properties
of stroke-related processes as neuronal apoptosis to
accompany more complex model systems. This would
allow to answer explicit questions concerning the role of
cell-cell interactions and production of metabolites to ver-
ify observations made in in vivo models. It furthermore
offers the possibility to precisely manipulate extra cellular
environments.
Well described human neuronal cell lines exhibit a multi-
tude of characteristics of typical central-nervous-system
(CNS) neurons, overall cell material can be achieved in
large quantities. Therefore, human neuronal cell lines,
such as the teratocarcinoma NT-2 cell line, became useful
tools to study the effects of hypoxic conditions on neu-
rons [14]. However, the utilisation of NT-2 neuronal cul-
tures is restricted by time-consuming and expensive
differentiation periods of up to 44–54 days [15,16] that
are also sensitive to environmental disturbances. In con-
trast, the SH-SY5Y neuroblastoma cell line was shown to
be differentiated into neuronal cells within a compara-
tively short time of 16 days [17]. Furthermore, the cell line
fits major relevant criteria (high vulnerability, irreversible
differentiation into pure neuronal cells) to serve as a
model of hypoxic injury of central neurons [18]. Hence,
our exclusive human model of neuronal hypoxia forms
the basis to identify possible anti-apoptotic neuroprotec-
tive potentials of therapeutic supplements. Mononuclear
cells (MNC) from human umbilical cord blood (HUCB)
were shown to improve functional outcome of animals
after focal cerebral ischemia. The cellular effects causing
the observed benefits are not fully understood for these
cells [19,20]. In this context we investigated whether
injured post-hypoxic neuronal cells or MNC initiated an
anti-apoptotic response mediated by cytokines or chem-
okines.
Results
After differentiation SH-SY5Y exhibited neuronal 
morphology and specific neuronal markers
Sixteen days of differentiation yielded cultures of fully
matured neuronal cells shown in Fig. 1A, B. Following the
seventh day of differentiation, the majority of SH-SY5Y
cells were stained positive for the specific neuronal mark-
ers (β-tubulin III, taurin I, neuron-specific enolase [NSE],
neurofilament [NF] H/M and microtubule-associated pro-
teins [Map] 2a/b). At Day 16 all cells exhibited all of these
markers. Time course of marker expression showing con-
tinuously increasing stages of differentiation is given in
Fig. 1C. Markers showed typical localisation to cytoplasm
and dendrites. The explicit majority of differentiated SH-
SY5Y cells (73% ± 11%) resembled typical neuronal mor-
phology with round phase-bright somata and long, termi-
nal- branched dendrites forming a dense network (Fig. 1A,
arrow 1). However, the neuronal culture is also character-
ised by a cell type (only 27% ± 11%) which shows abun-
dant cytoplasm and a lack of axonal extensions (Fig. 1A,
arrow 2). Remarkably, no differences were noted with
regard to expression of neuronal markers. Furthermore,
the number of this type of cells remained constant during
the culture time.
Absence of proliferation after termination of 
differentiation
At Day 4 of differentiation the total number of SH-SY5Y
cells, counted by nuclear staining with DAPI, increased by
twofold (21.2 ± 6.7 × 103/cm2) since seeding. Beginning
on the seventh day of culture numbers of nuclei remained
nearly stable (18.2 ± 2.2 × 103/cm2). Subsequent to
hypoxia, there was no significant alteration in numbers of
counted nuclei. Hence, the influence of oxygen depriva-
tion induced no further proliferation and also no signifi-
cant loss of cells in comparison to normoxic control
cultures (Fig. 2). Therefore all following results should be
seen in the context of the nearly constant numbers of neu-
ronal cells under normoxic and hypoxic cultivation condi-
tions. It is of note that the amount of stained nuclei as the
equivalent of adherent cells gives no information about
the physiologic status of these cells. On the whole the cul-
tures include cells in a viable, apoptotic or necrotic state.Page 2 of 15
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cells
Post-hypoxic and normoxic control cultures exhibited
pronounced differences in the quantity of apoptotic cells
as well as in cell morphology. Hypoxic conditions for 48
hours induced an initial apoptosis rate of 26% ± 13%.
There was a continuous increase in the apoptotic cell frac-
tion to 85% ± 11% within 3 days post-hypoxia as com-
pared to control cultures (p ≤ 0.001; Fig. 3). The clearest
effects of oxygen deficiency were seen three days following
induction of hypoxia as shown by annexin-V staining
(green fluorescence, Fig. 4A and 4B). Additionally, post-
hypoxic cultures were characterised by retracted dendrites,
indicating a loss of multiple cell-cell contacts. Debris and
apoptotic bodies were found in most culture dish areas,
evidencing late stage of apoptosis (Fig. 4A). In contrast,
normoxic cultures displayed a much more reduced
amount of apoptotic cells (Fig. 4B). Over the whole time,
apoptosis in these control cultures remained stable at
about 7% ± 3% (Fig. 3).
After hypoxia, on Day 0 and Day 1, number of late apop-
totic/necrotic cells significantly increased up to 27% ±
13%. Further progression of propidium iodide (PI) posi-
Phase contrast and fluorescence imaging of fully differentiated SH-SY5Y cells and the development of neuronal markersFigure 1
Phase contrast and fluorescence imaging of fully differentiated SH-SY5Y cells and the development of neuronal 
markers. Phase contrast image of fully matured SH-SY5Y cells at Day 16 (A) after seeding. Phase-bright neuronal cells (arrow 
1) with long dendrites forming a dense neuronal network and cells with large cytoplasm and no axonal extensions (arrow 2). 
Immunocytofluorescence micrograph of fully differentiated SH-SY5Y cells (Day 16) shows cultures stained positive for the neu-
ronal marker β-tubulin III (FITC, green) and nuclei (DAPI, blue) represented in B. Time course of detection of neuronal mark-
ers (β-tubulin III, taurin, NSE, NF-H/M and Map2a/b) on SH-SY5Y cells during the differentiation period at Day 0, 4, 7, 16 and 21 
(C).Page 3 of 15
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Day 3 (Fig. 5). By comparison, in normoxic control cul-
tures, necrosis levels remained stable below 17% and
therefore did not statistically differ from post-hypoxic cul-
tures on this time point. This fact was corroborated by
images that show no observable deviation in the amount
of necrotic and late apoptotic cells, as indicated by PI
staining (red fluorescence, Fig. 4C and 4D).
In general, an increased release of calcein-AM also indi-
cated a strong decrease of neuronal cell viability which
verifies the results of the apoptosis and necrosis rates
(data not shown).
Hypoxia increased quantities of Caspase-3 and cleaved 
PARP immediately and secretion of VEGF in delay
Bar charts in Figure 6 show the concentrations of Caspase-
3 and cleaved poly(ADP-ribose) polymerase (PARP). In
post-hypoxic cultures apoptotic proteins drastically rose
after oxygen deprivation. The highest concentration of
Caspase-3 was measured directly after hypoxia on Days 0
and 1 (2-fold and 5.8-fold, respectively). From Day 2 on,
the level of active Caspase-3 sharply decreased. The distri-
bution of cleaved PARP levels showed patterns similar to
Caspase-3. This decline was accompanied by a secretion
of VEGF on Day 3 after hypoxia (Fig. 7).
Adhesion molecules (L1, NCAM and ICAM-1) were 
upregulated after hypoxia
Independent of cultivation conditions immunofluores-
cence analysis revealed that nearly all (98%) of the cells
were positive for neurite cell adhesion molecule (L1; 98.3
± 0.1%) and Neural Cell Adhesion Molecule (NCAM; 99
± 0.8%) at Day 0. L1 and NCAM were detected on somata
and multiple dendrites. Furthermore, a few of the neuro-
nal cells also expressed Vascular Cell Adhesion Molecule
(VCAM-1; 5.7%) and Intercellular Adhesion Molecule
(ICAM-1; 14.6%) on their somata and dendrites. There
was no change in relative numbers of marked cells and
expression patterns in post-hypoxic cultures. To quantify
the density of adhesion molecule expression, highly sen-
sitive fluorescence measurement of supernatants of lysed
cultures was performed. Here, comparative studies
between cultures directly after 48 hours of hypoxia and
normoxic control cultures showed a significant upregula-
tion of L1, NCAM and ICAM-1 (Fig. 8). Hypoxic condi-
Progression of the number of nuclei after differentiation period and effect of hypoxia on cell countFigu  2
Progression of the number of nuclei after differentiation period and effect of hypoxia on cell count. Nuclei were 
stained with DAPI and counted in fluorescence micrographs. Data were calculated from three independent experiments includ-
ing multiple wells, each based on 25 micrographs. The white circles represent cultures that were cultivated under continuously 
normoxic conditions. The black circles illustrate the progression of the number of nuclei in post-hypoxic cultures. Under both 
conditions number of nuclei remained stable.Page 4 of 15
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protein expressions of up to 189% ± 74% and 155% ±
50%, respectively. Hypoxia also strongly upregulated the
ICAM-1 expression up to 424% ± 251%. The level of
expression of VCAM-1 was not altered by the hypoxic
environment. The continued degradation of the dendritic
networks did not allow assaying the specific expression of
adhesion molecules at late stages of post-hypoxic cultures.
Co-culturing with HUCB MNC strongly reduced apoptosis 
in post-hypoxic neuronal cell cultures
We found noticeable neuroprotective properties of HUCB
MNC in the co-culture experiments. Untreated post-
hypoxic mono-cultures of neuronal cells showed 85% ±
11% of apoptosis after three days, whereas in co-cultures
with MNC the rate of apoptosis was stable at a level of
6.3% ± 1% (p ≤ 0.001). This is comparable to normoxic
control cultures (7% ± 3%; Fig. 9A). Photographs of co-
cultures with MNC revealed clear effort of MNC to localise
next to somata and branches of post-hypoxic neuronal
cells. In the course of clustering MNC mostly avoided
areas that were not settled by neuronal cells (Fig. 9B). Fur-
thermore, the administration of MNC showed positive
influence on the conservation of neuronal networks as
compared to cultures that did not receive any cell therapy
(Fig. 4A and 4C).
MNC increased CCL5, CCL3, CCL4 and CXCL10 in post-
hypoxic neuronal cultures
The investigation of neuroprotective cytokines (G-CSF,
VEGF) (Fig. 7A), inflammatory cytokines (IL-1β, IL-6,
CXCL8) (Fig. 7B) and chemokines (CCL2, CCL5, CCL3,
CCL4, CXCL10) (Fig. 7C) in supernatants of normoxic
neuronal cultures revealed considerable amounts of
CXCL8, CCL2 and VEGF. Remarkably, after three days
under hypoxic conditions only VEGF was strongly upreg-
ulated (about threefold increase). After administration of
MNC, VEGF was downregulated regarding to the total
concentration measured in mono-cultures of MNC and in
post-hypoxic neuronal cells. Inflammatory cytokines as
IL-1β, IL-6 and CXCL8 were produced by MNC. The secre-
tion of cytokines such as IL-1β and IL-6 was not altered in
Temporal progression of annexin-V positive cells in post-hypoxic and normoxic culturesFigure 3
Temporal progression of annexin-V positive cells in post-hypoxic and normoxic cultures. Results are derived from 
three independent experiments. For each experiment 75 pictures were taken. Consistently, annexin-V positive (apoptotic) val-
ues in post-hypoxic cultures are markedly higher compared to control cultures increasing to an average level of 85% ± 11% 
within three days. The number of apoptotic cells did not vary significantly in normoxic cultures.Page 5 of 15
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Interestingly, the majority of chemokines was clearly
upregulated in co-cultures with MNC. We could show that
CCL5, CCL3, CCL4 and CXCL10 were increased up to the
tenfold (CCL3, CCL4), whereas the concentration CCL2
was not regulated.
Discussion
In this study, we introduce an experimental human in
vitro model to investigate (i) the mechanisms of neuronal
hypoxia and (ii) the interaction of neuronal cells with
external stem cell-containing fractions as possible thera-
peutic tools. According to the differentiation protocol of
Encinas et al. [17] we obtained fully matured neuronal
cells after 16 days. Previous, orientating experiments
showed typical response of differentiated SH-SY5Y cells to
N-methyl-D-aspartate (NMDA; 300 μM) application and
most pronounced vulnerability after 48 hours hypoxic
incubation (data not shown). These post-hypoxic neuro-
nal cultures can be employed already 18 days after the
seeding of naive cells. Therefore the time period until the
model of hypoxic neuronal cells is available is very short.
In comparison to other approaches that provide assimila-
ble hypoxic models using teratocarcinoma cell lines [16]
the generation of our model is shortened by at least 10
days [21]. The proved expression of specific neuronal
markers and the absence of any proliferation gave clear
evidence of matured neuronal cells in the G0-phase of the
cell cycle. This steady state allows making direct conclu-
sions about the influence of any external manipulation
because any change will most probably be due to these
procedures. Hence, the model of neuronal hypoxia
Long term effect of 48 hours of hypoxia on apoptosis (A-B) and necrosis (C-D)Figur  4
Long term effect of 48 hours of hypoxia on apoptosis (A-B) and necrosis (C-D). Cultures at Day 3 after hypoxia 
were compared with normoxic cultures of the same age. Combined phase contrast/fluorescence micrographs of neuronal post-
hypoxic cultures (A) and normoxic control cultures (B) show a conspicuous increase of apoptotic cells (annexin-V-staining, 
green fluorescence) and morphologic changes due to hypoxia (cell debris, retraction of dendrites). Propidium iodide (PI, red 
fluorescence) staining shows the influence of hypoxia (C) on the number of necrotic cells and cells in a late state of apoptosis 
compared to control cultures (D). In contrast to the level of apoptosis, there was no clear difference in the number necrotic 
cells following both culture conditions.Page 6 of 15
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concerning mechanisms triggered in response to hypoxia
and therapeutic interventions e.g. application of HUCB
MNC.
Following hypoxia, neuronal cultures displayed a correla-
tion between morphological changes and increase of
annexin-V positive cells as well as changes in adhesion
molecule expression. The specific apoptosis marker
annexin-V indicated that hypoxic cultivation preferen-
tially induced apoptosis. Moreover, there was a continu-
ous enlargement in number of apoptotic cells from initial
26% ± 13% until cultures almost completely consisted of
apoptotic cells (85% ± 11%) within three days. Conform-
ing to changes of morphology in post-hypoxic cultures,
there was an enhanced release of calcein-AM also observ-
able due to the loss of the integrity of membrane. This is
typical for late stages of apoptosis as well as of necrosis.
The model of neuronal hypoxia was approved by moder-
ate rates of PI positive cells (23% ± 16% at Day 3 post-
hypoxia). Therefore the overrun of 100% by the summa-
tion of annexin-V positive and PI positive cells is due to a
proportion of cells in a late state of apoptosis that are pos-
itive for annexin-V and PI [22]. We focused on apoptosis
because it is a reversible process which could be modulate
by external stimulation [23,24]. Moreover after stroke cell
death in the penumbra is predominantly considered to be
apoptosis [25-28]. Therefore apoptosis is a therapeutic
target of anti-apoptotic therapies like stem cells or
cytokines [29-32].
Apoptosis in the penumbra takes place in a time span of
about 72 hours after vessel occlusion in the rat after mid-
dle cerebral artery occlusion (MCAO) [33]. This time
course is represented by the model system introduced in
this study. The fact that there was no major alteration in
the number in DAPI-positive nuclei underlines that the
influence of hypoxia did not lead to an immediate
destruction of the cells but allows investigating apoptosis
and subsequent therapeutic interventions within 72
The progression of PI positive cells in post-hypoxic and normoxic SH-SY5Y culturesFigure 5
The progression of PI positive cells in post-hypoxic and normoxic SH-SY5Y cultures. Results are derived from 
three independent experiments, in which 75 pictures were taken for each analysis. Significant increases in the rate of PI positive 
cells were observed only at Day 0 (10% ± 6%) and Day 1 (27% ± 13%) compared to normoxic cultures (Day 0: 9% ± 10%); Day 
1: 9% ± 6%). Note PI stains necrotic and late apoptotic cells. No significant difference of necrosis rate was detected of post-
hypoxic cultures as well as in control cultures during the observation period.Page 7 of 15
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changes in the morphology of post-hypoxic cells. There
was a total retraction of dendrites and a resulting destruc-
tion of neuronal networks, grained cell surfaces and
extended cell degradation. This damage was accompanied
by an upregulation of neuronal adhesion molecules. We
hypothesize that this upregulation indicates a cellular
answer to compensate for a loss of direct cell-cell interac-
tion as a consequence of the preceding hypoxic stress as
described by several authors [34-36]. However, the final
loss of intercellular networks could not be compensated
by the increased expression of neuronal adhesion mole-
cules alone.
Neuronal cell death after hypoxia is caused by membrane
depolarisation subsequent to energy failure [37,38]. The
resulting calcium overload is the initial point of the acti-
vation of manifold biochemical pathways that affect cas-
pases, free radicals and gene expression [39,40]. The
specific apoptotic proteins Caspase-3 and cleaved PARP
were quantified to prove whether our microscopic obser-
vations are corroborated by biochemical pathways [41-
43]. After 24 hours post-hypoxia, both marker proteins
extensively increased. This was followed by a sharp drop
in their expression level. This reduced amount of cleaved
PARP might be due to an aggravating energy failure in the
cell. This in turn is attributed to the high levels of cleaved
PARP, evidenced above, which caused adenosintriphos-
phate (ATP) depletion [44,45] and which in this context
prevents the enzymatic activity of caspases. Furthermore,
an increase of the expression of VEGF, a key mediator of
angiogenesis [46,47], was observed in higher concentra-
tions in late post-hypoxic cultures. This might be a reflec-
tion of compensatory in vivo processes of revascularisation
in our model [48,49]. VEGF is also known to be involved
in neuronal protection through inhibition of Caspase-3
[50,51]. The time-delayed increased release of VEGF as an
effect of hypoxia does not seem to influence the number
of apoptotic cells in our cultures. This may be a result of
concentrations of VEGF that did not reach efficient thresh-
olds. In this context the measured reduction of caspases
on Days 2 and 3 after hypoxia is caused by the already
described ongoing energy failure in the post-hypoxic cells.
Effect of 48 hours of hypoxia on the concentration of active Caspase-3 and cleaved PARPFigure 6
Effect of 48 hours of hypoxia on the concentration of active Caspase-3 and cleaved PARP. Data are taken in a time 
course of three days after hypoxia and are based on pooled lysates of the totality of SH-SY5Y cells taken out of 12 individual 
wells. Data are expressed in units of protein [active Caspase-3] and cleaved protein [PARP] per millilitres. Hypoxia induced 
apoptosis specific proteins (Caspase-3, cleaved PARP) in a time-related manner.Page 8 of 15
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probably not related to VEGF mediated-effects.
The therapeutic benefit of cell administration after stroke
has been demonstrated in numerous animal studies
[52,53]. However, important questions in basic cellular
and molecular mechanisms of neuronal cell death and its
prevention after inadequate oxygen supply still remain
unanswered. To understand the mechanisms of cellular
neuroprotection after stroke we employed the model of
neuronal hypoxia and applied MNC from HUCB.
In vivo MNC are supposed to differentiate into neuronal
cells [54,55] to trophically support neuronal tissue
through the production of growth factors [56], to support
the new formation of synapses and migration as well as
the differentiation of endogenous neuronal progenitors
[54,55]. In our experiments, the administration of MNC
from HUCB to post-hypoxic neuronal cultures showed
remarkable beneficial effects. Over three days we could
show a clear reduction of neuronal apoptosis, even to the
level of normoxic control cultures (7% ± 3%). There are
two observations that contribute to an explanation of
neuroprotective mechanisms. First, MNC were preferen-
tially located close to hypoxically injured neuronal cells.
This phenomenon was facilitated through an intensive
upregulation of ICAM-1 on neuronal cells which is the
specific ligand for leukocyte cell adhesion molecule [LFA-
Cytokine profile in hypoxic injured SH-SY5Y cells and in direct co-cultures with MNC at Day 3Figure 7
Cytokine profile in hypoxic injured SH-SY5Y cells and in direct co-cultures with MNC at Day 3. Cytokine concen-
trations were measured in supernantes via cytometric bead array. Data originate from five independent experiments and are 
expressed as ng/mg. "+" indicates significant differences in cytokine concentration of post-hypoxic SH-SY5Y mono-cultures 
compared to normoxic controls. Double bars are the sum of cytokine concentration from mono-cultures. "*" shows significant 
differences in cytokine concentration in co-cultures with MNC compared to the total of mono-cultures. Note different scaling.Page 9 of 15
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the formation of cell chimera was not observed, as there
were no CFSE-stained cells with neuronal morphology. In
future experiments we will investigate whether blocking
of adhesion molecules on the surface of neuronal cells can
inhibit the co-localisation of MNC. Further it will be
proved whether this influences the rate of apoptosis. An
increase of apoptosis would be an evidence for the signif-
icance of direct cell-cell-contacts in context of therapeutic
mechanisms of MNC. The second observation would be
concomitance of an MNC indicated specific alteration in
levels of soluble factors. That change might be held
responsible for neuroprotection. Pronounced upregula-
tion of chemokines (CCL5, CCL3, CCL4, CXCL10) might
be causal for the enhanced effort of MNC to localise near
neuronal structures. High concentrations of VEGF are
known to be neuroprotective [58,59]. In contrast to post-
hypoxic mono-cultures, we found no increase of VEGF
after administration of MNC. It seems that presence of
MNC inhibited the induction of elevated levels of VEGF
and compensated its neuroprotective effects by other
mechanisms. Cord blood contains distinct cell types capa-
ble to differentiate into neuronal cells [60]. However, the
differentiation of stem cells (about 1% within the MNC
fraction) was not expected because of the short time of co-
cultivation that clearly undershoots time frames responsi-
ble for neuronal differentiation.
So far, it is unclear whether neuroprotection resulted from
one of the observed effects or from a combination of spa-
tial proximity and specific cytokine patterns. Conse-
quently, further studies in indirect co-cultures will be
necessary.
Conclusion
Pathophysiological models developed from animal stud-
ies form the basis of our understanding of the develop-
ment of stroke. In vivo data display a perfusion-related
dependency of neuronal cell damage. Residual energy
supply in the penumbra induces apoptosis, the early
phases of which are reversible. Consequently, rescue of
the penumbra is a major target of experimental stroke
therapy. Data obtained from complex animal models of
stroke strongly suggest that transplanted cells enhance
neuronal survival.
We established a standardized human in vitro model of
neuronal apoptotic cell death after hypoxia that can facil-
itate to address specific pathophysiological processes
underlying hypoxic damage and cell-mediated neuropro-
tection more precisely.
Expression of adhesion molecules after 48 hours of hypoxic cultivationFigure 8
Expression of adhesion molecules after 48 hours of hypoxic cultivation. Fluorescence intensities of cell lysates are 
shown after subtraction of specific isotype values with respect to normoxia. Data arise from six independent experiments. The 
dotted line indicates level of adhesion molecule expression (100%) in normoxic control cultures. Note statistically significant 
upregulation of L1, NCAM and ICAM-1 post-hypoxia.Page 10 of 15
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decreased the ratio of apoptosis in neuronal cells but also
triggered retaining neuronal characteristics such as form-
ing networks. MNC clustered around post-hypoxic neuro-
nal cells and induced an alteration in cytokine and
chemokine concentrations. Our data suggest that the neu-
roprotective effects of MNC might result from direct cell-
cell contacts and/or the adjustment of specific soluble
mediators.
Methods
Cultivation and differentiation of neuronal cells
All experiments were performed using SH-SY5Y human
neuroblastoma cells (DSMZ, German Collection of
Microorganisms and Cell Cultures, Braunschweig, Ger-
many) between passages 4–7. The common medium was
Dulbecco's Modified Eagle Medium (DMEM, high glu-
cose 4.5 g/l, L-Glutamine 580 mg/l; PAA, Pasching, Aus-
tria) with penicillin G (10,000 U/ml; PAA Laboratories,
Pasching, Austria) and streptomycin (10 mg/ml; PAA Lab-
oratories, Pasching, Austria]. Cells were maintained in
MM in a humidified atmosphere with 5.5% CO2 at 37°C
(Table 1). When cultures achieved subconfluence, cells
were subcultured with trypsin/EDTA (PAA Laboratories,
Pasching, Austria). Differentiation was carried out accord-
ing to the protocol of Encinas and colleagues [17] but was
adapted as follows: cells were plated at an initial density
of 0.9 × 104/cm2 in 16-mm-diameter cavity (Greiner Bio-
One, Frickenhausen, Germany) and differentiated over a
period of 16 days in relevant media and cultured thereaf-
ter according to Table 1. Cultivation procedure is illus-
trated by Fig. 10.
Immunocytofluorescence of neuronal markers
The primary antibodies used against neuronal epitopes
were: β-tubulin III (rabbit 10 μg/ml; BD PharMingen, Hei-
delberg, Germany), taurin I and neurofilament (NF) H/M
(rabbit 5 μg/ml and mouse 1:200; Chemicon, Hampshire,
UK), neuron-specific enolase (NSE) and microtubule-
associated proteins (Map) 2a/b (mouse 1:2 and mouse 5
μg/ml; Sigma-Aldrich, Munich, Germany). Fluoro-
chrome-conjugated secondary antibodies were purchased
from DAKO, Carpinteria, CA, USA (goat anti-mouse-PE
[1:200] and pork anti-rabbit-FITC [1:30]). Indirect immu-
nostaining was processed according to manufacturer's
instructions.
Hypoxia and post-hypoxic cultivation
Before enddifferentiated neuronal cells were exposed to
hypoxia they were refreshed with DM. Hypoxic condi-
Effect of co-culturing of MNC on ratio of neuronal apoptosis and preservation of neuronal networksFigure 9
Effect of co-culturing of MNC on ratio of neuronal apoptosis and preservation of neuronal networks. Apoptosis 
was induced by 48 hours incubation of neuronal cells under hypoxic conditions. Afterwards 4.5 × 105 CFSE stained MNC were 
directly applied to neuronal cells (0.3 × 105/well). For three days co-cultures were observed under normoxia. In co-cultures 
with MNC rate of apoptosis was clearly reduced compared to post-hypoxic cultures (A). Combined phase contrast and fluo-
rescence micrograph of post-hypoxic neuronal cells and MNC (green) in direct co-culture (B).Page 11 of 15
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and lasted 48 hours in a 37°C tempered and humidified
incubator (Binder GmbH, Tuttlingen). After hypoxia, cul-
tures were supplied with PHM (Table 1) and were trans-
ferred back to normoxic conditions for the following three
days (Fig. 10).
Quantification of cell numbers by nuclear staining
The total number of cells was measured by nuclear stain-
ing with 4', 6-diamidino-2-phenylindole (DAPI, Invitro-
gen, Karlsruhe, Germany). Cells were washed and stained
with 1 μg/ml (DAPI/Methanol) for 15 minutes at 37°C.
25 microphotographs of randomised fields were taken per
cavity using a Zeiss fluorescence microscope (Carl Zeiss
AG, Jena, Germany) equipped with Zeiss AxioVision-Soft-
ware. The number of nuclei was automatically determined
by means of Zeiss AutMess (Carl Zeiss AG, Jena, Ger-
many).
Cell viability assay
Apoptosis was determined via annexin-fluorescein isothi-
ocyanate (FITC) or annexin-phycoerythrin (PE; both 1:20
reaction buffer; BD PharMingen, Heidelberg, Germany)
using fluorescence microscopy. Necrosis was identified by
propidium iodide (PI) staining (1 μg/ml phosphate-buff-
ered saline [PBS]; Bender medSystems, Vienna, Austria).
Both methods detect cells in a late state of apoptosis.
Apoptosis and necrosis were ascertained in different cavi-
ties. Calcein-AM (40 μM/PBS; Invitrogen, Karlsruhe, Ger-
many) was utilised for detection of living cells.
Quantification of apoptotic proteins
BD Cytometric Bead Array for human apoptosis (Becton
Dickinson, Erembodegem, Belgium) was used for the
quantitative measurement of apoptotic proteins (cleaved
PARP and Caspase-3). Manufacturer' s instructions were
adapted to lyse cells directly within multi-well plates. For
cell lyses differentiated cells were rinsed with PBS and
incubated on ice in the provided buffer for 20 minutes.
Determination of adhesion molecules by 
immunocytochemistry and cell-based fluorescence 
measurement
The cultures were stained with antibodies against CD56-
phycoerythrin (PE; NCAM), CD171 (L1, both Becton
Dickinson, Erembodegem, Belgium), CD54-PE (ICAM-1;
Immunotech, Hamburg, Germany) and CD106-PE
(VCAM-1; Southern Biotech, Birmingham, Alabama,
USA) in order to investigate the distribution and localisa-
tion of adhesion molecules on differentiated neuronal
cells. The staining protocol proceeded as follows: Medium
(DM, Table 1) was removed and dishes were washed twice
with PBS. The cells were incubated with primary labelled
or unlabelled antibodies (1:100) for 10 minutes at 37°C
and afterwards washed in PBS. Thereafter the cells were
incubated with goat anti-mouse-PE (DAKO, Hamburg,
Schematic illustration of experimental set upFigure 10
Schematic illustration of experimental set up. Sixteen days of differentiation were followed by 48 hours cultivation 
under hypoxic conditions. Following hypoxia cultures were maintained under normoxic conditions for three days and are 
referred as post-hypoxic. Subsequently, cultures were analysed daily.Page 12 of 15
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detection. After labelling the cultures were immersed in
PBS.
The spatial distribution of adhesion molecules was
observed using fluorescence microscopy (Carl Zeiss AG,
Jena, Germany). The density of molecule expression was
measured in cell lysates. Therefore, antibody-labelled cul-
tures were treated with 1% Triton × 100 (Ferak, Berlin,
Germany)/PBS at 37°C. Whole-cell lysates were trans-
ferred to black 96-well-plates (Greiner Bio-One, Fricken-
hausen, Germany). PE-fluorescence signals were
determined with a spectrafluorometer (Tecan Spectrafluor
Plus, Tecan Trading AG, Switzerland) at an excitation
wavelength of 488 nm and an emission wavelength of
590 nm. Specific isotypes and 1% Triton × 100 served as
negative controls.
Preparation of Human Umbilical Cord Blood (HUCB) 
samples
Cord blood samples were obtained anonymously in
accordance to ethical prescripts immediately after deliv-
ery. HUCB samples of healthy full-term neonates were
processed according experienced methods including den-
sity gradient separation using Lymphocyte Separation
Medium (PAA Laboratories, Cölbe, Germany). Gained
MNC fraction was stored by freezing in the gaseous phase
of liquid nitrogen after the addition of FCS/8% dimethyl
sulfoxide (Serumwerke Bernburg Inc., Bernburg, Ger-
many). Prior to use cryopreserved MNC were thawed rap-
idly in 75 U/ml DNaseI/0.5 M MgCl2 (Roche Diagnostics
GmbH, Mannheim, Germany/Sigma, Germany) and
washed in RPMI (PAA Laboratories, Austria). Cell suspen-
sion was stained with carboxy fluoresceindiacetate succin-
imidyl ester (CFSE 5 μM; Molecular Probes, Inc., Eugene,
OR, USA) for 10 minutes at 37°C.
Co-culture of neuronal cells and MNC
Direct co-culturing of fully differentiated neuronal cells
and MNC was carried out under normoxic conditions
(37°C) over a period of 3 days following 48 hours of
hypoxia. A total amount of 4.5 × 105 CFSE stained MNC
were dissolved in 500 μl PHM and were added to the post-
hypoxic neuronal cells (0.3 × 105/cavity). The ratio of neu-
ronal cells to MNC was 1:15.
Cytokine profiling
The supernatants from normoxic cultures on Day 21 as
well as from hypoxic cultures on Day 3 post-hypoxia were
collected in order to characterise soluble factors produced
by cultured cells. They were detected simultaneously by
means of Becton Dickinson Cytometric Bead Array. Super-
natants were tested for neuroprotective (Granulocyte Col-
ony-Stimulating Factor [G-CSF], Vascular Endothelial
Growth Factor [VEGF]) and inflammatory cytokines
(Interleukin [IL]-1β, IL-6, CXCL8) as well as chemokines
(CXCL10, CCL3, CCL4, CCL5, CCL2). The detection limit
was 0.02 ng/ml, except for VEGF and CCL2 (0.04 ng/ml).
Statistical analyses of data
Except for apoptosis and necrosis rates all results have
been reported as mean values ± SD. Statistical differences
were analysed by the Student s t-test or the Mann-Whitney
rank sum-test. P values of ≤ 0.05 were considered statisti-
cally significant (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001).
Apoptosis and necrosis rates were logit-transformed to
obtain normally distributed quantities. The effects of
time, experimental setting (hypoxia), experimental run
and the investigated cavity were determined univariately,
and, finally multivariately using a mixed-model approach
with time and experimental setting as fixed effects and
cavity and experimental run as random effects. Cytokine
concentrations were compared between the normoxic and
the hypoxic group by means of the Mann-Whitney rank
Table 1: Composition of culture media
Supplements in DMEM
Day of culture Culture condition Description of media FCS (15%) RA (10 μM) BDNF (5 ng/ml) HSA (0.1%) Ham's F12
Seeding Normoxia Maintenance medium 
(MM)
x - - - -
1 – 4 Normoxia Basic medium (BM) x x - - -
5 – 16 Normoxia Differentiation medium 
(DM)
- x x x x
16 – 18 Normoxia/hypoxia Differentiation medium 
(DM)
- x x x x
18 – 21 Normoxia Post-hypoxic medium 
(PHM)
- - x x x
The experimental design demanded varying culture media. Supplements in DMEM were purchased from: fetal calf serum (FCS, PAN-Biotech, 
Aidenbach, Germany), all-trans-retinoic acid (RA, Sigma-Aldrich, Steinheim, Germany), recombinant brain-derived neurotrophic factor (rhBDNF; 
ImmunoTools, Friesoythe, Germany), human serum albumin (HSA, PAN Biotech, Aidenbach, Germany).Page 13 of 15
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tures were compared with the sum of the concentrations
obtained in the post-hypoxic neuronal cultures and in the
MNC mono-cultures via a bootstrapping algorithm. This
was performed by resampling and by the addition of con-
centrations of cytokines measured in post-hypoxic neuro-
nal cultures and MNC mono- cultures. Results were
compared with the Mann-Whitney rank sum test. The
mean and standard deviations of the sum of the concen-
trations were also determined by bootstrapping. Boot-
strapping analysis was performed using the statistical
software package "R" [61,62]. Mixed-model analyses were
performed using PROC MIXED from the statistical soft-
ware package SAS 9.1 (SAS Institute Inc., Cary, NC, USA).
Box plots (if applicable) and univariate analyses were
determined using the software package SPSS (SPSS Inc.,
Chicago IL, USA).
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Abstract
Background: The therapeutic capacity of human umbilical cord blood mononuclear cells (HUCB-MNC)
and stem cells derived thereof is documented in animal models of focal cerebral ischemia, while
mechanisms behind the reduction of lesion size and the observed improvement of behavioral skills still
remain poorly understood.
Methods: A human in vitro model of neuronal hypoxia was used to address the impact of total HUCB-
MNC (tMNC), a stem cell enriched fraction (CD133+, 97.38% CD133-positive cells) and a stem cell
depleted fraction (CD133-, 0.06% CD133-positive cells) of HUCB-MNC by either direct or indirect co-
cultivation with post-hypoxic neuronal cells (differentiated SH-SY5Y). Over three days, development of
apoptosis and necrosis of neuronal cells, chemotaxis of MNC and production of chemokines (CCL2,
CCL3, CCL5, CXCL8, CXCL9) and growth factors (G-CSF, GM-CSF, VEGF, bFGF) were analyzed using
fluorescence microscopy, FACS and cytometric bead array.
Results: tMNC, CD133+ and surprisingly CD133- reduced neuronal apoptosis in direct co-cultivations
significantly to levels in the range of normoxic controls (7% ± 3%). Untreated post-hypoxic control
cultures showed apoptosis rates of 85% ± 11%. tMNC actively migrated towards injured neuronal cells.
Both co-cultivation types using tMNC or CD133- reduced apoptosis comparably. CD133- produced high
concentrations of CCL3 and neuroprotective G-CSF within indirect co-cultures. Soluble factors produced
by CD133+ cells were not detectable in direct co-cultures.
Conclusion: Our data show that heterogeneous tMNC and even CD133-depleted fractions have the
capability not only to reduce apoptosis in neuronal cells but also to trigger the retaining of neuronal
phenotypes.
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Transplantation of adult stem cells has been shown to be
an auspicious and effective treatment for degenerative and
traumatic neurological diseases [1]. Among degenerative
neurological disorders acute ischemic stroke is the leading
cause of disability and death in industrial nations [2-4].
Acute stroke leads to an increased release of hematopoi-
etic stem and progenitor cells from bone marrow into
peripheral blood [5]. It is assumed that these cells take
part in self-healing processes occurring after neuronal
injury. They are supposed to promote the survival of the
injured brain tissue by producing neurotrophic factors
[6], to enhance endogenous angiogenesis [7] and neuro-
genesis [8] or even to transdifferentiate into neuronal cells
[9]. However, the stroke induced endogenous release of
hematopoietic stem and progenitor cells seems not to be
sufficient to compensate massive loss of brain tissue after
extended ischemic stroke. Therefore, external application
of hematopoietic stem and progenitor cells is expected to
complement current treatment of acute stroke based on
thrombolytic therapy. An appropriate source of hemat-
opoietic stem cells is the mononuclear cell (MNC) frac-
tion of human umbilical cord blood (HUCB) [10-12].
Transplantation of HUCB-MNC as well as enriched HUCB
hematopoietic stem cells into animals which were sub-
jected to focal stroke caused by middle cerebral artery
occlusion (MCAO) ameliorated the animals' functional
outcome and reduced the lesion size [13]. However, there
are still manifold unanswered questions addressing the
beneficial influence of such grafts on injured neuronal
cells.
It has been documented that there is no neuronal transdif-
ferentiation of hematopoietic stem cells in vitro [14-16].
Though so far there is no convincing proof that locally
administered hematopoietic stem cells transdifferentiate
into functionally neuronal cells forming the basis of the
animals' behavioral progression [17].
It has recently been shown that there is no need for MNC
to enter the brain for neuroprotection. Soluble factors like
GDNF, NGF, BDNF or G-CSF are known to promote neu-
roprotection over long-distances [18,19]. This raises many
questions about the cellular mechanisms causing the
functional improvement after grafting [20]. Prevention of
neurons from apoptotic cell death [21] is considered to be
supported by the transplantation and could be directly
connected to improved tissue conservation, lesion size
reduction and superior functional outcome [22].
Cell culture models of neuronal hypoxia complement the
exploration of particular interactions between grafts and
neuronal tissue. Our study is based on a well established
post-hypoxic neuronal cell culture model (SH-SY5Y). This
model was used to address (i) the neuroprotective poten-
tial of stem cell enriched and -depleted HUCB derived cell
fractions, (ii) the impact of these cells especially on apop-
totic status of oxygen-deprived neurons, and (iii) the
mediation of cell-derived survival signals (soluble or cell-
attached).
Results
Direct co-cultivation with each fraction of HUCB-MNC 
reduced apoptosis in post-hypoxic neuronal cells
Hypoxic cultivation (48 hours) of fully matured neuronal
SH-SY5Y cells resulted in an initial rate of apoptosis of
26% ± 13%. Within the following three days rate of apop-
tosis increased to 85% ± 11%. By contrast, normoxic con-
trol cultures showed a stable amount of apoptotic cells
(7% ± 3%) over the whole observation time (data not
shown). Direct co-cultivation with tMNC and CD133-
showed pronounced reduction of neuronal apoptosis.
Similar results were obtained after application of CD133+.
By application of 4.5 × 103 CD133+ they were given in
equal amounts as they exist in tMNC. Though the whole
cell amount of CD133+ was 100 times less then tMNC
administered (Fig. 1A).
Levels of necrosis in post-hypoxic control cultures
remained nearly stable (approximately 25%) over three
days. tMNC and CD133- cell application also induced a
significant reduction of necrosis. CD133+ cells did not
influence the level of necrosis (Fig. 1B).
In indirect co-cultures tMNC and CD133- were also 
sufficient to decrease apoptosis of post-hypoxic neuronal 
cells
Over the entire observation period, direct as well as indi-
rect co-cultivation with tMNC or CD133- exhibited a sig-
nificant reduction of apoptosis. In all co-culture set-ups
percentage of annexin-V positive cells was significantly
lower (p ≤ 0.001) than in post-hypoxic control cultures
(Fig. 2A, B). Direct and indirect co-cultivation of CD133-
resulted in similar rates of apoptosis continuously below
5% of annexin-V positive cells (Fig. 2B). However, still
generating strong neuroprotective effects, the number of
apoptotic neuronal cells in indirect tMNC co-cultures was
significantly higher than in direct co-cultures at Day 2 and
Day 3 (p ≤ 0.001) as shown in figure 2A. Direct co-culti-
vation with tMNC resulted in a stable level of 6% ± 1%
neuronal apoptosis and was therefore significantly lower
than in post-hypoxic control cultures (Day 2: 46% ± 20%;
Day 3: 85% ± 11%).
When tMNC were indirectly co-cultured neuroprotection
was as pronounced as in direct co-cultures on the first day
after hypoxia. Two and three days after application there
was still a significant, but compared to control cultures
reduced, protective effect in the indirect co-cultures whilePage 2 of 12
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(7% ± 8%).
The comparison of both application types using tMNC
and CD133- showed that soluble factors seem to have
strong therapeutic potential (Fig. 2A).
The positive influence of indirect co-cultivation on the
amount of apoptotic cells, revealed by annexin-V detec-
tion, was also confirmed by typical patterns in the cleav-
age of PARP, a late marker of apoptosis (Fig. 3). In indirect
co-cultures with tMNC and CD133- quantities of cleaved
PARP were nearly at the same level on Day 1 post-
hypoxia. On Day 2 and Day 3 neuroprotection by CD133-
resulted in concentrations of cleaved PARP ranging in the
level of the normoxic control (Fig. 3).
Only direct co-cultures of tMNC and CD133- displayed
improved protection from necrosis/late apoptosis as
revealed by Propidium Iodide labeling of post-hypoxic
neuronal cells (Fig. 2C, D). Indirect co-cultivation did not
reduce the percentage of necrotic/late apoptotic neuronal
cells.
tMNC localized in close proximity to post-hypoxic 
neuronal cells
In direct co-cultures many tMNC were found in close spa-
tial relation with post-hypoxic neuronal cells already at
Day 1 (Fig. 4B). This became even more evident at later
time points (Fig. 4D, F). At Day 3, the vast majority of
tMNC was found adjacent to neuronal somata and proc-
esses (Fig. 4F). Interestingly, co-cultivation with tMNC
seemed to have strong positive effects on the preservation
of typical neuronal cell morphology as the formation of
branched processes.
In contrast, in normoxic control cultures tMNC were
evenly spread throughout the culture dish (Fig. 4A, C, E).
Time course of apoptosis and necrosis of post-hypoxic neuronal cells in direct co-cultures with tMNC, CD133+ and CD133-F gure 1
Time course of apoptosis and necrosis of post-hypoxic neuronal cells in direct co-cultures with tMNC, CD133+ 
and CD133-. Box plots showing time course of apoptosis (A) and necrosis/late apoptosis (B) in direct co-cultures of post-
hypoxic neuronal cells with tMNC, CD133- or CD133+ (colored plots). Grey boxes display the development of cell death in 
post-hypoxic neuronal cells directly after hypoxic pre-cultivation of SH-SY5Y cells (Day 0) and 1–3 days post-hypoxia. The 
ordinate represents the percentage of apoptotic and necrotic cells, respectively. Rates of apoptosis and necrosis were calcu-
lated in relation to the total number of SH-SY5Y cells.
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Effects of direct and indirect application of tMNC and CD133- on apoptosis and necrosis of post-hypoxic neuronal cellsFigure 2
Effects of direct and indirect application of tMNC and CD133- on apoptosis and necrosis of post-hypoxic neuro-
nal cells. Box plots represent the percentage of annexin-V positive post-hypoxic neuronal cells (A, B) and of PI positive post-
hypoxic neuronal cells (C, D) in direct and indirect co-cultures. Co-cultures were performed with tMNC (A, C) and CD133- 
(B, D). The extents of apoptosis (annexin-V-binding) and necrosis (PI) were analyzed for three days after hypoxia.
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cultivation with tMNC or CD133- were similar; cytokines 
produced by CD133+ were not detectable
In supernatants of direct co-cultures and corresponding
mono-cultures we assessed concentrations of CCL2,
CCL5, CXCL8, VEGF and bFGF (Fig. 5).
Post-hypoxic neuronal cells secreted the chemokines
CXCL8 and CCL2 and the growth factor VEGF. Low
amounts of CCL5 and bFGF were detectable, as well.
Mono-cultures of tMNC and CD133- displayed similar
growth factor and chemokine secretion patterns: CXCL8
and CCL2 were produced in considerable amounts while
CCL5 and bFGF were secreted at low levels. VEGF was not
present. None of the investigated soluble factors was
detected in supernatants of purified CD133+ mono-cul-
tures.
In direct co-cultures with tMNC or CD133- secretion of
cytokines was regulated very similar: reduction of CXCL8
(p ≤ 0.001) and VEGF (p ≤ 0.001) and increase of CCL5
(Fig. 5). CD133+ co-cultivation only influenced VEGF lev-
els, which decreased significantly (Fig. 5).
Up-regulation of soluble factors in indirect CD133- co-
cultures was associated with long term neuroprotection
In a second set of experiments we investigated different
effects of direct and indirect co-culturing on cytokine
secretion. Therefore, concentrations of CXCL9, CCL3,
VEGF, G-CSF and GM-CSF were measured in normoxic
and post-hypoxic mono-cultures, and co-cultures with
tMNC and CD133-.
Except VEGF neuronal cells did not secret detectable
amounts of either CXCL9, CCL3, G-CSF nor GM-CSF in
mono-cultures. Both, tMNC and CD133- cells expressed
CCL3 and G-CSF but only CD133- produced GM-CSF
(Fig. 6).
In co-cultures with tMNC direct co-cultivation generated
more pronounced effects than indirect co-cultivation, as
seen for the relative up-regulation of CXCL9, GM-CSF
(both, p ≤ 0.05) and CCL3 and the relative down-regula-
tion of VEGF.
Only direct CD133- co-cultivation had an impact on regu-
lation of CCL3, VEGF and GM-CSF. Secretion of all three
cytokines was markedly decreased compared to controls
whereas indirect co-cultivation with CD133- had no effect.
In contrast, the secretion of CXCL9 and G-CSF (p ≤ 0.01)
was markedly induced by indirect co-cultivation with
CD133-. For these cytokines direct co-cultivation showed
no effect (G-CSF) or resulted in a remarkably reduced pro-
duction (CXCL9) as compared to indirect co-cultivation
with CD133- (Fig. 6).
The experiment also revealed the influence of different
HUCB-MNC-derived cell preparations on the cytokine
secretion.
Most prominent, direct co-cultivation with tMNC signifi-
cantly increased expression of CCL3 (p ≤ 0.05) whereas
direct co-cultivation with CD133- resulted in a relative
reduction of this chemokine (p ≤ 0.01).
Discussion
It has been previously shown that HUCB derived MNC as
well as nearly pure stem cell populations obtained from
MNC are able to improve the clinical outcome of animals
after MCAO [23]. In an in vitro model of neuronal hypoxia
we discern cell populations within MNC being able to
improve neuronal survival and disclose potential neuro-
protective mechanisms.
First we studied the effects of tMNC application on the
apoptotic status of post-hypoxic neurons. We found that
direct application of tMNC results in preservation of neu-
ronal morphology based on a constant protection from
apoptosis (Fig. 2A).
For in vivo experiments it has been described that none or
only a minority of systemically administrated cells were
detected in the brain while large quantities were found in
the spleen, in the lungs and in the blood of the animals.
Direct comparison of effects of tMNC and CD133- on late apoptosis (PARP cleavag )Figure 3
Direct comparison of effects of tMNC and CD133- on 
late apoptosis (PARP cleavage). Bar chart showing con-
centrations of cleaved PARP in lysates of post-hypoxic neu-
ronal cells which were indirectly co-cultivated with tMNC 
(grey shaded bars) or CD133- (black bars). Controls are 
post-hypoxic mono-cultures (grey bars) and normoxic cul-
tures (white bars). Each bar visualizes pooled samples 
obtained from three independent experiments.
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BMC Neuroscience 2008, 9:91 http://www.biomedcentral.com/1471-2202/9/91Nevertheless, some studies showed that cell-treatment
improved behavioral deficits [18,23,24]. This indicates
the importance of soluble factors for neuroprotection.
Our data obtained from indirect co-cultures strongly sup-
port this hypothesis. tMNC application was highly protec-
tive, although the anti-apoptotic effect was slightly
weakened after two days (Fig. 2A). Probably, soluble fac-
tors act as "first aid" messengers while longer protection
seems to demand close proximity between tMNC and
neuronal cells. The comparison of direct application of
tMNC to normoxic and post-hypoxic neuronal cells
revealed that only post-hypoxic neuronal cells attracted
tMNC (Fig. 4). The clustering of tMNC around neuronal
cells could explain the enhanced protection from apopto-
sis in direct co-cultures with tMNC at Day 2 and Day 3
(Fig. 4, Fig. 2A). Spatial contiguity is possibly associated
with higher concentrations of neuroprotective mediators
in the micro-environment of injured neuronal cells. Post-
Distribution of tMNC in direct co-culturesFigure 4
Distribution of tMNC in direct co-cultures. Phase contrast fluorescence micrographs of co-cultures of neuronal cells 
(unstained) and tMNC (green). Representative images show post-hypoxic neuronal cultures (B, D, F) in contrast to normoxic 
control cultures (A, C, E) over a time course of three days. Images illustrate the distribution of tMNC in relation to neuronal 
cells. White arrows point at spatial accumulation of tMNC which are clustered around neuronal somata and processes in post-
hypoxic cultures (B, D, F). In normoxic cultures no clustering of tMNC was observed (A, C, E). The black arrow points at a 
conserved neuronal morphology including branched processes. Scale bars indicate 100 μm.
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Cytokine profile in direct co-cultures with tMNC, CD133+and CD133- on Day 3Figure 5
Cytokine profile in direct co-cultures with tMNC, CD133+and CD133- on Day 3. Control: sum of cytokine concen-
tration from single cultured (grey) post-hypoxic SH-SY5Y cells and HUCB-MNC (light green = tMNC, light red = CD133-, not 
detectable = CD133+). Co-culture: direct co-culture of post-hypoxic SH-SY5Y cells and HUCB-MNC (dark green = tMNC, 
dark red = CD133-, dark yellow = CD133+). Data are derived from four independent experiments and are expressed as pg/ml. 
* significant differences in cytokine concentrations of co-cultures compared to control cultures. Note different axis scaling.
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Effect of co-cultivation system (direct v. indirect) on cytokine secretion during co-cultivation of post-hypoxic neuronal cells with tMNC and CD133-Figure 6
Effect of co-cultivation system (direct v. indirect) on cytokine secretion during co-cultivation of post-hypoxic 
neuronal cells with tMNC and CD133-. Control: sum of cytokine concentration from single cultured (grey) post-hypoxic 
SH-SY5Y cells and HUCB-MNC (light green = tMNC, light red = CD133-). Co-cultures: co-culture of post-hypoxic SH-SY5Y 
cells and tMNC (direct: dark green, filled; indirect: dark green, striped), co-culture of post-hypoxic SH-SY5Y cells and CD133- 
(direct: dark red, filled; indirect: dark red, striped). Effects are displayed in percent as relative changes to control. Mono-cul-
tures: absolute cytokine concentrations in supernatants of SH-SY5Y normoxic and post-hypoxic mono-cultures (white or grey 
bars, respectively) and tMNC (light green bars) or CD133- (light red bars). * significant changes to control. + significant differ-
ences between co-cultivation systems.
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BMC Neuroscience 2008, 9:91 http://www.biomedcentral.com/1471-2202/9/91hypoxic neuronal cells were shown to significantly up-reg-
ulate the adhesion molecule ICAM-1 following hypoxia
[25]. Hence, ICAM-1 (CD54) expression could underlay
the observed co-localization via binding of LFA-1 (CD11)
[26]. Besides adhesion molecules, chemotaxis could
mediate this cellular co-localization. VEGF, known to
exert chemotactic effects on monocytes [27], was pro-
duced by post-hypoxic SH-SY5Y cells (Fig. 6).
To focus the neuroprotective effects of stem cells we
enriched or depleted CD133+ cells from HUCB-MNC.
Purities of 97.38% for the stem cell preparation and a
reduction of CD133+ up to 0.06% for the stem cell
depleted fraction were achieved. In direct co-cultures
CD133+ were applied to neuronal cells in quantities of 4.5
× 103 resembling 1% of the applied tMNC, since CD133+
account for about 1% of total cell number in tMNC prep-
arations. Neuroprotective capacity of nearly pure CD133+
cells was comparable to tMNC (Fig. 1A). According to our
analyses of cytokine production CD133+ cells did not
secrete measureable cytokines neither in mono-cultures
nor in co-cultures with injured neuronal cells (Fig. 5).
Additional experiments using even tenfold elevated num-
bers of stem cells (4.5 × 104) also revealed no detectable
cytokine concentrations and did not result in an increased
neuroprotective capacity (data not shown). Neuroprotec-
tion by the absence of measurable soluble mediators
argues for a stem cell specific therapeutic mechanism
through contiguity. Due to this assumption we did not
include CD133+ in the investigation of indirect co-cul-
tures in this study.
Surprisingly, CD133- cell fractions were also highly suffi-
cient in protection from apoptosis. Therefore, the
observed anti-apoptotic neuroprotective effects of tMNC
in our experiments do not only relay on hematopoietic
stem cell-specific mechanisms. This assumption is sup-
ported by the missing significance in the effect of CD133+
on necrotic/late apoptotic loss of post-hypoxic neuronal
cells (Fig. 1B). tMNC and CD133- significantly reduced
the percentage of PI-positive neuronal cells, whereas
CD133+ did not. Since CD133- in indirect co-cultures were
superior to tMNC in protection from apoptosis and
because of very low amounts of CD133+ in this prepara-
tion, CD133- seem to mediate additional neuroprotective
effects. Possibly, the separation process influenced the
functionality of CD133- cells. FACS analyses of the activa-
tion markers CD25, CD38, CD71 and HLA-DR on tMNC
and on the separated CD133- fraction did not reveal an
increased population of activated cells in our preparations
(data not shown). However, the expression of other acti-
vation molecules cannot be excluded, since this cell pop-
ulation displayed an enhanced secretion of cytokines like
G-CSF, GM-CSF and CCL-3 (Fig. 6). We also cannot rule
out that remaining CD34+ cells could account for the neu-
roprotective activity of the CD133- fraction, since deple-
tion did only reduce the number of CD34+ cells to 77%
(Tab. 1).
The investigation of soluble mediators exhibited that
hypoxia induced a significant increase of VEGF in neuro-
nal cells (Fig. 6, [28]). VEGF is documented to inhibit pro-
apoptotic signaling by Bad (BCL2 antagonist of cell
death), and cleavage of caspase-3, and caspase-9 [29] and
therefore can be claimed as an autocrine self-protection
mechanism of damaged neuronal cells. The neuroprotec-
tive impact of tMNC and CD133-cells in direct applica-
tions was accompanied by prevention of VEGF
production which is typically induced in post-hypoxic
neuronal cells (Fig. 5).
Neuroprotective effects of cell application could be medi-
ated by G-CSF that was found only in mono-cultures of
CD133- but not in mono-cultures of post-hypoxic SH-
SY5Y cells. Schneider et al., 2005 [30] pointed out that
human SH-SY5Y neuroblastoma cells express the G-CSF
receptor and that activation by the neurotrophic G-CSF
reduced NO-induced poly-ADP ribose polymerase
Table 1: Cellular subfractions of MNC
Cellular fractions of Markers Content in tMNC (%) Content in CD133- (%)
I) Myeloid cells CD14+/CD45+ 14.1 ± 4.4 19.5 ± 2.4
II) Lymphocytes (including stem cells) 85.9 ± 4.4 80.5 ± 2.4
Subpopulations of II
B-lymphocytes CD19+/CD45+ 12.3 ± 5.5 14.6 ± 0.5
T-lymphocytes CD3+/CD45+ 73.0 ± 10.2 76.8 ± 1.9
NK-cells CD56+/CD45+ 12.7 ± 4.5 8.3 ± 1.4
Hematopoietic stem/progenitor cells CD133+/CD34+ 1.2 ± 1.0 0.03 ± 0.01
CD133+/CD34- 0.4 ± 0.2 0.03 ± 0.02
CD133-/CD34+ 0.4 ± 0.2 0.34 ± 0.06
Cellular fractions of HUCB-MNC after thawing of cryopreservated cells.
Subpopulations of lymphocytes and stem/progenitor cells are expressed as percent of total lymphocytes.Page 9 of 12
(page number not for citation purposes)
BMC Neuroscience 2008, 9:91 http://www.biomedcentral.com/1471-2202/9/91(PARP) and caspase-3 cleavage. Our data support these
observations. At Day 3 in indirect co-cultures supply of G-
CSF by CD133- was associated with cleaved PARP levels in
the range of normoxic cultures (Fig. 3, Fig. 6). G-CSF lev-
els in mono-cultures of tMNC were only slightly above
detection limit and could not provide this anti-apoptotic
effect (Fig. 6).
The decrease of cleaved PARP observed in post-hypoxic
neuronal mono-cultures at Day 3 (Fig. 3) was probably
induced by rising lack of energy due to increased rate of
apoptosis (Fig. 1).
Noticeably, there are application-specific differences in
the regulation of cytokine secretion in co-cultures with
CD133- fractions. Concentrations of CCL3 and G-CSF
were significantly higher in indirect co-cultures than in
direct co-cultures. Possibly these enhanced concentrations
are responsible for a protection from apoptosis in indirect
co-cultures similar to that in direct co-cultures at Day 3.
Indirect co-cultivation with tMNC did not induce
enhanced cytokine levels (Fig. 6) and at the same time did
not exert the same neuroprotective effect on post-hypoxic
SH-SY5Y neurons. This could be explained by spatial
effects: paracrine released cytokines could be more effec-
tive than action of cytokines over a longer distance.
Conclusion
In this study we investigated human umbilical cord blood
derived cell populations (tMNC, CD133+, and CD133-)
according to their ability to protect post-hypoxic neuronal
cells.
For different reasons, as the missing systemic effects and
the disregard of brain cell interactions this in vitro system
does only simplified reflect the action of MNC after
hypoxic brain lesions in vivo. But taken this into account,
our study delivers useful indications for the in vivo appli-
cation of such cells:
So, since purified CD133+ fractions are not superior to
total HUCB-MNC in mediating neuroprotective anti-
apoptotic effects, expensive and time consuming stem cell
separations are not necessarily needed to yield neuropro-
tective cell populations. Furthermore, our study under-
lines the importance of MNC derived soluble factors for
the mediation of neuroprotective effects visible as preven-
tion of neuronal cells from apoptosis. Therefore, future
therapeutic approaches should focus on the sufficient
supply of soluble anti-apoptotic mediators, to reduce
post-hypoxic brain damage.
Methods
Preparation of HUCB samples and isolation of CD133+ 
cells
HUCB samples of healthy full-term neonates were
obtained in accordance with ethical prescripts immedi-
ately after delivery. Samples were processed and analyzed
as described previously [25]. The total MNC (tMNC) frac-
tion gained from Ficoll density gradient (Tab. 1) was
stored in the gaseous phase of liquid nitrogen. Cellular
sub-fractions of tMNC were characterized using CD3-Phy-
coerythrin (PE, Immunotech, Hamburg, Germany),
CD14-Fluorescein isothiocyanate (FITC), CD16+56-PE
(both, Becton-Dickinson, Franklin Lakes, NJ, USA),
CD19-Allophycocyanin (APC) and CD45-FITC, (both,
Beckman Coulter, Krefeld, Germany). Prior to use tMNC
were thawed and stained with carboxy fluoresceindiace-
tate succinimidyl ester (CFSE, Invitrogen, Karlsruhe, Ger-
many).
CD133 positive cells (CD133+) were isolated from
HUCB-MNC using the MACS® immunomagnetic positive
selection protocol (Miltenyi Biotech, Bergisch Gladbach,
Germany). The flow-through fraction was collected as
negative fraction (CD133-) depleted of CD133+. Final
populations were analyzed using a FACSCalibur flow
cytometer equipped with the CellQuest™ software (both
Becton-Dickinson, Franklin Lakes, NJ, USA) and charac-
terized by the use of the following antibodies: CD133/2-
PE, Miltenyi Biotech Bergisch Gladbach, Germany),
CD45-FITC and CD34-APC (both Beckman Coulter,
Krefeld, Germany). Isotype-identical monoclonal anti-
bodies served as controls. CD133+ and CD133- fractions
contained 97.38% and 0.06% CD133 positive cells,
respectively.
Status of activation of tMNC and CD133- was analyzed via
FACS using the antibodies CD25-PE, HLA-DR (Major His-
tocompatibility Complex, class II, cell surface receptor)-
APC (both Becton-Dickinson, Franklin Lakes, NJ, USA),
CD38-PE and CD71-FITC (both Beckman Coulter,
Krefeld, Germany).
Differentiation and hypoxic induction of SH-SY5Y cells
For differentiation 0.9 × 104/cm2 SH-SY5Y cells were
seeded in 16-mm-diameter wells (Greiner Bio-One, Frick-
enhausen, Germany). After 5 days Dulbecco's Modified
Eagle Medium (DMEM)/10 μM all-trans retinoic acid
(Sigma-Aldrich, Steinheim, Germany)/15% fetal calf
serum (PAN-Biotech, Aidenbach, Germany) media was
changed into DMEM-Ham's F12/10 μM RA/5 ng/ml Brain
Derived Neuronal Factor [BDNF, Immunotools Biolance
GmbH, Hanover, Germany]/0.1% Human Serum Albu-
mine [HSA, PAN Biotech GmbH, Aidenbach, Germany]
for another 11 days. Media were exchanged every third
day. Afterwards fully matured neuronal cells were cul-Page 10 of 12
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[25]. Number of viable cells remained stable between Day
16 and Day 21.
Direct and indirect co-cultivation of post-hypoxic 
neuronal cells with tMNC, CD133+ and CD133- cell 
fractions
Subsequent to hypoxia, direct and indirect co-cultivation
with tMNC, CD133+ or CD133- was carried out under nor-
moxic conditions over a period of three days. Added
tMNC, CD133- (4.5 × 105 cells, both) and CD133+ (4.5 ×
103 cells) were dissolved in 500 μl co-culture medium
(DMEM-Ham's F12, 5 ng/ml BDNF and 0.1% HSA) and
added to differentiated post-hypoxic neuronal SH-SY5Y
cells cultivated in adequate volume of post-hypoxic
medium. Cell ratio of post-hypoxic neuronal cells to
MNC was 1:15 and to CD133+ 1:0.15. For indirect co-cul-
tivation tMNC or CD133- were added in cell impassable
cell culture inserts with a pore size of 0.4 μm (Greiner Bio-
One GmbH, Frickenhausen, Germany).
Prior to co-cultivation with post-hypoxic neuronal cells,
tMNC as well as CD133+ and CD133- were labeled with
CFSE.
Cell viability assay of neuronal cells
Within direct and indirect co-cultures and control cultures
the influence of tMNC, CD133+ and CD133- on neuronal
viability was detected via i) Propidium Iodide (PI, Invitro-
gen, Karlsruhe, Germany) assay for necrosis and late
apoptosis and ii) annexin-V assay (Becton-Dickinson,
Heidelberg, Germany) for apoptosis. The PI- and annexin-
V assays were performed in cell culture plates as described
previously [25]. tMNC, CD133+ and CD133- were distin-
guished from annexin-V-PE or PI positive neuronal cells
by the green CFSE staining.
Cytometric Bead Array for human apoptosis (CBA, Becton
Dickinson, Erembodegem, Belgium) was used to quantify
the apoptosis specific parameter cleaved Poly-ADP-
Ribose-Polymerase I (PARP) in lysates of post-hypoxic
neuronal cells after indirect co-cultivation with tMNC and
CD133-. For cell lyses adherent neuronal cells were rinsed
with PBS and incubated on ice in the supplied buffer for
20 minutes. For analyses pooled samples obtained from
three independent experiments were used.
Cytokine profiling
For cytokine profiling supernatants of direct and indirect
co-cultures were analyzed on Day 3. Supernatants of
tMNC, CD133+ and CD133- mono-cultures and those of
post-hypoxic neuronal cells were also investigated on Day
3. Cytokines were simultaneously measured using CBA
for human soluble proteins (Becton Dickinson, Erembo-
degem, Belgium). Supernatants were screened for the fol-
lowing cytokines: CCL2, CCL3, CCL5, CXCL8, CXCL9
and for the growth factors basic Fibroblast Growth Factor
(bFGF), Granulocyte Colony-Stimulating Factor (G-CSF),
Granulocyte-Macrophage Colony-Stimulating Factor
(GM-CSF) and Vascular Endothelial Growth Factor
(VEGF). The detection limit was 20 pg/ml, except for
CCL2 and VEGF (40 pg/ml).
Statistical analyses of data
Except for apoptosis and necrosis rates all results have
been reported as mean ± SD. Statistical differences were
analyzed by Student's t-test or Mann-Whitney rank sum-
test. P values of ≤ 0.05 were considered statistically signif-
icant (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). Apoptosis
and necrosis rates were logit-transformed to obtain nor-
mally distributed quantities. The effects of time, experi-
mental setting (post-hypoxia), experimental run and the
investigated well were determined univariately, and,
finally multivariately using a mixed-model approach with
time and experimental setting as fixed effects and well and
experimental run as random effects.
Cytokine concentrations of indirect and direct co-cultures
with tMNC, CD133- and CD133+ were compared with the
sum of the concentrations obtained after post-hypoxia of
neuronal cells and corresponding tMNC, CD133+ and
CD133- mono-cultures using a bootstrapping algorithm.
Therefore, we added concentrations which were resam-
pled from e.g. the experiment post-hypoxia and the tMNC
mono-culture and compared the results with concentra-
tions obtained from e.g. the experiment of indirect co-cul-
ture with tMNC. Results were compared with Student's t-
test or Mann-Whitney rank sum test. P-values reported are
based on 10,000 bootstrapping simulations.
Box plots (if applicable) and univariate analyses were
determined using the software package SPSS (SPSS Inc.,
Chicago IL, USA). Mixed Model analyses were performed
using PROC MIXED of the statistical software package SAS
9.1 (SAS Institute Inc., Cary, NC, USA). Bootstrapping
analysis was performed using the statistical software pack-
age "R" [31].
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